syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187000000002	100.0
OCULOFACIOCARDIODENTAL SYNDROME	2.003831844	75.17605650262367
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	2.00342466	75.16078052650688
CHILDHOOD ABSENCE EPILEPSY	1.52074085	57.05234219516073
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	1.29241286	48.48635501975656
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
BEHR SYNDROME	1.2023546200000002	45.10771655813182
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.782803437094614
260150 PALANT CLEFT PALATE SYNDROME	1.166667	43.768854444727765
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.1528726900000001	43.25134503839722
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	1.091996073	40.96748872930435
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.0355697729999997	38.85059118137118
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	1.021378854	38.31820253221258
JERVELL AND LANGE-NIELSEN SYNDROME	1.021374719	38.31804740293136
MOWAT-WILSON SYNDROME; MOWS	1.003080379	37.631714195064546
DUPLICATION OF THE PITUITARY GLAND	1.0028194339999998	37.621924543241796
CHOREA, REMITTING, WITH NYSTAGMUS AND CATARACT	1.00178253	37.583023896999855
GOLDENHAR SYNDROME	1.00151745	37.573079115895894
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	1.001301984	37.56499566106964
COLOBOMA OF MACULA AND SKELETAL ANOMALIES	1.00120482	37.56135044184833
INHERITED CREUTZFELDT-JAKOB DISEASE	1.000541419	37.53646219026713
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	1.000541419	37.53646219026713
IDIOPATHIC UVEAL EFFUSION SYNDROME	1.0	37.516150233723735
ANAPLASTIC THYROID CARCINOMA	1.0	37.516150233723735
OCULAR MOTOR APRAXIA	1.0	37.516150233723735
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.516150233723735
NYSTAGMUS 3, CONGENITAL, AUTOSOMAL DOMINANT; NYS3	1.0	37.516150233723735
DEHYDRATED HEREDITARY STOMATOCYTOSIS	1.0	37.516150233723735
MYOCLONIC EPILEPSY OF LAFORA	0.93444076	35.056619936674984
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.833878554	31.283913108544308
OROFACIODIGITAL SYNDROME TYPE 3	0.833333	31.263446022719705
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.8272315589999999	31.034543445521496
%187370 ARTHROGRYPOSIS, DISTAL, TYPE 10; DA10;;CONGENITAL PLANTAR CONTRACTURES;;TENDO CALCANEUS, SHORT	0.79684233	29.89445656487047
LAFORA DISEASE	0.7715289599999999	28.94479637302863
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.91058689627651
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.083800875229276
BENIGN SCHWANNOMA	0.7357142999999999	27.60116820789889
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.7263814	27.251033729382574
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.722566614	27.10791764469707
PHEOCHROMOCYTOMA	0.7094339599999999	26.61523102426555
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.588780412607864
PHEOCHROMOCYTOMA--ISLET CELL TUMOR SYNDROME	0.7	26.261305163606615
15Q OVERGROWTH SYNDROME	0.6672074189999999	25.03105376825906
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.635819274	23.853491404881158
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.634205864	23.79296247293256
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.237375787309237
ROLANDIC EPILEPSY	0.5906213	22.15783742203722
MUCOPOLYSACCHARIDOSIS TYPE 2	0.5893486929999999	22.110094106636726
ARTHROGRYPOSIS, DISTAL, TYPE 2E	0.56408717	21.16237901463606
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5555556	20.84230735278653
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5497264000000001	20.62361820984411
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.532803654	19.98874192854096
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.77202410922872
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.5232558	19.6305432034673
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.5231222799999999	19.62553404708809
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.390112100883027
WIEACKER-WOLFF SYNDROME	0.516180503	19.365105298267085
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.51341463	19.261340391271688
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.508698	19.084390591594797
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.50704225	19.02227322584531
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.50704225	19.02227322584531
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.02227322584531
INHALATIONAL ANTHRAX	0.5035461	18.891111137205677
PAROXYSMAL HEMICRANIA	0.50342466	18.88655517592129
NON-DISTAL MONOSOMY 20Q	0.502815299	18.86369429709872
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.502604423	18.855783041402034
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.500545554	18.778542202686477
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.500541419	18.778387073405263
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.500541419	18.778387073405263
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.758075116861868
118230 CHARCOT-MARIE-TOOTH DISEASE, GUADALAJARA NEURONAL TYPE	0.5	18.758075116861868
BRANCHIOOTORENAL SYNDROME 1	0.5	18.758075116861868
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.5	18.758075116861868
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.758075116861868
CREST SYNDROME	0.5	18.758075116861868
BICD2-RELATED AUTOSOMAL DOMINANT CHILDHOOD-ONSET PROXIMAL SPINAL MUSCULAR ATROPHY	0.5	18.758075116861868
MYOPATHIC EHLERS-DANLOS SYNDROME	0.4700791	17.635558137333646
ULNAR HEMIMELIA	0.4455281	16.71449913294549
ANOCTAMIN-5-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R12	0.4383321	16.444532915863615
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.43830404999999995	16.443480587849557
WILLIAMS SYNDROME	0.43737572	16.40865322010309
SPINOCEREBELLAR ATAXIA TYPE 42	0.43333299999999997	16.256985929230204
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.43228657	16.21772790414113
SPINOCEREBELLAR ATAXIA TYPE 10	0.4321471	16.212495526668036
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42149728	15.81295527958592
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415887734	15.602506709106937
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.39840321900000003	14.946555017603142
CANAVAN DISEASE	0.37309227	13.996985652361019
CALPAIN-3-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R1	0.37166509999999997	13.943443728231955
MYOSCLEROSIS, AUTOSOMAL RECESSIVE	0.36781579999999997	13.799032811137282
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769361
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769361
ACITRETIN/ETRETINATE EMBRYOPATHY	0.35492272999999996	13.315334460043365
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.34973511999999995	13.120715303929398
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.3497264	13.120388163099362
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.3497264	13.120388163099362
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.34825195999999997	13.065072850548749
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.34754957000000003	13.038721881786087
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	12.957059877313934
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.345019934	12.943819677573448
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.34406480899999997	12.90798706458146
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841275
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.33894881	12.716054477501881
EMERY-NELSON SYNDROME	0.33814068999999997	12.685736926175004
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.337299079	12.654162921460651
COG4-CDG	0.33583980399999996	12.599416541328331
EPIDERMAL NEVUS SYNDROME	0.333878554	12.525837991682442
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.333874419	12.525682862401228
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.333333	12.505370905857834
PLACENTAL INSUFFICIENCY	0.333333	12.505370905857834
ALBINISM, OCULAR, TYPE I	0.333333	12.505370905857834
NEUROMYELITIS OPTICA	0.333333	12.505370905857834
FRASER-LIKE SYNDROME	0.333333	12.505370905857834
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31913092	11.97256353894647
JUVENILE HYALINE FIBROMATOSIS	0.311111	11.671687015364027
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.3098717	11.625193250379374
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.30521293	11.450414135155006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252717
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.29420263	11.037350066236638
PALLISTER-HALL SYNDROME	0.29402385400000003	11.030643078962454
SCHWARTZ-JAMPEL SYNDROME	0.2894951	10.860741663526877
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.28689034	10.763021096044083
SPINOCEREBELLAR ATAXIA TYPE 20	0.2732558	10.251505645036367
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.2732558	10.251505645036367
EPISODIC ATAXIA, TYPE 2	0.2732558	10.251505645036367
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.267678154	10.042253839749838
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.267212554	10.024786320201017
SPINOCEREBELLAR ATAXIA TYPE 6	0.266667	10.004319234376407
STUVE-WIEDEMANN SYNDROME	0.26294890000000004	9.8648304361924
H SYNDROME	0.25866031	9.703939049461555
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.257587804	9.663702753238983
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.255941763	9.601949631792115
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.2545048	9.548040312003812
USHER SYNDROME	0.25449111	9.547526715907113
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.25449111	9.547526715907113
SCLERODERMA	0.254087519	9.532385535318134
INFANTILE MYOFIBROMATOSIS	0.2530914	9.495014985263468
AL KAISSI SYNDROME; ALKAS	0.251843403	9.448194942320232
MUCOPOLYSACCHARIDOSIS TYPE 1	0.25150376	9.435452844506399
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.251301984	9.427882985776838
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.25129784899999996	9.427727856495622
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.25119335000000004	9.42380745631235
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.251086973	9.419816600798935
MICROPHTHALMIA WITH LIMB ANOMALIES	0.25	9.379037558430934
CARNEY COMPLEX	0.25	9.379037558430934
%614826 NYSTAGMUS 7, CONGENITAL, AUTOSOMAL DOMINANT; NYS7	0.25	9.379037558430934
IDIOPATHIC BRONCHIECTASIS	0.25	9.379037558430934
METHIONINE ADENOSYLTRANSFERASE I/III DEFICIENCY	0.25	9.379037558430934
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430934
HYPERPARATHYROIDISM 2	0.25	9.379037558430934
EXTRAORAL HALITOSIS DUE TO METHANETHIOL OXIDASE DEFICIENCY; EHMTO	0.25	9.379037558430934
PARAGANGLIOMAS 4	0.25	9.379037558430934
DYSTONIA 6, TORSION	0.25	9.379037558430934
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430934
WILD TYPE ABETA2M AMYLOIDOSIS	0.25	9.379037558430934
PARAGANGLIOMAS 3	0.25	9.379037558430934
PRIMARY CILIARY DYSKINESIA	0.25	9.379037558430934
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.25	9.379037558430934
EXUDATIVE VITREORETINOPATHY 4	0.25	9.379037558430934
PLEURAL MESOTHELIOMA	0.25	9.379037558430934
HYPEREKPLEXIA 1; HKPX1	0.25	9.379037558430934
PARAGANGLIOMAS 1	0.25	9.379037558430934
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.249693714	9.367546886840449
ISOLATED OPTIC NERVE HYPOPLASIA/APLASIA	0.24359010000000003	9.138562787047789
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.243045154	9.118118511042523
JUVENILE MYOCLONIC EPILEPSY	0.2427134	9.105672378137882
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.2426566	9.103541460804607
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.238637019	8.952742256131986
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.238039464	8.930324292979073
ARTHROGRYPOSIS, DISTAL, TYPE 1B	0.2371406	8.896602376115387
LENNOX-GASTAUT SYNDROME	0.23257131	8.725180206013935
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.22756148	8.537230671088519
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577506
POLYARTERITIS NODOSA	0.22425796	8.413295318468409
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.219107254	8.220060658362666
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.20962820000000001	7.864443044425087
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2087344	7.830911109346184
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.20757706	7.787492168034686
SARCOIDOSIS	0.20532863	7.703139730364675
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20492842	7.688125391879636
KUFOR-RAKEB SYNDROME	0.20475092	7.68146627521315
BETHLEM MYOPATHY 2; BTHLM2	0.20409836	7.656984736216632
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.20402425400000002	7.654204564387411
HEREDITARY PHEOCHROMOCYTOMA-PARAGANGLIOMA	0.2035461	7.636266067088555
NON-FUNCTIONING PARAGANGLIOMA	0.2035461	7.636266067088555
SPORADIC PHEOCHROMOCYTOMA/SECRETING PARAGANGLIOMA	0.2035461	7.636266067088555
FAMILIAL CERVICAL ARTERY DISSECTION	0.20342466	7.6317101058041725
ANEURYSM OR DILATATION OF ASCENDING AORTA	0.20342466	7.6317101058041725
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.20308968000000002	7.619142945798879
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.20151745000000001	7.560158928916912
6P22 MICRODELETION SYNDROME	0.20151745000000001	7.560158928916912
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.20150376	7.559645332820211
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.20054555400000001	7.523697132569357
WHIM SYNDROME	0.200541419	7.52354200328814
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.200541419	7.52354200328814
RIGID SPINE SYNDROME	0.20024095400000003	7.512269713208165
SALIVARY DUCT CALCULI	0.2	7.503230046744748
BETA-THALASSEMIA	0.2	7.503230046744748
RADIATION PROCTITIS	0.2	7.503230046744748
MALARIA	0.2	7.503230046744748
MYOFIBROMATOSIS, INFANTILE, 1; IMF1	0.2	7.503230046744748
SECONDARY NON-TRAUMATIC AVASCULAR NECROSIS	0.2	7.503230046744748
MELIOIDOSIS	0.2	7.503230046744748
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.2	7.503230046744748
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.2	7.503230046744748
RAT-BITE FEVER	0.2	7.503230046744748
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.2	7.503230046744748
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.2	7.503230046744748
TRANSIENT NEONATAL DIABETES MELLITUS	0.192225754	7.211570265854822
PERMANENT NEONATAL DIABETES MELLITUS	0.192225754	7.211570265854822
ROBERTS SYNDROME	0.190558534	7.149022589862152
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.1899228	7.125172297609467
EMERY-DREIFUSS MUSCULAR DYSTROPHY 1, X-LINKED; EDMD1	0.1895349	7.110619782933806
AUTOSOMAL RECESSIVE EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
AUTOSOMAL DOMINANT EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
X-LINKED EMERY-DREIFUSS MUSCULAR DYSTROPHY	0.18953489999999998	7.110619782933804
ZUNICH NEUROECTODERMAL SYNDROME	0.187009479	7.015875709294404
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.18458690000000003	6.92498987157734
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.184369054	6.916817128313523
SPINOCEREBELLAR ATAXIA TYPE 11	0.1830604	6.867721468245561
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266897
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266897
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.17932520000000002	6.727591143892557
DUPUYTREN CONTRACTUREDUPUYTREN CONTRACTURE 1, INCLUDED	0.17932520000000002	6.727591143892557
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.17794436300000002	6.675787455552272
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.177885354	6.673573665043129
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.176133809	6.607862439682003
GRANULOMATOSIS WITH POLYANGIITIS	0.175682939	6.590947533026123
PORPHYRIA	0.174179179	6.534532246950659
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.17375885400000002	6.51876327110367
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.171984449	6.452194426548198
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17118598399999999	6.422239093651827
BERARDINELLI-SEIP CONGENITAL LIPODYSTROPHY	0.17076536	6.4064589004759185
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.170754519	6.406052187891234
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17046255300000002	6.395098747572095
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.17045877399999998	6.394956974040361
PFAPA SYNDROME	0.1702131	6.3857402313478415
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.16975151400000002	6.368423301626058
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.16894088000000002	6.338011434697495
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.16885877900000001	6.334931321247156
UNILATERAL POLYMICROGYRIA	0.16875813	6.331155358242281
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 10	0.16818445	6.309633093176199
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.167964849	6.3013945090687224
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.167212554	6.273171296828643
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.167212554	6.273171296828643
ENCEPHALITIS LETHARGICA	0.167208419	6.273016167547427
JUVENILE HUNTINGTON DISEASE	0.167208419	6.273016167547427
GM2 GANGLIOSIDOSIS, AB VARIANT	0.167208419	6.273016167547427
SANDIFER SYNDROME	0.166667	6.252704211004034
GRAFT VERSUS HOST DISEASE	0.166667	6.252704211004034
NYSTAGMUS, HEREDITARY VERTICAL	0.166667	6.252704211004034
FASCIAL DYSTROPHY, CONGENITAL	0.166667	6.252704211004034
CUTANEOUS SMALL VESSEL VASCULITIS	0.166667	6.252704211004034
CEREBROOCULONASAL SYNDROME	0.166667	6.252704211004034
PEYRONIE DISEASE	0.166667	6.252704211004034
SYNPOLYDACTYLY 1	0.166667	6.252704211004034
PITYRIASIS RUBRA PILARIS	0.166667	6.252704211004034
MUCOLIPIDOSIS TYPE II	0.166667	6.252704211004034
PEMPHIGUS VULGARIS	0.166667	6.252704211004034
DERMATOLEUKODYSTROPHY	0.166667	6.252704211004034
CRANIOACROFACIAL SYNDROME	0.166667	6.252704211004034
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	6.252704211004034
NYSTAGMUS 1, CONGENITAL, X-LINKED; NYS1	0.166126	6.2324079737275895
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.165673564	6.215434316780445
CAMPTODACTYLY-ARTHROPATHY-COXA VARA-PERICARDITIS SYNDROME	0.1625	6.096374412980107
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.1595057	5.984039804335269
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.1595057	5.984039804335269
OXOGLUTARIC ACIDURIA	0.157803654	5.920185590894559
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.15699616	5.889891524677729
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.15565328399999998	5.839511986916466
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.155498773	5.833715329027704
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.15201728400000003	5.703103264666649
TUBEROUS SCLEROSIS COMPLEX	0.15187796	5.697876364551484
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.1515915	5.687129488155532
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.14990567900000001	5.623883974252366
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.14880960000000001	5.582763309820336
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.14825734399999999	5.56204479075686
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.14632200999999997	5.489438509660427
AMISH NEMALINE MYOPATHY	0.1458333	5.471103991879703
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
PSEUDOXANTHOMA ELASTICUM; PXE	0.14188616	5.323022494646164
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089111	5.285692049356097
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.139785573	5.2442165571751564
YUNIS-VARON SYNDROME	0.138328334	5.1895465599247155
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.137843653	5.171363194713284
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.13756670399999998	5.160973134422203
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13754538400000002	5.160173290099221
AUTOSOMAL DOMINANT DOPA-RESPONSIVE DYSTONIA	0.13599260999999999	5.1019191874362
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.13545377299999997	5.081704097592711
BLAU SYNDROME	0.13501488	5.065238521868182
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.13500953899999998	5.0650381481097835
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.13434641900000002	5.040160438566798
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968417
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.13110385400000002	4.918511882884183
INSULIN-RESISTANCE SYNDROME TYPE B	0.1285461	4.822554799559275
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.128360853	4.815605045276928
DOORS SYNDROME	0.128062864	4.8044256451849305
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.126843403	4.758676163104764
HEARING LOSS-FAMILIAL SALIVARY GLAND INSENSITIVITY TO ALDOSTERONE SYNDROME	0.12650376	4.745934065290931
LAMBOTTE SYNDROME	0.12575643	4.717897120736763
VAN DER WOUDE SYNDROME	0.125	4.689518779215467
MARFANOID HYPERMOBILITY SYNDROME	0.125	4.689518779215467
KIMURA DISEASE	0.125	4.689518779215467
SARCOIDOSIS, SUSCEPTIBILITY TO, 1; SS1	0.125	4.689518779215467
CHEILITIS GLANDULARIS	0.125	4.689518779215467
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.125	4.689518779215467
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.125	4.689518779215467
SEVERE HEMOPHILIA A	0.125	4.689518779215467
ANTERIOR SEGMENT DYSGENESIS 1; ASGD1	0.125	4.689518779215467
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.12480361400000001	4.682151132535668
FRONTOMETAPHYSEAL DYSPLASIA	0.12396775	4.650792733136706
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.121353463	4.552714749290635
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12091581399999998	4.536295843656996
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.12084480000000003	4.5336316717643
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.1208333	4.533200236036611
ROBERTS SYNDROME; RBS	0.12019526	4.509263431541485
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.4326550776027185
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.11795960000000003	4.42539007510996
SAY-BARBER-MILLER SYNDROME	0.11706438400000002	4.3918050171623255
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.11667834399999999	4.377322282526099
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.11520935999999998	4.322211658091161
TAKAYASU ARTERITIS	0.11519851899999999	4.321804945506478
SYSTEMIC SCLEROSIS	0.11519851899999999	4.321804945506478
22Q11.2 DELETION SYNDROME	0.11473693299999999	4.3044880157846945
CUSHING SYNDROME DUE TO ECTOPIC ACTH SECRETION	0.11465709999999998	4.301492988963085
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.11465709999999998	4.301492988963085
NEUROLEPTIC MALIGNANT SYNDROME	0.11465709999999998	4.301492988963085
SCHINZEL-GIEDION SYNDROME	0.11428576000000001	4.287561741735296
FG SYNDROME TYPE 1	0.113701733	4.265651297062744
BILATERAL POLYMICROGYRIA	0.11335876400000001	4.252784420533234
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.11231581999999998	4.213657176743872
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.11207652000000001	4.204679561992943
CAREY-FINEMAN-ZITER SYNDROME	0.11186742999999999	4.196835310140573
ACUTE INTERMITTENT PORPHYRIA	0.11165241899999999	4.1887689251626705
TERMINAL OSSEOUS DYSPLASIA; TOD	0.11139679000000002	4.1791787091945745
HYALINE FIBROMATOSIS SYNDROME; HFS	0.11111099999999999	4.168456968619277
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.10908715000000001	4.092529907968757
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.10868948300000002	4.077610973053763
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.10818720000000001	4.058767248565917
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.10815050000000001	4.057390405852339
BLAU SYNDROME	0.10743062000000002	4.030383279622087
AICARDI SYNDROME; AIC	0.10743048000000001	4.030378027361054
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.105694673	3.965257231172304
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.105694673	3.965257231172304
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.1046077	3.9244781888043025
ALSTRÃ–M SYNDROME	0.10407432300000001	3.90446793714109
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.1035461	3.8846510437161816
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.10310420000000001	3.868072656927899
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10170259999999999	3.8154900207603113
SPINOCEREBELLAR ATAXIA 31	0.10150376000000001	3.8080303094478385
TRISOMY 8P	0.101476749	3.807016960713875
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.10088861400000002	3.7849523996961643
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10066773400000002	3.77666583243254
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.10056594000000002	3.772846913435648
VASCULAR EHLERS-DANLOS SYNDROME	0.10054555400000001	3.7720821091969827
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.10054555400000001	3.7720821091969827
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.100541419	3.7719269799157664
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.100017124	3.752257449928976
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.1	3.751615023372374
CAMPTOBRACHYDACTYLY	0.1	3.751615023372374
SPINOCEREBELLAR ATAXIA 15	0.1	3.751615023372374
UROCANIC ACIDURIA	0.1	3.751615023372374
GRANGE SYNDROME; GRNG	0.1	3.751615023372374
9Q31.1Q31.3 MICRODELETION SYNDROME	0.1	3.751615023372374
AUTOIMMUNE ENTEROPATHY AND ENDOCRINOPATHY-SUSCEPTIBILITY TO CHRONIC INFECTIONS SYNDROME	0.1	3.751615023372374
FIBROMUSCULAR DYSPLASIA OF ARTERIES	0.1	3.751615023372374
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.1	3.751615023372374
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.09994674300000002	3.7496170257593766
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.09915028400000002	3.719736950260376
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.09915028400000002	3.719736950260376
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310399999999	3.712339515757289
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.09879724400000003	3.706492248581862
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185	3.681154065810905
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185	3.681154065810905
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185	3.681154065810905
ECTODERMAL DYSPLASIA-SENSORINEURAL DEAFNESS SYNDROME	0.09722055000000002	3.6473407596052505
PIERPONT SYNDROME	0.096667153	3.6265794346143583
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.09653291900000001	3.6215434917038847
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.09599150000000001	3.601231535160492
ALLAN-HERNDON-DUDLEY SYNDROME	0.09576389	3.592692484205794
PELIZAEUS-MERZBACHER DISEASE	0.09547477300000001	3.581845927398671
JUVENILE ABSENCE EPILEPSY	0.09540435	3.579203927550761
OCULODENTODIGITAL DYSPLASIA; ODDD	0.09398947900000001	3.526123414553423
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.09397259	3.5254898042921248
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.09389645	3.5226333246133295
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.093875834	3.521859891660111
OTOONYCHOPERONEAL SYNDROME	0.09320629999999999	3.4967415535295245
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.09315583900000002	3.4948484510725817
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.093138154	3.494184977955697
TRICHOTHIODYSTROPHY	0.093066864	3.4915104516055355
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.09275250300000001	3.479716837101912
MARDEN-WALKER SYNDROME	0.09252750900000001	3.471275928396225
WT LIMB-BLOOD SYNDROME	0.09241286000000001	3.4669747392880796
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.09177107900000002	3.4428975868749303
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.09166553000000001	3.438937794733911
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.09166553000000001	3.438937794733911
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.09145465400000001	3.431026539037224
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.09119704400000002	3.421362003575515
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.0909091	3.4105594532126147
NYSTAGMUS, CONGENITAL MOTOR, AUTOSOMAL RECESSIVE	0.0909091	3.4105594532126147
APLASIA CUTIS-MYOPIA SYNDROME	0.0909091	3.4105594532126147
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.0909091	3.4105594532126147
HERMANSKY-PUDLAK SYNDROME 9	0.0909091	3.4105594532126147
APLASIA CUTIS CONGENITA, HIGH MYOPIA, AND CONE-ROD DYSFUNCTION	0.0909091	3.4105594532126147
SENIOR-LOKEN SYNDROME 4; SLSN4	0.0909091	3.4105594532126147
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.0902778	3.386875507570065
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.090100804	3.3802352990432967
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.08998439300000001	3.375868006478439
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.0896686	3.3640206688476804
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.08913594900000002	3.344037653909538
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.08897280900000001	3.3379172691604078
3Q29 MICRODUPLICATION SYNDROME	0.08847668300000001	3.3193045316095517
CAMPTODACTYLY-TAURINURIA SYNDROME	0.08814099000000002	3.3067106225891423
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.08788528300000001	3.2971174803613272
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.08704935900000002	3.265756829993352
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.08618236000000001	3.2332303652568637
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.085672754	3.214111910000857
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.08489203000000001	3.184822151125783
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.08463114900000002	3.1750349003366587
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.08456377300000001	3.1725072121985116
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.08442027300000002	3.167123644639972
MONOSOMY 22	0.08408973000000002	3.1547229437932667
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.08387885400000002	3.1468116880965797
8P INVERTED DUPLICATION/DELETION SYNDROME	0.08387471900000001	3.146656558815363
MANDIBULOACRAL DYSPLASIA	0.08333330000000001	3.126344602271971
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.0825032	3.0952024459629564
CONGENITAL PROGRESSIVE BONE MARROW FAILURE-B-CELL IMMUNODEFICIENCY-SKELETAL DYSPLASIA SYNDROME	0.08022308000000002	3.0096611214920386
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.965381934855681
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.07899125000000001	2.9634476021496305
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.07898196900000001	2.9630994147593115
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC TYPE; AMCN	0.07862284000000001	2.9496262772420243
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.07845034000000001	2.943154741326707
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.07822094900000001	2.934548874108443
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.07775374000000002	2.9170209910738953
WHITE-SUTTON SYNDROME; WHSUS	0.077690884	2.9146628759348037
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.906325661868364
ETHYLMALONIC ENCEPHALOPATHY	0.07746451900000001	2.906170532587147
DDOST-CDG	0.07746451900000001	2.906170532587147
TRICHOHEPATOENTERIC SYNDROME 1	0.07692310000000001	2.8858585760437547
CONGENITAL ENTEROVIRUS INFECTION	0.07692310000000001	2.8858585760437547
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.8858585760437547
IMMUNODEFICIENCY 36; IMD36	0.07692310000000001	2.8858585760437547
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.8858585760437547
BECKWITH-WIEDEMANN SYNDROME	0.07692310000000001	2.8858585760437547
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0763091	2.8628236598002483
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.07627505400000001	2.861546384949391
URBAN-ROGERS-MEYER SYNDROME	0.07623629000000001	2.860092108901731
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.07610066	2.8550037934455306
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07561588	2.836816714135226
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.07552696	2.8334807780564435
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.075054533	2.815757135749976
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.07487236900000001	2.8089230437588
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.07458247	2.7980471493221937
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.07418566	2.78316036574795
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.0737813	2.767990335239441
17Q23.1Q23.2 MICRODELETION SYNDROME	0.07370248000000001	2.7650333122780193
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.07286200300000001	2.7335018508780298
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.07272644900000001	2.728416386649248
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.07198275400000001	2.7005158133011786
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.07197415400000001	2.700193174409169
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.07197415400000001	2.700193174409169
LOCALIZED SCLERODERMA	0.07142860000000001	2.6797260885845593
MYOPATHY, PROXIMAL, AND OPHTHALMOPLEGIA	0.07142860000000001	2.6797260885845593
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.07142860000000001	2.6797260885845593
LETHAL CONGENITAL CONTRACTURE SYNDROME 6; LCCS6	0.07142860000000001	2.6797260885845593
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.07098874	2.6632242347427537
YOU-HOOVER-FONG SYNDROME; YHFS	0.070791834	2.6558370796648316
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07077939999999999	2.6553706038528255
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.07073001300000001	2.653517793741233
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.07021279999999999	2.6341139531303974
BETHLEM MYOPATHY 1	0.07003308999999999	2.6273719257718953
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.069718639	2.6155749348147506
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.06965405	2.6131518041873045
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.06965405	2.6131518041873045
MICROHYDRANENCEPHALY; MHAC	0.06898579	2.5880812616321167
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.0688549	2.5831707727280246
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103482
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.06851795399999999	2.5705298559713716
AUTOIMMUNE HYPOPARATHYROIDISM	0.06844923	2.5679515960627097
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.068417074	2.5667452267357938
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067964549	2.5497682308512784
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.06776525	2.5422912996258473
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.06742313	2.529456274307886
LETHAL CONGENITAL CONTRACTURE SYNDROME 4; LCCS4	0.0667341	2.5036065213123435
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.50107793278659
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.50107793278659
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.50107793278659
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.50107793278659
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.50107793278659
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.50107793278659
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.065901773	2.4723808165367585
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.06470255	2.427390586305022
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.06454336399999999	2.421418540413916
CHROMOSOME 17Q12 DELETION SYNDROME	0.0642537	2.4105514622726147
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.063898499	2.397225688193446
SLC39A8-CDG	0.06383128900000001	2.394704227736238
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.06327884	2.3739784680557667
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.062297580000000005	2.3371653704774236
PEHO SYNDROME	0.062030924	2.3271614639206994
LOEYS-DIETZ SYNDROME 3; LDS3	0.06155699	2.3093812847758297
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.0611888	2.295568213421275
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.061062323	2.290823283288164
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.060792330000000006	2.2806941853381106
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.06060603	2.2737049265495677
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.060125484	2.255676690619353
BLUE CONE MONOCHROMACY; BCM	0.06002832	2.2520314713980434
FETAL HYDANTOIN SYNDROME	0.059743584	2.2413492728450937
BLEPHAROCHALASIS AND DOUBLE LIP	0.0592948	2.2245126248786025
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.05910170000000001	2.2172682562684702
CONGENITAL ISOLATED ACTH DEFICIENCY	0.05910170000000001	2.2172682562684702
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.059050269	2.2153387631458
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.0588235	2.206831263273448
CATARACT 48; CTRCT48	0.0588235	2.206831263273448
ACHROMATOPSIA	0.0588235	2.206831263273448
LEBER CONGENITAL AMAUROSIS 4; LCA4	0.0588235	2.206831263273448
BETHLEM MYOPATHY	0.05836648999999999	2.189686007455134
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.167604751750569
AMISH INFANTILE EPILEPSY SYNDROME	0.05771586000000001	2.165276874628567
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.057439290000000004	2.1549010329584255
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.05734132000000001	2.151225575720028
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0573294	2.150778383209242
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.057305974	2.1498995298738666
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.0842322359246626
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.0842322359246626
GITELMAN SYNDROME	0.055555600000000004	2.0842322359246626
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.0842322359246626
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.0842322359246626
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.0842322359246626
208080 ARTHROGRYPOSIS, DISTAL, WITH HYPOPITUITARISM, MENTAL RETARDATION,AND FACIAL ANOMALIES	0.055480230000000005	2.0814046436815468
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.0553161	2.0752471179436855
RAMOS-ARROYO SYNDROME	0.0553161	2.0752471179436855
DISTAL MONOSOMY 12Q	0.055163783999999993	2.0695328080046855
ISOLATED CEREBELLAR AGENESIS	0.054832549	2.0571061459820186
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.05459812	2.048311272398877
COG2-CDG	0.05426045399999999	2.0356433440140558
SHEEHAN SYNDROME	0.05413536	2.0309502987167183
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.052905669	1.9848170264196607
JEJUNAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412542
ILEAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412542
LARYNGEAL NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412542
PRIMARY HEPATIC NEUROENDOCRINE CARCINOMA	0.0526316	1.9745350126412542
GALLBLADDER NEUROENDOCRINE TUMOR	0.0526316	1.9745350126412542
VIPOMA	0.0526316	1.9745350126412542
FAMILIAL PANCREATIC CARCINOMA	0.0526316	1.9745350126412542
144120 HYPERIMMUNOGLOBULIN G1(A1) SYNDROMEIMMUNOGLOBULIN HEAVY CHAIN REGULATOR, INCLUDED; IGHR	0.0526316	1.9745350126412542
ADENOCARCINOMA OF THE ANAL CANAL	0.0526316	1.9745350126412542
GLUCAGONOMA	0.0526316	1.9745350126412542
AUTOIMMUNE HEPATITIS	0.0526316	1.9745350126412542
JUVENILE POLYPOSIS SYNDROME	0.0526316	1.9745350126412542
MARFAN SYNDROME	0.0526316	1.9745350126412542
SOMATOSTATINOMA	0.0526316	1.9745350126412542
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.052037644	1.9522520701130326
HYPEREKPLEXIA 4; HKPX4	0.051708133	1.939890085933368
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.051471769	1.9310226185995243
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.05126819	1.923385118251093
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.05081072300000001	1.9062227175521222
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.05067254	1.9010386233643755
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.049954319000000004	1.8740937364273604
ERYTHERMALGIA, PRIMARY	0.0494995	1.857030678494208
CORNELIA DE LANGE SYNDROME 3	0.049135423000000004	1.8433719110655649
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.048849473000000004	1.8326441679062315
MENTAL RETARDATION, X-LINKED 98; MRX98	0.048814133	1.8313183471569718
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.04873482300000001	1.8283429412819352
GERMAN SYNDROME	0.048261784	1.8105963390915247
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.047617973	1.7864430288934006
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.04757886	1.7849756597093087
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.046876744000000005	1.7586349703718078
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.04680156	1.7558143561326356
MYOPATHY, MYOFIBRILLAR, 7; MFM7	0.0466779	1.7511751089947334
CHRISTIANSON SYNDROME	0.04619249	1.7329643945097815
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.045662999	1.713099930606377
MICROCEPHALY 10, PRIMARY, AUTOSOMAL RECESSIVE; MCPH10	0.0454475	1.7050152377471595
3P25.3 MICRODELETION SYNDROME	0.04538887	1.7028156658589562
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.685432182486658
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.04469101	1.6766346452568501
16P13.11 MICRODELETION SYNDROME	0.044650434	1.6751123899449665
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.044596313000000005	1.6730819783781672
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.04456062	1.6717429144278748
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297954	1.6618886973105835
PYRIDOXINE-DEPENDENT EPILEPSY	0.044297954	1.6618886973105835
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.044260310000000004	1.6604764393511853
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.04423473000000001	1.6595167762282066
GENITOPATELLAR SYNDROME	0.044046593	1.6524586002716846
ISPD-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R20	0.0435606	1.634226013871146
PREPAPILLARY VASCULAR LOOPS	0.0435606	1.634226013871146
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.043531344	1.6331284413799083
GABRIELE-DE VRIES SYNDROME	0.043478300000000004	1.631138434706911
CHROMOSOME 1P36 DELETION SYNDROME	0.04340030299999999	1.6282122875371305
INCONTINENTIA PIGMENTI	0.043391493	1.6278817702535722
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.043248754	1.6225267524853604
MERRF	0.043021119999999996	1.6139868011430567
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.0429612	1.611738833421052
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.042253623	1.5851932683871246
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.042218459	1.5838740504803062
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.04152505	1.5578600142628898
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.041524624	1.5578440323828904
ZELLWEGER SYNDROME	0.041503259	1.5570424998331467
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.04111050900000001	1.542308031828852
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.041110509	1.542308031828852
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.04073417	1.5281892413660423
FIBROCHONDROGENESIS	0.04052199000000001	1.5202290646094512
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.039968699999999996	1.4994717538466338
ATYPICAL RETT SYNDROME	0.039881088999999995	1.496184926408507
SLC35A2-CDG	0.039871534	1.495826459593024
SARCOSINEMIA	0.039845903999999994	1.4948649206625335
INSULINOMA	0.039801819	1.4932110211794798
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.039760144	1.4916475356184893
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.039702879	1.4894991732753553
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0397012	1.4894361836591128
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0396492	1.4874853438469593
WAGR SYNDROME	0.039458080000000006	1.4803152572142901
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.4743978348379245
AUTOSOMAL RECESSIVE AXONAL NEUROPATHY WITH NEUROMYOTONIA	0.03929049	1.47402792559662
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938222
MUCOLIPIDOSIS TYPE III	0.0392604	1.4728990646360873
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.03913896000000001	1.4683431033517043
ALKAPTONURIA	0.03913896000000001	1.4683431033517043
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.039075153	1.4659493103537409
PEROXISOME BIOGENESIS DISORDER 11B	0.03901428	1.4636655897405633
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.03899825	1.4630642058523167
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.445170877998342
TONGUE CURLING, FOLDING, OR ROLLINGCLOVERLEAF TONGUE, INCLUDED	0.0384615	1.4429274122143656
AMYLOIDOSIS OF GINGIVA AND CONJUNCTIVA, WITH MENTAL RETARDATION	0.0384615	1.4429274122143656
CYCLIC NEUTROPENIA	0.0384615	1.4429274122143656
TUBULOINTERSTITIAL NEPHRITIS WITH UVEITIS; TINU	0.0384615	1.4429274122143656
%189700 TORUS PALATINUS AND TORUS MANDIBULARIS	0.0384615	1.4429274122143656
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.0384615	1.4429274122143656
ACROCEPHALOPOLYDACTYLY	0.0384615	1.4429274122143656
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.0384615	1.4429274122143656
BAZEX SYNDROME; BZX	0.0384615	1.4429274122143656
ABLEPHARON-MACROSTOMIA SYNDROME	0.0384615	1.4429274122143656
MAL DE MELEDA	0.0384615	1.4429274122143656
%112200 BLUE RUBBER BLEB NEVUS;;BEAN SYNDROME	0.0384615	1.4429274122143656
LIP, MEDIAN NODULE OF UPPER	0.0384615	1.4429274122143656
SHPRINTZEN OMPHALOCELE SYNDROME	0.0384615	1.4429274122143656
VENOUS MALFORMATIONS, MULTIPLE CUTANEOUS AND MUCOSAL	0.0384615	1.4429274122143656
LIP, HAMARTOMATOUS	0.0384615	1.4429274122143656
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.03841658	1.4412421867458665
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.038363639000000005	1.4392560442363433
LISSENCEPHALY 2; LIS2	0.038338984	1.4383310835523306
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0380747	1.428416165303961
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.038011569	1.4260477332235562
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.421234073503217
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.03779343	1.4178639977277216
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.03771556399999999	1.4149427651736224
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.037513904	1.40737725831749
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.037511	1.407268311417211
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.037499954	1.4068539080217295
HARLEQUIN ICHTHYOSIS	0.03749683	1.4067367075683992
OLIVER SYNDROME	0.03745967	1.405342607425714
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.037416454	1.4037213094772134
AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY	0.0372267	1.3966024699057635
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.037218060000000004	1.3962783303677442
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.037073533	1.3908562337229147
MCLEOD SYNDROME; MCLDS	0.037037	1.389485656206426
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.389485656206426
MYOCLONUS AND ATAXIA	0.037037	1.389485656206426
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.389485656206426
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.037016284	1.3887084716381843
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.037016284	1.3887084716381843
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.03701214900000001	1.388553342356968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.037012149	1.3885533423569678
PAPILLARY TUMOR OF THE PINEAL REGION	0.03691912000000001	1.385063252416875
PINEOCYTOMA	0.03691912000000001	1.385063252416875
DE BARSY SYNDROME	0.036859984	1.382844697356653
WOLF-HIRSCHHORN SYNDROME	0.036823773	1.3814862000405397
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.03668001300000001	1.37609287828294
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.036541669	1.3709027439950054
LEPRECHAUNISM	0.03647073000000001	1.3682413858135756
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.03647073000000001	1.3682413858135756
NIJMEGEN BREAKAGE SYNDROME	0.03647073000000001	1.3682413858135756
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.036326203	1.3628192891687458
GENITOPATELLAR SYNDROME; GTPTS	0.036310934	1.3622464550708273
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.036259854	1.3603301301168886
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.036255719000000006	1.3601750008356723
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.036255719000000006	1.3601750008356723
LISSENCEPHALY, X-LINKED, 2	0.036255719000000006	1.3601750008356723
STURGE-WEBER SYNDROME	0.036255719000000006	1.3601750008356723
ALPERS-HUTTENLOCHER SYNDROME	0.036122034	1.3551596542916766
THUMBS, CONGENITAL CLASPED	0.0361093	1.3546819236346004
MYOPATHY AND DIABETES MELLITUS	0.03598656	1.3500771913549134
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.035819623999999994	1.3438143952994963
UNDIFFERENTIATED PLEOMORPHIC SARCOMA	0.035804199999999994	1.3432357461982913
CROSSED POLYSYNDACTYLY	0.035714300000000004	1.3398630442922796
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.035714300000000004	1.3398630442922796
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.035714300000000004	1.3398630442922796
MCCUNE-ALBRIGHT SYNDROME	0.035714300000000004	1.3398630442922796
ROWLEY-ROSENBERG SYNDROME	0.03568276	1.338679784913908
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 1	0.03568276	1.338679784913908
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.338060393273549
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.338060393273549
HYDRANENCEPHALY	0.035569773	1.3344409476474501
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.035551613999999995	1.333759691875356
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.035483850000000004	1.3312174474709182
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.035306323	1.3245573178683756
CHONDRODYSPLASIA PUNCTATA, AUTOSOMAL DOMINANTCHONDRODYSPLASIA PUNCTATA DUE TO VITAMIN K DEFICIENCY, INCLUDED	0.03527403	1.323345808828878
RESTRICTIVE DERMOPATHY	0.03525773	1.3227342955800685
FETAL AKINESIA DEFORMATION SEQUENCE	0.03525773	1.3227342955800685
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.03523923	1.3220402468007446
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.035028354	1.3141289911040577
JAWAD SYNDROME	0.035028354	1.3141289911040577
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.035028354	1.3141289911040577
COSTELLO SYNDROME; CSTLO	0.035028354	1.3141289911040577
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.035024219	1.3139738618228414
PRIMROSE SYNDROME; PRIMS	0.03500895	1.3134010277249226
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.03500895	1.3134010277249226
FAMILIAL OR SPORADIC HEMIPLEGIC MIGRAINE	0.03496668	1.3118152200545432
ACRORENAL-MANDIBULAR SYNDROME	0.0349224	1.3101540049221938
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457724
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457724
SILVER-RUSSELL SYNDROME	0.0347755	1.30464288245286
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.03469632	1.3016723536773536
FLYNN-AIRD SYNDROME	0.034582049	1.2973853456739954
GRISCELLI SYNDROME TYPE 1	0.034549893	1.29617897634708
MYOTILINOPATHY	0.0344828	1.293661905279449
MYOPATHY, SCAPULOHUMEROPERONEAL	0.0344828	1.293661905279449
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.0344828	1.293661905279449
ALPHA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R3	0.0344828	1.293661905279449
MICROCEPHALY-GLOMERULONEPHRITIS-MARFANOID HABITUS SYNDROME	0.0344828	1.293661905279449
GAMMA-SARCOGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R5	0.0344828	1.293661905279449
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 5; MDDGC5	0.0344828	1.293661905279449
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0344828	1.293661905279449
RECOMBINANT CHROMOSOME 8 SYNDROME	0.034453683000000006	1.2925695475330936
HYDROXYKYNURENINURIA	0.03432110399999999	1.2875956938512563
SANDHOFF DISEASE	0.034316969	1.2874405645700404
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.034247929999999996	1.284850487074054
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.03421949	1.283783527761407
AICARDI SYNDROME	0.034219349999999996	1.2837782755003742
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.034072884	1.2782834350402417
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.278147101350292
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.278147101350292
HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER	0.034040629999999995	1.277073389130603
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.034032919	1.276784102096151
LEIGH SYNDROME	0.034004339	1.2757118905224711
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.033560084	1.2590451532003881
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.033560084	1.2590451532003881
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.033555949	1.2588900239191718
CAMURATI-ENGELMANN DISEASE, TYPE 2	0.0334915	1.2564721455527585
SPINOCEREBELLAR ATAXIA TYPE 34	0.03346292	1.2553999339790787
DIENCEPHALIC SYNDROME	0.03346292	1.2553999339790787
ALG13-CDG	0.03346292	1.2553999339790787
TREMOR-NYSTAGMUS-DUODENAL ULCER SYNDROME	0.03346292	1.2553999339790787
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.03346292	1.2553999339790787
DYSSEGMENTAL DYSPLASIA WITH GLAUCOMA	0.0330284	1.2390984163795211
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.032803653999999995	1.2306668116790924
NETHERTON SYNDROME; NETH	0.032803653999999995	1.2306668116790924
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.032799519	1.2305116823978761
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.032799519	1.2305116823978761
NEURONAL CEROID LIPOFUSCINOSIS	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978761
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978761
PROGRESSIVE HEMIFACIAL ATROPHY	0.032799519	1.2305116823978761
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978761
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.03239481400000001	1.2153287088175373
AYMÃ‰-GRIPP SYNDROME	0.032324734	1.2126995770091578
PERONEUS TERTIUS MUSCLE, ABSENCE OF	0.0322581	1.2101997258544837
STORMORKEN-SJAASTAD-LANGSLET SYNDROME	0.0322581	1.2101997258544837
OSSEOUS HETEROPLASIA, PROGRESSIVE; POH	0.0322581	1.2101997258544837
APLASIA OF EXTENSOR MUSCLES OF FINGERS, UNILATERAL, WITH GENERALIZEDPOLYNEUROPATHY	0.0322581	1.2101997258544837
LESCH-NYHAN SYNDROME	0.0322581	1.2101997258544837
GLYCOGEN STORAGE DISEASE DUE TO GLYCOGEN BRANCHING ENZYME DEFICIENCY	0.0322581	1.2101997258544837
LYMPHEDEMA-DISTICHIASIS SYNDROME; LPHDST	0.0322581	1.2101997258544837
WEST SYNDROME	0.0322581	1.2101997258544837
3-METHYLCROTONYL-COA CARBOXYLASE DEFICIENCY	0.0322581	1.2101997258544837
HSD10 DISEASE, ATYPICAL TYPE	0.0322581	1.2101997258544837
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 2	0.0322581	1.2101997258544837
DESMOID TUMOR	0.0322581	1.2101997258544837
HUNTINGTON DISEASE	0.0322581	1.2101997258544837
CRAMPS, FAMILIAL ADOLESCENT	0.0322581	1.2101997258544837
TRISMUS-PSEUDOCAMPTODACTYLY SYNDROME	0.0322581	1.2101997258544837
ATTENUATED CHÃ‰DIAK-HIGASHI SYNDROME	0.0322581	1.2101997258544837
THROMBOCYTOPENIA 1	0.0322581	1.2101997258544837
MYALGIA-EOSINOPHILIA SYNDROME ASSOCIATED WITH TRYPTOPHAN	0.0322581	1.2101997258544837
%153300 YELLOW NAIL SYNDROME;;YNS;;LYMPHEDEMA AND YELLOW NAILS	0.0322581	1.2101997258544837
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544837
19P13.3 MICRODUPLICATION SYNDROME	0.031393984	1.1777814201791192
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.031389972999999995	1.1776309429005316
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.031389972999999995	1.1776309429005316
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.031255202999999995	1.1725748913335328
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.17151344689497
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.031178973	1.169715035201216
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.031114519	1.1672969692540516
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.030932133	1.1604545486775237
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.030848553999999997	1.1573189863571391
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.030616619999999997	1.1486177155688309
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.030467402999999997	1.1430196681794051
LETHAL CONGENITAL CONTRACTURE SYNDROME 3; LCCS3	0.03045004	1.1423682752628972
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.030302999999999997	1.1368519005325304
ALPHA-DYSTROGLYCAN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R16	0.030302999999999997	1.1368519005325304
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2Y; LGMD2Y	0.030302999999999997	1.1368519005325304
DISTAL NEBULIN MYOPATHY	0.030302999999999997	1.1368519005325304
KLHL9-RELATED EARLY-ONSET DISTAL MYOPATHY	0.030302999999999997	1.1368519005325304
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.030284604	1.1361617534328308
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.030267259999999997	1.135511073323177
VELOCARDIOFACIAL SYNDROME	0.030168229999999997	1.1317958489655313
ROSSELLI-GULIENETTI SYNDROME	0.029957354	1.1238845932688446
STÃœVE-WIEDEMANN SYNDROME	0.02966099	1.1127661569209775
15Q13.3 MICRODELETION SYNDROME	0.029621203000000002	1.1112735018516282
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.02947992	1.105973107598157
EAR WITHOUT HELIX	0.0294118	1.1034175074442356
EXCHONDROSIS OF PINNA, POSTERIOR	0.0294118	1.1034175074442356
ALKAPTONURIA	0.0294118	1.1034175074442356
FRYNS MICROPHTHALMIA SYNDROME	0.0294118	1.1034175074442356
AREDYLD	0.0294118	1.1034175074442356
DARWINIAN TUBERCLE OF PINNA	0.0294118	1.1034175074442356
OSTEOMA OF MIDDLE EAR	0.0294118	1.1034175074442356
OSSIFIED EAR CARTILAGES	0.0294118	1.1034175074442356
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.0294118	1.1034175074442356
EAR WAX, WET/DRY	0.0294118	1.1034175074442356
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.0294118	1.1034175074442356
HAIRY EARS, Y-LINKED	0.0294118	1.1034175074442356
MUSICAL PERFECT PITCH	0.0294118	1.1034175074442356
EAR MALFORMATION	0.0294118	1.1034175074442356
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.0294118	1.1034175074442356
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.0294118	1.1034175074442356
DARWINIAN POINT OF PINNA	0.0294118	1.1034175074442356
EAR FOLDING	0.0294118	1.1034175074442356
EAR ANTITRAGUS, TAG AT BASE OF	0.0294118	1.1034175074442356
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.0294118	1.1034175074442356
WAARDENBURG SYNDROME, TYPE IIB	0.02928156	1.0985314040377958
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.029189684	1.095084570218922
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.029079784	1.0909615453082357
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.029079784	1.0909615453082357
MENKES DISEASE	0.029075649000000002	1.0908064160270192
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.028987154000000005	1.087486424312086
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.028960879000000002	1.086500687464695
BRUCK SYNDROME 2	0.02895166	1.0861548260756904
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.02881992	1.0812124484438994
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901082
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901082
GAUCHER DISEASE	0.0285593	1.0714349893699862
15Q24 RECURRENT MICRODELETION SYNDROME	0.02853423	1.070494459483627
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02853423	1.070494459483627
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.02853423	1.070494459483627
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0632588696526495
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	1.0632588696526495
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.028323354000000002	1.0625832037869403
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.02831885	1.0624142310462874
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.02818422	1.057363431740321
AASE-SMITH SYNDROME	0.02806349	1.052834106922604
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.027872539	1.045670360519324
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623313
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623313
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623313
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623313
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623313
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623313
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623313
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623313
EDINBURGH MALFORMATION SYNDROME	0.027777800000000002	1.0421161179623313
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623313
MENINGIOMA	0.027777800000000002	1.0421161179623313
CLEFT CHIN	0.027777800000000002	1.0421161179623313
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623313
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623313
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623313
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623313
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623313
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623313
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623313
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623313
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623313
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623313
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623313
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623313
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623313
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.027751730000000002	1.0411380719257382
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.027519154	1.0324127157689795
LOWE OCULOCEREBRORENAL SYNDROME	0.027441269	1.029490770408026
OROFACIODIGITAL SYNDROME TYPE 4	0.027386274	1.0274275697259223
WARBURG MICRO SYNDROME 3; WARBM3	0.027326759000000003	1.0251947960447623
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.027113490000000004	1.0171937642005662
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668514
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668514
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668514
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668514
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.0267345	1.0029755184234874
KEPPEN-LUBINSKY SYNDROME	0.026672809	1.0006611095994185
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.026635830000000003	0.9992737998799258
COWDEN SYNDROME 5; CWS5	0.026568698999999998	0.9967553031985855
COWDEN SYNDROME 6; CWS6	0.026568698999999998	0.9967553031985855
XQ21 MICRODELETION SYNDROME	0.026549753	0.9960445222162575
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.026532200000000002	0.9953860012312051
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.026494883999999996	0.9939860485690831
AICARDI-GOUTIÃˆRES SYNDROME	0.026304023	0.9868256786193245
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.026125303000000002	0.9801207922495536
PMM2-CDG	0.026125303	0.9801207922495534
POTOCKI-LUPSKI SYNDROME	0.026088153	0.9787270672683707
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.025940273	0.9731791789718076
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.025842273	0.9695025962489026
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.02579476	0.9677200914028476
WRINKLY SKIN SYNDROME	0.025738453999999997	0.9656077070477876
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.025738453999999997	0.9656077070477876
PEHO-LIKE SYNDROME; PEHOL	0.025738453999999997	0.9656077070477876
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.025605504	0.960619934874214
WARBURG MICRO SYNDROME 2; WARBM2	0.025580520000000002	0.9596826313767749
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.025528424	0.9577281900141987
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.025417438999999997	0.9535644600805088
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.025398854000000002	0.9528672224284153
CHROMOSOME 17P13.1 DELETION SYNDROME	0.025398854000000002	0.9528672224284153
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.025292874	0.948891260826645
MELAS	0.02524997	0.9472816679170173
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.025242679	0.9470081376656633
EMANUEL SYNDROME	0.025099203	0.9416254704947296
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.024853300000000002	0.9324001366038063
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.024853300000000002	0.9324001366038063
CEREBELLAR ATAXIA WITH NEUROPATHY AND BILATERAL VESTIBULAR AREFLEXIA SYNDROME	0.02475956	0.9288833726808968
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.024730214	0.9277824237361381
HUNTER-MACDONALD SYNDROME	0.02472948	0.9277548868818665
CEDNIK SYNDROME	0.024623763	0.923788792027608
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.024570703	0.9217981850962065
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.024557784	0.9213135139513371
SPASTIC PARAPLEGIA-OPTIC ATROPHY-NEUROPATHY SYNDROME	0.02446062	0.9176682947300275
SPINOCEREBELLAR ATAXIA 1	0.02446062	0.9176682947300275
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.02446062	0.9176682947300275
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.02443564	0.9167311412971892
RENPENNING SYNDROME 1; RENS1	0.024398889000000003	0.9153523852599497
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.024362069	0.9139710406083438
GAUCHER DISEASE, TYPE I	0.02425796	0.9100652717236609
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.024088054	0.9036910527020501
HOLOPROSENCEPHALY WITH FETAL AKINESIA/HYPOKINESIA SEQUENCE	0.02401223	0.9008464281267281
ANE SYNDROME	0.02401223	0.9008464281267281
WYBURN-MASON SYNDROME	0.023881023	0.895924046603012
KAGAMI-OGATA SYNDROME	0.023814273	0.893419843574911
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.023801354	0.8929351724300414
SPINOCEREBELLAR ATAXIA 5; SCA5	0.023801354	0.8929351724300414
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.023797219	0.892780043148825
EPISODIC ATAXIA TYPE 6	0.023797219	0.892780043148825
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.023718023999999997	0.889808951631065
OCULOSKELETODENTAL SYNDROME; OCSKD	0.023692064	0.8888350323709977
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.0235425	0.8832239668774411
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.0235425	0.8832239668774411
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.023445882999999997	0.8795992689903092
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.023432193	0.8790856728936097
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.023339604	0.8756120900596194
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.023321779	0.8749433646817033
SILVER-RUSSELL SYNDROME; SRS	0.023272854	0.8731078870315184
HYPOADRENOCORTICISM, FAMILIAL	0.023268719	0.872952757750302
MILLER-DIEKER SYNDROME	0.023268719	0.872952757750302
EPISODIC ATAXIA, TYPE 4	0.0232558	0.8724680866054324
SPINOCEREBELLAR ATAXIA 30; SCA30	0.0232558	0.8724680866054324
MACHADO-JOSEPH DISEASE TYPE 1	0.0232558	0.8724680866054324
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.0232558	0.8724680866054324
EPISODIC ATAXIA, TYPE 5	0.0232558	0.8724680866054324
CEREBELLAR ATAXIA, NEUROPATHY, AND VESTIBULAR AREFLEXIA SYNDROME; CANVAS	0.0232558	0.8724680866054324
MYASTHENIC SYNDROME, CONGENITAL, 15; CMS15	0.0232558	0.8724680866054324
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.0232558	0.8724680866054324
DISTAL MYOTILINOPATHY	0.0232558	0.8724680866054324
MACHADO-JOSEPH DISEASE TYPE 3	0.0232558	0.8724680866054324
CENTRAL CORE DISEASE	0.0232558	0.8724680866054324
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0232558	0.8724680866054324
SPINOCEREBELLAR ATAXIA TYPE 27	0.0232558	0.8724680866054324
SPINOCEREBELLAR ATAXIA TYPE 14	0.0232558	0.8724680866054324
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.0232558	0.8724680866054324
ATAXIA-TELANGIECTASIA-LIKE DISORDER 1; ATLD1	0.0232558	0.8724680866054324
SPINOCEREBELLAR ATAXIA 2; SCA2	0.0232558	0.8724680866054324
BATHING SUIT ICHTHYOSIS	0.0232558	0.8724680866054324
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.0232558	0.8724680866054324
SPINOCEREBELLAR ATAXIA TYPE 30	0.0232558	0.8724680866054324
MULTIPLE SYSTEM ATROPHY	0.0232558	0.8724680866054324
ATAXIA, EARLY-ONSET, WITH OCULOMOTOR APRAXIA AND HYPOALBUMINEMIA; EAOH	0.0232558	0.8724680866054324
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.0232558	0.8724680866054324
EPISODIC ATAXIA TYPE 4	0.0232558	0.8724680866054324
MACHADO-JOSEPH DISEASE; MJD	0.0232558	0.8724680866054324
SPINOCEREBELLAR ATAXIA 27; SCA27	0.0232558	0.8724680866054324
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.0232558	0.8724680866054324
CLASSIC MULTIMINICORE MYOPATHY	0.0232558	0.8724680866054324
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.0232558	0.8724680866054324
EPISODIC ATAXIA TYPE 5	0.0232558	0.8724680866054324
MACHADO-JOSEPH DISEASE TYPE 2	0.0232558	0.8724680866054324
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.023157249	0.8687708324837488
PYRUVATE DEHYDROGENASE DEFICIENCY	0.023120003	0.8673735059521435
AICARDI-GOUTIERES SYNDROME 7	0.023120003	0.8673735059521435
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.023120003	0.8673735059521435
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.023120003	0.8673735059521435
X-LINKED RETINOSCHISIS	0.02305913	0.8650897853389661
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.022904464	0.8592873124469168
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.022896304	0.8589811806610097
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.022794549999999997	0.8551637623101273
DEAFNESS-SMALL BOWEL DIVERTICULOSIS-NEUROPATHY SYNDROME	0.02278036	0.8546314081383108
SUSAC SYNDROME	0.02278036	0.8546314081383108
WATSON SYNDROME	0.0227273	0.8526408012069095
THUMB DEFORMITY	0.0227273	0.8526408012069095
GLYCOGEN STORAGE DISEASE DUE TO MUSCLE GLYCOGEN PHOSPHORYLASE DEFICIENCY	0.0227273	0.8526408012069095
NECROTIZING ENCEPHALOMYELOPATHY, SUBACUTE, OF LEIGH, ADULT	0.0227273	0.8526408012069095
VENULAR INSUFFICIENCY, SYSTEMIC	0.0227273	0.8526408012069095
SIRENOMELIA	0.0227273	0.8526408012069095
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.0227273	0.8526408012069095
PARIS-TROUSSEAU THROMBOCYTOPENIA	0.0227273	0.8526408012069095
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0227273	0.8526408012069095
CONGENITAL ATRANSFERRINEMIA	0.0227273	0.8526408012069095
COCAINE EMBRYOFETOPATHY	0.0227273	0.8526408012069095
LARSEN SYNDROME	0.0227273	0.8526408012069095
AMYLOIDOSIS	0.0227273	0.8526408012069095
%113950 BUNDLE BRANCH BLOCK, FAMILIAL ISOLATED COMPLETE RIGHT	0.0227273	0.8526408012069095
ATROPHODERMA VERMICULATA; AVA	0.0227273	0.8526408012069095
140450 HEART-HAND SYNDROME, SPANISH TYPE	0.0227273	0.8526408012069095
150590 LEG ULCERS, FAMILIAL, OF JUVENILE ONSET	0.0227273	0.8526408012069095
MUSCULAR HYPERTONIA, LETHAL	0.0227273	0.8526408012069095
ARTERIES, ANOMALIES OF	0.0227273	0.8526408012069095
FATCO SYNDROME	0.0227273	0.8526408012069095
ACUTE RESPIRATORY CORONAVIRUS INFECTION	0.0227273	0.8526408012069095
CRANIOFACIOFRONTODIGITAL SYNDROME	0.0227273	0.8526408012069095
RHOMBENCEPHALOSYNAPSIS	0.0227273	0.8526408012069095
HEMANGIOPERICYTOMA, MALIGNANT	0.0227273	0.8526408012069095
DISTAL TRISOMY 17Q	0.022676703	0.8507425965535338
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.022676703	0.8507425965535338
MICROPHTHALMIA, SYNDROMIC 1	0.022616359000000003	0.8484787219838301
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.022606804	0.8481202551683468
DYSTONIA 28, CHILDHOOD-ONSET	0.022578584	0.847061549408751
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.022513204	0.8446087435064701
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064701
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064701
JOUBERT SYNDROME 30; JBTS30	0.022363573	0.838995164430848
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.022363573	0.838995164430848
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.022363573	0.838995164430848
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.022363573	0.838995164430848
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.02233706	0.8380004987397012
CRANDALL SYNDROME	0.02233706	0.8380004987397012
STICKLER SYNDROME, TYPE III	0.02233706	0.8380004987397012
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.022335163	0.8379293306027078
THROMBOCYTHEMIA, ESSENTIAL	0.02229256	0.8363310300543004
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.022173119999999998	0.8318501010703843
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.022170223	0.8317414167831574
ROIFMAN SYNDROME; RFMN	0.022135283999999998	0.8304306400101413
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.022125009000000005	0.83004516156649
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.022117899	0.829778421738328
MEIER-GORLIN SYNDROME 1; MGORS1	0.02207494	0.8281667654404375
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.022055544	0.8274391021905041
MOSAIC TRISOMY 15	0.02204909	0.8271969729568958
3MC SYNDROME 1	0.02203303	0.826594463584142
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818612
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.021920273	0.8223642550322381
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.021846239000000003	0.8195867843658347
JOUBERT SYNDROME 23; JBTS23	0.021822154	0.8186832078874554
HUNTINGTON DISEASE; HD	0.021818019	0.818528078606239
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.021818019	0.818528078606239
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.021695843	0.8139445054352835
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.02162906	0.8114390643742246
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.021589729999999998	0.8099635541855323
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.021589729999999998	0.8099635541855323
ISOTRETINOIN-LIKE SYNDROME	0.021589729999999998	0.8099635541855323
ROIFMAN SYNDROME	0.021589729999999998	0.8099635541855323
FRONTONASAL DYSPLASIA 1; FND1	0.021583590000000003	0.8097332050230974
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.021378854	0.8020522984888456
MEDULLOBLASTOMA	0.021378854	0.8020522984888456
N SYNDROME	0.021378854	0.8020522984888456
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.021374719	0.8018971692076292
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.021374719	0.8018971692076292
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.021374719	0.8018971692076292
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.021374719	0.8018971692076292
DILATED CARDIOMYOPATHY WITH ATAXIA	0.021374719	0.8018971692076292
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.021374719	0.8018971692076292
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.021355984	0.8011943041330004
SALT-AND-PEPPER SYNDROME	0.021342293999999998	0.8006807080363005
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.7985839303997377
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.0212766	0.7982161220628465
RAVINE SYNDROME	0.0212766	0.7982161220628465
NEUROFERRITINOPATHY	0.0212766	0.7982161220628465
SPINOCEREBELLAR ATAXIA 12	0.0212766	0.7982161220628465
KURU, SUSCEPTIBILITY TO	0.0212766	0.7982161220628465
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 76	0.0212766	0.7982161220628465
LEBER OPTIC ATROPHY AND DYSTONIA	0.0212766	0.7982161220628465
INFANTILE-ONSET ASCENDING HEREDITARY SPASTIC PARALYSIS	0.0212766	0.7982161220628465
PRIMARY BASILAR INVAGINATION	0.0212766	0.7982161220628465
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.0212766	0.7982161220628465
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.021103044	0.7917049690928823
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.02100588	0.7880597498715728
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.020992814000000002	0.787569563852619
WEAVER SYNDROME	0.020888033000000004	0.7836385841149793
611961 STEVENSON-CAREY SYNDROME	0.020888033000000004	0.7836385841149793
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.02084172	0.7819010986492048
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.0208333	0.7815852126642366
MELKERSSON-ROSENTHAL SYNDROME	0.0208333	0.7815852126642366
CARNEY COMPLEX, TYPE 1; CNC1	0.0208333	0.7815852126642366
PUPIL, EGG-SHAPED	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL DOMINANT 20	0.0208333	0.7815852126642366
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0208333	0.7815852126642366
SETTING-SUN PHENOMENON, FAMILIAL BENIGN	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.0208333	0.7815852126642366
MYDRIATIC RESPONSE TO PHARMACOLOGIC AGENTS	0.0208333	0.7815852126642366
PROTRUSIO ACETABULI	0.0208333	0.7815852126642366
OCULAR CICATRICIAL PEMPHIGOID	0.0208333	0.7815852126642366
DERMOIDS OF CORNEA	0.0208333	0.7815852126642366
MYELINATED OPTIC NERVE FIBERS	0.0208333	0.7815852126642366
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.0208333	0.7815852126642366
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.0208333	0.7815852126642366
UNIQUE GREEN PHENOMENON	0.0208333	0.7815852126642366
WOODHOUSE-SAKATI SYNDROME	0.0208333	0.7815852126642366
SCHOPF-SCHULZ-PASSARGE SYNDROME; SSPS	0.0208333	0.7815852126642366
AGNATHIA-OTOCEPHALY COMPLEX	0.0208333	0.7815852126642366
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 1	0.0208333	0.7815852126642366
%271530 BRACHYOLMIA TYPE 1, HOBAEK TYPE;;BRACHYOLMIA, RECESSIVE TYPE OF HOBAEK;;SPONDYLODYSPLASIA WITH PURE BRACHYOLMIA	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.0208333	0.7815852126642366
TIETZ SYNDROME	0.0208333	0.7815852126642366
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0208333	0.7815852126642366
SEA-BLUE HISTIOCYTE DISEASE	0.0208333	0.7815852126642366
IMINOGLYCINURIA	0.0208333	0.7815852126642366
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.0208333	0.7815852126642366
MYOPATHY, CENTRONUCLEAR, 5	0.0208333	0.7815852126642366
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 5	0.0208333	0.7815852126642366
OCULOCEREBRAL SYNDROME WITH HYPOPIGMENTATION	0.0208333	0.7815852126642366
JUVENILE-ONSET DIABETES MELLITUS-CENTRAL AND PERIPHERAL NEURODEGENERATION SYNDROME	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.0208333	0.7815852126642366
MELANOMA, CUTANEOUS MALIGNANT	0.0208333	0.7815852126642366
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.0208333	0.7815852126642366
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.0208333	0.7815852126642366
LARYNGOONYCHOCUTANEOUS SYNDROME	0.0208333	0.7815852126642366
LEVATOR-MEDIAL RECTUS SYNKINESIS	0.0208333	0.7815852126642366
ACROMEGALOID CHANGES, CUTIS VERTICIS GYRATA, AND CORNEAL LEUKOMA	0.0208333	0.7815852126642366
611426 TENTED EYEBROWS	0.0208333	0.7815852126642366
MYOCLONUS-CEREBELLAR ATAXIA-DEAFNESS SYNDROME	0.0208333	0.7815852126642366
HYPERCALCEMIA, INFANTILE, 1	0.0208333	0.7815852126642366
OSTEOGENESIS IMPERFECTA, TYPE V	0.0208333	0.7815852126642366
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.0208333	0.7815852126642366
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0207875	0.7798669729835321
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751289
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751289
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020711303	0.7770083548841731
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.02055749	0.7712378832682734
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.02055749	0.7712378832682734
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.020392434	0.7650456175752959
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.020387693	0.7648677535070377
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.02038535	0.7647798531670402
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.020346614000000002	0.7633266275715868
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.020346614000000002	0.7633266275715868
FRYNS SYNDROME; FRNS	0.020342479000000004	0.7631714982903703
311450 PALLISTER W SYNDROME;;W SYNDROME	0.020342479000000004	0.7631714982903703
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.020329413000000005	0.7626813122714166
AYME-GRIPP SYNDROME; AYGRP	0.020139449	0.7555545943084173
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.020088752999999997	0.7536526755561683
PALLISTER-KILLIAN SYNDROME	0.019987959000000003	0.7498712727095106
BAND HETEROTOPIA; BH	0.019954873	0.7486300133628775
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.01989336	0.7463222824135504
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.019879379000000003	0.7457977691171329
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.019852440000000002	0.7447871215459865
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.019801060000000002	0.7428595417469778
264010 PRADER-WILLI HABITUS, OSTEOPENIA, AND CAMPTODACTYLY;;URBAN-ROGERS-MEYER SYNDROME	0.019801060000000002	0.7428595417469778
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.019801060000000002	0.7428595417469778
FIBROCHONDROGENESIS 1; FBCG1	0.019801060000000002	0.7428595417469778
%211960 CAMPTODACTYLY WITH MUSCULAR HYPOPLASIA, SKELETAL DYSPLASIA, AND ABNORMALPALMAR CREASES;;TEL HASHOMER CAMPTODACTYLY SYNDROME	0.019801060000000002	0.7428595417469778
601016 MIDLINE MALFORMATIONS, MULTIPLE, WITH LIMB ABNORMALITIES AND HYPOPITUITARISM;;DINCSOY SYNDROME	0.019801060000000002	0.7428595417469778
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.019801060000000002	0.7428595417469778
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.019801060000000002	0.7428595417469778
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.019801060000000002	0.7428595417469778
BRACHYDACTYLY, TYPE B1	0.019801060000000002	0.7428595417469778
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.019801060000000002	0.7428595417469778
KAPUR-TORIELLO SYNDROME	0.019789839	0.7424385730252051
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.01974137	0.7406202027395268
SCHAAF-YANG SYNDROME; SHFYNG	0.019522433000000002	0.7324065293558061
BRANCHIOOCULOFACIAL SYNDROME	0.019501509	0.7316215414283156
HHHH SYNDROME	0.019409319	0.7281629275382686
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	0.7281629275382686
OPTIC DISC ANOMALIES WITH RETINAL AND/OR MACULAR DYSTROPHY; ODRMD	0.019380750000000002	0.7270911286422415
ATELOSTEOGENESIS TYPE II	0.01933796	0.7254858125737403
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.019208699000000003	0.720636437478379
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395406
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.019017054	0.7134466548668369
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.018883933	0.7084524674315733
CARPAL DISPLACEMENT	0.0188679	0.707850970994876
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	0.707850970994876
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0188679	0.707850970994876
NEPHROSIALIDOSIS	0.0188679	0.707850970994876
BEEMER LETHAL MALFORMATION SYNDROME	0.0188679	0.707850970994876
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	0.707850970994876
THALIDOMIDE SUSCEPTIBILITY	0.0188679	0.707850970994876
VAN DEN BOSCH SYNDROME	0.0188679	0.707850970994876
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0188679	0.707850970994876
MONOPHALANGY OF GREAT TOE	0.0188679	0.707850970994876
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	0.707850970994876
KNUCKLE PADS	0.0188679	0.707850970994876
SPINAL ARACHNOIDITIS	0.0188679	0.707850970994876
MEGAEPIPHYSEAL DWARFISM	0.0188679	0.707850970994876
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	0.707850970994876
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	0.707850970994876
LETTERER-SIWE DISEASE	0.0188679	0.707850970994876
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	0.707850970994876
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	0.707850970994876
PACHYDERMODACTYLY, FAMILIAL	0.0188679	0.707850970994876
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	0.707850970994876
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	0.707850970994876
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	0.707850970994876
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0188679	0.707850970994876
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	0.707850970994876
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	0.707850970994876
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	0.707850970994876
TRACHEOBRONCHOMEGALY	0.0188679	0.707850970994876
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	0.707850970994876
DOUBLE NAIL FOR FIFTH TOE	0.0188679	0.707850970994876
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	0.707850970994876
PUBIC BONE DYSPLASIA	0.0188679	0.707850970994876
VESICOURETERAL REFLUX 1	0.0188679	0.707850970994876
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0188679	0.707850970994876
RAYNAUD DISEASE	0.0188679	0.707850970994876
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	0.707850970994876
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	0.707850970994876
TOE, MISSHAPEN	0.0188679	0.707850970994876
THROMBOCYTOPENIA 3	0.0188679	0.707850970994876
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.018843614	0.7069398537703
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.01875885	0.7037598348118885
COCKAYNE SYNDROME	0.018749139	0.7033955154769689
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.018553389999999996	0.6960517665848676
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.018438353000000005	0.6917360212104309
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.018438353	0.6917360212104308
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.018262760000000003	0.6851484478424407
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.018193223999999997	0.6825397248197882
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.018099464	0.6790222105738744
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.017897160000000002	0.6714325433169912
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.017897160000000002	0.6714325433169912
SPINOCEREBELLAR ATAXIA TYPE 37	0.017897160000000002	0.6714325433169912
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.017695384	0.6638626845874314
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.01759822	0.6602174653661218
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.017507843	0.6568268682564484
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.017494153	0.6563132721597488
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.017480373000000004	0.6557962996095282
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.017480373000000004	0.6557962996095282
SYNDACTYLY, TYPE V	0.01746589	0.6552529532056931
FIBROSCLEROSIS, MULTIFOCAL	0.01746589	0.6552529532056931
SPONDYLOCHEIRODYSPLASIA, EHLERS-DANLOS SYNDROME-LIKE	0.01746589	0.6552529532056931
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.01740912	0.6531231613569246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397245
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397245
TRANSSEXUALITY	0.0172414	0.6468309526397245
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397245
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397245
DIASTEMATOMYELIA	0.0172414	0.6468309526397245
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397245
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397245
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397245
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397245
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397245
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397245
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397245
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397245
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397245
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397245
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397245
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397245
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397245
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397245
CERVICAL RIB	0.0172414	0.6468309526397245
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397245
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397245
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397245
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397245
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397245
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	0.6468309526397245
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397245
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397245
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397245
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397245
PALMOMENTAL REFLEX	0.0172414	0.6468309526397245
MOTION SICKNESS	0.0172414	0.6468309526397245
SICKLE CELL ANEMIA	0.0172414	0.6468309526397245
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397245
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397245
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397245
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397245
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397245
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397245
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397245
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397245
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397245
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397245
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397245
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.017206603	0.6455255031600415
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.01714983	0.6433955987628224
AUTOSOMAL DOMINANT PRIMARY MICROCEPHALY	0.01714983	0.6433955987628224
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.01714983	0.6433955987628224
MICROCEPHALY, AUTOSOMAL DOMINANT	0.01714983	0.6433955987628224
MOSAIC TRISOMY 1	0.01700279	0.6378792240324557
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.016948598999999998	0.6358461863351398
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.016938954000000003	0.6354843430661357
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.016938954000000003	0.6354843430661357
GAUCHER DISEASE, TYPE IIIC	0.016934819000000004	0.6353292137849192
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.016894643999999997	0.6338220024492792
221810 DERMATOOSTEOLYSIS, KIRGHIZIAN TYPE;;KIRGHIZIAN DERMATOOSTEOLYSIS	0.01675656	0.6286416223604059
HYPERMANGANESEMIA WITH DYSTONIA 2	0.016692114	0.6262238565424433
HAREL-YOON SYNDROME; HAYOS	0.016675773999999997	0.6256108426476241
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.016675773999999997	0.6256108426476241
COFS SYNDROME	0.016586069000000002	0.622245456390908
CEREBRAL PALSY, ATAXIC, AUTOSOMAL RECESSIVE	0.016393400000000002	0.6150172572415268
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.016393400000000002	0.6150172572415268
CHILDHOOD-ONSET AUTOSOMAL RECESSIVE SLOWLY PROGRESSIVE SPINOCEREBELLAR ATAXIA	0.016393400000000002	0.6150172572415268
CRANIOFACIOFRONTODIGITAL SYNDROME	0.016393400000000002	0.6150172572415268
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.016393400000000002	0.6150172572415268
RETINAL CONE DYSTROPHY 3B	0.016393400000000002	0.6150172572415268
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.016393400000000002	0.6150172572415268
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.016393400000000002	0.6150172572415268
SPINOCEREBELLAR ATAXIA 42	0.016393400000000002	0.6150172572415268
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.016393400000000002	0.6150172572415268
VAN DEN BOSCH SYNDROME	0.016393400000000002	0.6150172572415268
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.016393400000000002	0.6150172572415268
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.016393400000000002	0.6150172572415268
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.016393400000000002	0.6150172572415268
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.016393400000000002	0.6150172572415268
WERNICKE-KORSAKOFF SYNDROME	0.016393400000000002	0.6150172572415268
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.016393400000000002	0.6150172572415268
OPTIC ATROPHY 1; OPA1	0.016393400000000002	0.6150172572415268
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.016333929	0.612786134270977
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
CORNELIA DE LANGE SYNDROME 1	0.016201529	0.6078189959800319
NIEMANN-PICK DISEASE TYPE B	0.016130219999999997	0.6051437568230152
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.016059972999999998	0.6025083598175468
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.016040634	0.601782834988177
MARINESCO-SJOGREN SYNDROME; MSS	0.016039124	0.601726185601324
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.015990393	0.5998979860842844
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.015990393	0.5998979860842844
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.015990393	0.5998979860842844
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.015990393	0.5998979860842844
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.015875909	0.5956029871409269
MEIER-GORLIN SYNDROME 7	0.015761604	0.5913147035884609
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.015757469	0.5911595743072445
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.015747914	0.5908011074917613
MYHRE SYNDROME	0.015710903000000002	0.589412597255461
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.015542002999999999	0.583076119480985
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.015477634	0.5806612424065904
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230291
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.015470953999999999	0.5804106345230291
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230291
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.015025733	0.5637076565998205
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.015000583999999997	0.5627641629375925
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.015000583999999997	0.5627641629375925
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.015000583999999997	0.5627641629375925
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.014996448999999999	0.562609033656376
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.014996448999999999	0.562609033656376
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984202
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984202
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984202
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984202
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.014918959999999998	0.559701944690915
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.014903419999999999	0.5591189437162829
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.014903419999999999	0.5591189437162829
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.014834304000000001	0.5565259774767289
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.014785572999999998	0.5546977779596893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.014785572999999998	0.5546977779596893
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.014785572999999998	0.5546977779596893
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.014785572999999998	0.5546977779596893
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.014785572999999998	0.5546977779596893
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.014785572999999998	0.5546977779596893
PEHO SYNDROME; PEHO	0.014785572999999998	0.5546977779596893
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.014785572999999998	0.5546977779596893
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.014785572999999998	0.5546977779596893
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.014785572999999998	0.5546977779596893
W SYNDROME	0.014730664000000001	0.5526378036665058
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.014652623000000002	0.549710005786116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.014638933000000003	0.5491964096894162
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.014578814	0.5469409762535149
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.014578814	0.5469409762535149
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.014501603000000002	0.544044316777819
ALPORT SYNDROME, X-LINKED; ATS	0.01436238	0.5388212057938291
ANGELMAN SYNDROME	0.014339993000000002	0.5379813317385468
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.014339993	0.5379813317385468
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.0143371	0.5378727975159205
MOEBIUS SYNDROME; MBS	0.0143371	0.5378727975159205
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.0143371	0.5378727975159205
NATIVE AMERICAN MYOPATHY	0.0143371	0.5378727975159205
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014313734	0.5369961951495593
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.014313734	0.5369961951495593
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.5343858214162969
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.5343858214162969
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.014244153999999998	0.5343858214162969
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.014244153999999998	0.5343858214162969
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.014244153999999998	0.5343858214162969
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.014244153999999998	0.5343858214162969
PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA 2; PPKCA2	0.01424165	0.5342918809761116
RETT SYNDROME, CONGENITAL VARIANT	0.014240018999999998	0.5342306921350803
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.014240018999999998	0.5342306921350803
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.014240018999999998	0.5342306921350803
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.014240018999999998	0.5342306921350803
COG8-CDG	0.014240018999999998	0.5342306921350803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.014240018999999998	0.5342306921350803
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.014240018999999998	0.5342306921350803
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.014240018999999998	0.5342306921350803
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.014240018999999998	0.5342306921350803
HALLERMANN-STREIFF SYNDROME; HSS	0.014210689999999998	0.5331303809648755
SENGERS SYNDROME	0.01418488	0.5321620891273432
TIBIAL HEMIMELIA	0.014175650000000001	0.531815815060686
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.014161960000000001	0.5313022189639862
BARAITSER-WINTER SYNDROME 2; BRWS2	0.014107069000000002	0.529242919961507
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.014001103999999999	0.5252675211019903
VICI SYNDROME; VICIS	0.013985943	0.5246987387482969
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.013960184000000002	0.5237323602344264
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.013863020000000002	0.5200871410131169
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.013845333000000001	0.519423592863933
CODAS SYNDROME	0.013807223	0.5179938523785258
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.013798574000000001	0.5176693751951543
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.013794439000000002	0.5175142459139379
PELVISCAPULAR DYSPLASIA	0.01371255	0.5144420858874484
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.5139187355916879
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.013698599999999998	0.5139187355916879
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.5139187355916879
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.5139187355916879
TRICHOTHIODYSTROPHY 5, NONPHOTOSENSITIVE	0.013698599999999998	0.5139187355916879
COG1-CDG	0.013698599999999998	0.5139187355916879
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.5139187355916879
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.5139187355916879
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.5139187355916879
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.5139187355916879
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.013565650000000002	0.5089309634181144
MOSAIC TRISOMY 8	0.013519380000000001	0.5071950911468001
SECKEL SYNDROME 1; SCKL1	0.013492949	0.5062035017799724
DESMOSTEROLOSIS	0.01345555	0.5048004352773815
ROTHMUND-THOMSON SYNDROME	0.013424644000000001	0.5036409611382581
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.013399920000000001	0.5027134118398794
GAUCHER DISEASE TYPE 2	0.01335762	0.5011264786849928
MARDEN-WALKER SYNDROME	0.013303914	0.4991116363205405
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.013244674	0.4968891795806947
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.013135173000000002	0.49278112361395177
WEBB-DATTANI SYNDROME; WEDAS	0.013135173000000002	0.49278112361395177
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.013135173000000002	0.49278112361395177
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.013135173000000002	0.49278112361395177
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.013135173000000002	0.49278112361395177
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.013135173000000002	0.49278112361395177
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.013135173000000002	0.49278112361395177
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.013135173000000002	0.49278112361395177
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.013135173000000002	0.49278112361395177
8Q24.3 MICRODELETION SYNDROME	0.013135173000000002	0.49278112361395177
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.013135173000000002	0.49278112361395177
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.013135173000000002	0.49278112361395177
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.013135173000000002	0.49278112361395177
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.013135173000000002	0.49278112361395177
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.013135173000000002	0.49278112361395177
LISSENCEPHALY 1; LIS1	0.013135173000000002	0.49278112361395177
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.012951530000000001	0.48589154523658
ATYPICAL WERNER SYNDROME	0.01285862	0.4824059197183647
SCALP-EAR-NIPPLE SYNDROME; SENS	0.01285862	0.4824059197183647
GAUCHER DISEASE TYPE 3	0.01280536	0.4804078095569166
BETA-UREIDOPROPIONASE DEFICIENCY	0.012796284	0.4800673129773953
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012796284	0.4800673129773953
RING CHROMOSOME 14 SYNDROME	0.012796284	0.4800673129773953
FUMARASE DEFICIENCY; FMRD	0.012796284	0.4800673129773953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012796284	0.4800673129773953
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012796284	0.4800673129773953
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.01275836	0.4786445504959316
MYOPATHY, DISTAL 3	0.012658200000000001	0.47488693288852185
OTOONYCHOPERONEAL SYNDROME	0.012658200000000001	0.47488693288852185
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.012658200000000001	0.47488693288852185
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.012658200000000001	0.47488693288852185
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 4	0.012658200000000001	0.47488693288852185
CONGENITAL PATELLA DISLOCATION	0.012658200000000001	0.47488693288852185
MYOPATHY, MYOFIBRILLAR, 6; MFM6	0.012658200000000001	0.47488693288852185
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.012658200000000001	0.47488693288852185
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 62	0.012658200000000001	0.47488693288852185
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.012658200000000001	0.47488693288852185
ATAXIA-TELANGIECTASIA WITH GENERALIZED SKIN PIGMENTATION AND EARLY DEATH	0.012658200000000001	0.47488693288852185
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.012658200000000001	0.47488693288852185
FINNISH UPPER LIMB-ONSET DISTAL MYOPATHY	0.012658200000000001	0.47488693288852185
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.012606423	0.47294445917787026
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.012593754000000002	0.4724691670705593
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.012589619000000002	0.47231403778934283
MENTAL RETARDATION, X-LINKED 1	0.012589619000000002	0.47231403778934283
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.012589619000000002	0.47231403778934283
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.012589619000000002	0.47231403778934283
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.012589619000000002	0.47231403778934283
RETT SYNDROME; RTT	0.012589619000000002	0.47231403778934283
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4720009279994921
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.012410923	0.46561005180717735
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.01225073	0.45960022715278637
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01225073	0.45960022715278637
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.0121951	0.4575132037152843
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.0121951	0.4575132037152843
RUIJS-AALFS SYNDROME; RJALS	0.0121951	0.4575132037152843
CYANIDE-INDUCED PARKINSONISM-DYSTONIA	0.0121951	0.4575132037152843
RARE CIRCULATORY SYSTEM DISEASE	0.0121951	0.4575132037152843
INFANTILE CATARACT, SKIN ABNORMALITIES, GLUTAMATE EXCESS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; CASGID	0.012048200000000002	0.45200208124595037
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.012048200000000002	0.45200208124595037
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.4516889714560996
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.4516889714560996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.4516889714560996
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.4516889714560996
PERLMAN SYNDROME	0.012039854	0.4516889714560996
CONGENITAL CONTRACTURAL ARACHNODACTYLY	0.012001930000000001	0.450266208974636
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.012001930000000001	0.450266208974636
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.012001930000000001	0.450266208974636
CROME SYNDROME	0.011936629	0.4478163668482236
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.011786774	0.4421943841549488
19P13.12 MICRODELETION SYNDROME	0.011746223000000002	0.4406730667468212
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.011708533000000002	0.43925908304451217
DUANE RETRACTION SYNDROME	0.011694843000000002	0.43874548694781246
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.011529813	0.432554196674741
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.011494299999999999	0.4312218856314908
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.011494299999999999	0.4312218856314908
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.011492829	0.431166699374497
HALLERMANN-STREIFF SYNDROME	0.011395210000000001	0.42750441030483105
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.01139521	0.42750441030483105
BIOTINIDASE DEFICIENCY	0.011322264	0.4247677572098819
KRABBE DISEASE	0.011308574	0.4242541611131822
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.011304439	0.42409903183196573
NEMALINE MYOPATHY 2; NEM2	0.0112926	0.4236548781293487
METATROPIC DYSPLASIA	0.0112926	0.4236548781293487
ADAMS-OLIVER SYNDROME 2; AOS2	0.011277363	0.4230832445482374
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.011277363	0.4230832445482374
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.01124122	0.4217272983303399
CATARACT 15, MULTIPLE TYPES; CTRCT15	0.011216489999999999	0.4207995239350599
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.011184334	0.4195931546081444
KNOBLOCH SYNDROME 1; KNO1	0.011180199	0.4194380253269279
1P36 DELETION SYNDROME	0.011142203	0.41801256168264733
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.011012464	0.4131452538674742
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.011009634	0.4130390831623128
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.010989793000000001	0.4122947252255255
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.010974704000000002	0.41172864403464887
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.010938413000000001	0.41036714542651676
CATARACT-DEAFNESS-HYPOGONADISM SYNDROME	0.01093772	0.41034114673440475
FABRY DISEASE	0.010798469	0.40511698529820855
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.01077671	0.404300671385273
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.01076302	0.40378707528857327
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.010735944	0.402771288004845
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.010735944	0.402771288004845
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.010731809	0.4026161587236285
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.01063878	0.39912606878353546
PEROXISOME BIOGENESIS DISORDER 14B	0.01063878	0.39912606878353546
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.01063878	0.39912606878353546
CATARACT 17, MULTIPLE TYPES	0.01063878	0.39912606878353546
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.01063878	0.39912606878353546
NANCE-HORAN SYNDROME	0.01063878	0.39912606878353546
CATARACT 2, MULTIPLE TYPES; CTRCT2	0.01063878	0.39912606878353546
MICROPHTHALMIA, LENZ TYPE	0.010610339	0.3980590719547381
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.010561244000000001	0.39621721655901343
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.010561244000000001	0.39621721655901343
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.010561244000000001	0.39621721655901343
RFT1-CDG	0.010555093	0.3959864547189258
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.010520933	0.3947049030269417
PHACE ASSOCIATION	0.010520933	0.3947049030269417
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.010503713000000001	0.3940588749199171
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.010444239000000001	0.3918276394009166
CONGENITAL MYASTHENIC SYNDROME	0.010444239000000001	0.3918276394009166
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.010392859	0.3899000596019079
HURLER SYNDROME	0.010295354	0.3862420473733686
ALPORT SYNDROME	0.01025705	0.38480502875481604
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.01019039	0.3823042021802361
MICROCEPHALY, CATARACTS, IMPAIRED INTELLECTUAL DEVELOPMENT, AND DYSTONIA WITH ABNORMAL STRIATUM; MCIDDS	0.01019039	0.3823042021802361
OSTEOGENESIS IMPERFECTA CONGENITA, MICROCEPHALY, AND CATARACTS	0.01019039	0.3823042021802361
WARBURG MICRO SYNDROME 1	0.01019039	0.3823042021802361
1Q21.1 MICRODUPLICATION SYNDROME	0.010063743	0.3775528943015856
PAINE SYNDROME	0.01001569	0.3757501307344045
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.01001569	0.3757501307344045
XQ12-Q13.3 DUPLICATION SYNDROME	0.01001569	0.3757501307344045
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.01001569	0.3757501307344045
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.010012363	0.3756253145025769
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.009979514	0.3743929464835493
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.009975379	0.37423781720233285
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.009975379	0.37423781720233285
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.009861683999999999	0.3699724185015096
ROIFMAN-CHITAYAT SYNDROME	0.009804814	0.3678388750377178
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.3678388750377178
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.3678388750377178
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.3678388750377178
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.3678388750377178
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.3678388750377178
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.3678388750377178
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.3678388750377178
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.3676837457565013
NEU-LAXOVA SYNDROME	0.009733200000000001	0.3651521934548799
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.009696909	0.3637906948467478
HENNEKAM-BEEMER SYNDROME	0.009651639	0.36209233872566715
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.009586024	0.3596307165280814
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00958121	0.3594501137808562
COHEN-GIBSON SYNDROME; COGIS	0.009470944	0.3553133579591844
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.009466809	0.355158228677968
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00943396	0.3539258606589404
49,XYYYY SYNDROME	0.00943396	0.3539258606589404
HYDROCEPHALUS, ENDOCARDIAL FIBROELASTOSIS, AND CATARACTS	0.00943396	0.3539258606589404
INSULINOMATOSIS AND DIABETES MELLITUS; INSDM	0.00943396	0.3539258606589404
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.00943396	0.3539258606589404
CATARACT, CONGENITAL OR JUVENILECATARACT, JUVENILE, HUTTERITE TYPE, INCLUDED	0.00943396	0.3539258606589404
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00943396	0.3539258606589404
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00943396	0.3539258606589404
CATARACT 44; CTRCT44	0.00943396	0.3539258606589404
HEC SYNDROME	0.00943396	0.3539258606589404
CATARACT 3, MULTIPLE TYPES; CTRCT3	0.00943396	0.3539258606589404
CATARACT 13 WITH ADULT I PHENOTYPE	0.00943396	0.3539258606589404
CATARACT-HYPERTRICHOSIS-INTELLECTUAL DISABILITY SYNDROME	0.00943396	0.3539258606589404
CATARACT 7; CTRCT7	0.00943396	0.3539258606589404
%115665 CATARACT, CONGENITAL, VOLKMANN TYPE; CCV	0.00943396	0.3539258606589404
CATARACT, CRYSTALLINE ACULEIFORM	0.00943396	0.3539258606589404
CATARACT 1, MULTIPLE TYPES	0.00943396	0.3539258606589404
CATARACT, NUCLEAR TOTAL	0.00943396	0.3539258606589404
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 25	0.00943396	0.3539258606589404
CATARACT 22, MULTIPLE TYPES; CTRCT22	0.00943396	0.3539258606589404
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00943396	0.3539258606589404
SUPERNUMERARY NOSTRIL	0.00943396	0.3539258606589404
CONGENITAL FIBRINOGEN DEFICIENCY	0.00943396	0.3539258606589404
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00943396	0.3539258606589404
EDICT SYNDROME	0.00943396	0.3539258606589404
RETINAL DYSTROPHY AND IRIS COLOBOMA WITH OR WITHOUT CONGENITAL CATARACT	0.00943396	0.3539258606589404
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00943396	0.3539258606589404
FECHTNER SYNDROME	0.00943396	0.3539258606589404
CATARACT 45	0.00943396	0.3539258606589404
PUPILLARY MEMBRANE, PERSISTENCE OF	0.00943396	0.3539258606589404
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00943396	0.3539258606589404
%614422 CATARACT, CONGENITAL, CERULEAN TYPE, 5; CCA5	0.00943396	0.3539258606589404
15Q24 MICRODELETION SYNDROME	0.009373363	0.3516524945032274
CARNOSINASE DEFICIENCY	0.00925926	0.34737178921310885
HYDROXYLYSINURIA	0.00925926	0.34737178921310885
GLYCINE ENCEPHALOPATHY	0.00925926	0.34737178921310885
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.34737178921310885
CARNOSINEMIA	0.00925926	0.34737178921310885
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.00925926	0.34737178921310885
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.00925926	0.34737178921310885
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.34737178921310885
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.34737178921310885
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.34737178921310885
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.00925926	0.34737178921310885
COCKAYNE SYNDROME A; CSA	0.009213619	0.34565951460029143
20Q11.2 MICRODELETION SYNDROME	0.009205864000000001	0.345368576855229
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.009205864000000001	0.345368576855229
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.009205864000000001	0.345368576855229
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.009124183	0.3423042201879881
BUSCHKE-OLLENDORFF SYNDROME	0.00904047	0.33916363070347244
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.009037643	0.33905757254676167
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.009037643	0.33905757254676167
WILLIAMS-BEUREN SYNDROME; WBS	0.00902678	0.3386500346067728
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.0090035	0.33777665862933165
BOHRING-OPITZ SYNDROME	0.008986263000000001	0.337129992747753
GLASS SYNDROME	0.008986263000000001	0.337129992747753
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.008986263000000001	0.337129992747753
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.008929113	0.3349859447618957
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.008929113	0.3349859447618957
CUSHING SYNDROME	0.00875329	0.32838974267935167
CUSHING DISEASE	0.00875329	0.32838974267935167
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.008711690000000001	0.3268290708296288
MOEBIUS SYNDROME	0.008711690000000001	0.3268290708296288
TRISOMY 17P	0.008700324	0.3264026622660723
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.008696189	0.32624753298485576
16P13.2 MICRODELETION SYNDROME	0.008664033000000002	0.3250411636579402
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.008660310000000001	0.32490149103062005
13Q12.3 MICRODELETION SYNDROME	0.008660310000000001	0.32490149103062005
OTOPALATODIGITAL SYNDROME TYPE 2	0.008653224000000001	0.32463565159006386
BRITTLE CORNEA SYNDROME	0.00864662	0.32438789493392034
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.00864662	0.32438789493392034
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.008496224	0.31874561600336926
RAINE SYNDROME	0.008496224	0.31874561600336926
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.008496224	0.31874561600336926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.008496224	0.31874561600336926
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.008496224	0.31874561600336926
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.008496224	0.31874561600336926
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.008492089000000001	0.31859048672215284
GAUCHER DISEASE, PERINATAL LETHAL	0.008492089000000001	0.31859048672215284
RETT SYNDROME	0.008492089000000001	0.31859048672215284
BARDET-BIEDL SYNDROME 1; BBS1	0.008475014	0.3179498984569119
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.008444844	0.3168180362043605
OROFACIODIGITAL SYNDROME IX; OFD9	0.008444844	0.3168180362043605
CEREBROFACIOARTICULAR SYNDROME	0.008444844	0.3168180362043605
21Q22.11Q22.12 MICRODELETION SYNDROME	0.008440709000000001	0.3166629069231441
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00840089	0.3151690513369874
1Q44 MICRODELETION SYNDROME	0.008344233999999999	0.3130435363293455
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.008344233999999999	0.3130435363293455
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.008340594	0.31290697754249475
OCULODENTODIGITAL DYSPLASIA	0.008336459000000001	0.3127518482612784
CATEL-MANZKE SYNDROME; CATMANS	0.008229833	0.30875165122645737
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.008229833	0.30875165122645737
LYNCH SYNDROME	0.008185879	0.30710266635908423
FAMILIAL COLORECTAL CANCER TYPE X	0.008185879	0.30710266635908423
BOHRING-OPITZ SYNDROME	0.008168543	0.3064522863786324
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.008154853	0.3059386902819327
6Q25 MICRODELETION SYNDROME	0.008154853	0.3059386902819327
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00814108	0.30542198034476364
XERODERMA PIGMENTOSUM	0.008130239	0.3050152677600798
8Q21.11 MICRODELETION SYNDROME	0.00810767	0.3041685657654549
ADDUCTED THUMBS SYNDROME	0.00795067	0.2982785301787603
LISSENCEPHALY TYPE 3-METACARPAL BONE DYSPLASIA SYNDROME	0.00795067	0.2982785301787603
MECKEL SYNDROME 12; MKS12	0.00795067	0.2982785301787603
VON HIPPEL-LINDAU DISEASE	0.007915769999999999	0.2969692165356033
GERODERMA OSTEODYSPLASTICUM; GO	0.00789929	0.29635095037975157
TEEBI-SHALTOUT SYNDROME; TBSH	0.00789929	0.29635095037975157
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.00789929	0.29635095037975157
MEIER-GORLIN SYNDROME 2; MGORS2	0.00789929	0.29635095037975157
TRISOMY 18	0.007892204	0.2960851109391954
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00784214	0.29420690239389424
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00779868	0.29257645050473663
AMISH LETHAL MICROCEPHALY	0.00779868	0.29257645050473663
NOONAN SYNDROME 2; NS2	0.007739794	0.29036727448207356
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.007739794	0.29036727448207356
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.007739794	0.29036727448207356
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.007739794	0.29036727448207356
FETAL GAUCHER DISEASE	0.007735659000000001	0.29021214520085714
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.007724293	0.2897857366373006
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.007688414	0.28843969468306485
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.007688414	0.28843969468306485
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.007688414	0.28843969468306485
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.007688414	0.28843969468306485
RAHMAN SYNDROME	0.007688414	0.28843969468306485
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.007688414	0.28843969468306485
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.007688414	0.28843969468306485
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.007688414	0.28843969468306485
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.007677193	0.2880187259612922
EAR-PATELLA-SHORT STATURE SYNDROME	0.007627124	0.2861403298352399
2P15P16.1 MICRODELETION SYNDROME	0.007627124	0.2861403298352399
COG5-CDG	0.007609299	0.28547160445732384
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.2846651948080499
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.007587804	0.2846651948080499
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.2846651948080499
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.2846651948080499
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.007587804	0.2846651948080499
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.2846651948080499
PELGER-HUET ANOMALY; PHA	0.007587804	0.2846651948080499
X SMALL RINGS	0.007587804	0.2846651948080499
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.28451006552683344
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.28451006552683344
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00752302	0.2822347485313083
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.00752302	0.2822347485313083
ARTERIAL TORTUOSITY SYNDROME	0.00752302	0.2822347485313083
ARTERIAL TORTUOSITY SYNDROME	0.007516314	0.28198316522784095
TSH-SECRETING PITUITARY ADENOMA	0.007512178999999999	0.28182803594662453
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.007459213	0.27984095553334515
RECOMBINANT 8 SYNDROME	0.007412113	0.2780739448573367
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.00739834	0.27755723492016765
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00739834	0.27755723492016765
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.007387499	0.2771505223354839
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.007362049	0.2761957363120356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.007362049	0.2761957363120356
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007341652999999999	0.2754305569118686
MOWAT-WILSON SYNDROME	0.007310359	0.27425652650645443
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.007310359	0.27425652650645443
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.007310359	0.27425652650645443
CONGENITAL HYPOTHYROIDISM	0.007270194000000001	0.2727496903323169
NEUROFIBROMATOSIS TYPE 1	0.007266059	0.27259456105110047
MUSCULAR DYSTROPHY, CONGENITAL, PRODUCING ARTHROGRYPOSIS	0.00719424	0.2699001886574647
PELVIC DYSPLASIA - ARTHROGRYPOSIS OF LOWER LIMBS	0.00719424	0.2699001886574647
ARTHROGRYPOSIS - HYPERKERATOSIS, LETHAL FORM	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 3; NEM3	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00719424	0.2699001886574647
NEUROPATHY, CONGENITAL, WITH ARTHROGRYPOSIS MULTIPLEX	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.00719424	0.2699001886574647
BRUCK SYNDROME	0.00719424	0.2699001886574647
NEMALINE MYOPATHY 10	0.00719424	0.2699001886574647
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.00719424	0.2699001886574647
GLYCOGEN STORAGE DISEASE IV	0.00719424	0.2699001886574647
TYPICAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
INTERMEDIATE NEMALINE MYOPATHY	0.00719424	0.2699001886574647
SEVERE CONGENITAL NEMALINE MYOPATHY	0.00719424	0.2699001886574647
POLYMICROGYRIA, PERISYLVIAN, WITH CEREBELLAR HYPOPLASIA AND ARTHROGRYPOSIS; PMGYCHA	0.00719424	0.2699001886574647
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
GERMAN SYNDROME	0.00719424	0.2699001886574647
LETHAL CONGENITAL CONTRACTURE SYNDROME 2	0.00719424	0.2699001886574647
MULTIMINICORE MYOPATHY	0.00719424	0.2699001886574647
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.00719424	0.2699001886574647
NAKAJO-NISHIMURA SYNDROME	0.00719424	0.2699001886574647
ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00719424	0.2699001886574647
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.00719424	0.2699001886574647
INIENCEPHALY	0.00719424	0.2699001886574647
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.00719424	0.2699001886574647
SPONDYLOSPINAL THORACIC DYSOSTOSIS	0.00719424	0.2699001886574647
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.00719424	0.2699001886574647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.00719424	0.2699001886574647
CONTRACTURES, CONGENITAL, TORTICOLLIS, AND MALIGNANT HYPERTHERMIA	0.00719424	0.2699001886574647
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.00719424	0.2699001886574647
MYASTHENIC SYNDROME, CONGENITAL, 11, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS11	0.00719424	0.2699001886574647
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.007182874	0.26947378009390816
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.007146583	0.2681122814857761
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.007146583	0.2681122814857761
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.007146583	0.2681122814857761
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.007146583	0.2681122814857761
ARTHROGRYPOSIS, DISTAL, TYPE 2B2; DA2B2	0.00714286	0.2679726088584559
SILLENCE SYNDROME	0.00714286	0.2679726088584559
ARTHROGRYPOSIS, DISTAL, TYPE 2B3; DA2B3	0.00714286	0.2679726088584559
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.00714286	0.2679726088584559
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.00714286	0.2679726088584559
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00714286	0.2679726088584559
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.00714286	0.2679726088584559
MEESTER-LOEYS SYNDROME; MRLS	0.00714286	0.2679726088584559
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00714286	0.2679726088584559
WAHAB SYNDROME	0.00714286	0.2679726088584559
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.00714286	0.2679726088584559
PSEUDODIASTROPHIC DYSPLASIA	0.00714286	0.2679726088584559
2Q24 MICRODELETION SYNDROME	0.007131639	0.2675516401366833
WAARDENBURG SYNDROME TYPE 3	0.00708157	0.265673244010631
CHOREOACANTHOCYTOSIS	0.007074868999999999	0.2654218482879148
CRANIOFRONTONASAL DYSPLASIA	0.00706788	0.2651596479139313
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.264198108983441
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.264198108983441
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.264198108983441
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.264198108983441
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.264198108983441
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.264198108983441
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.264198108983441
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.264198108983441
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.264198108983441
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.264198108983441
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.00704225	0.264198108983441
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.264198108983441
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.264198108983441
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00704225	0.264198108983441
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.00704225	0.264198108983441
SOMATOMAMMOTROPINOMA	0.0069707599999999995	0.261516079403232
PRIMARY PIGMENTED NODULAR ADRENOCORTICAL DISEASE	0.0069707599999999995	0.261516079403232
PITUITARY APOPLEXY	0.0069707599999999995	0.261516079403232
GLUCOCORTICOID RESISTANCE, GENERALIZED; GCCR	0.0069707599999999995	0.261516079403232
CUSHING SYNDROME DUE TO MACRONODULAR ADRENAL HYPERPLASIA	0.0069707599999999995	0.261516079403232
GENERALIZED GLUCOCORTICOID RESISTANCE SYNDROME	0.0069707599999999995	0.261516079403232
POLYCYTHEMIA VERA	0.0069707599999999995	0.261516079403232
LIDDLE SYNDROME	0.0069707599999999995	0.261516079403232
CLASSICAL EHLERS-DANLOS SYNDROME	0.0069707599999999995	0.261516079403232
ACROMEGALY	0.0069707599999999995	0.261516079403232
POSTORGASMIC ILLNESS SYNDROME	0.0069707599999999995	0.261516079403232
ACTH-INDEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.261516079403232
ACTH-DEPENDENT CUSHING SYNDROME	0.0069707599999999995	0.261516079403232
CORTICOSTEROID-BINDING GLOBULIN DEFICIENCY	0.0069707599999999995	0.261516079403232
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA 2; AIMAH2	0.0069707599999999995	0.261516079403232
HEMORRHAGIC FEVER-RENAL SYNDROME	0.0069707599999999995	0.261516079403232
AL AMYLOIDOSIS	0.0069707599999999995	0.261516079403232
CARNEY TRIAD	0.0069707599999999995	0.261516079403232
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.0069707599999999995	0.261516079403232
PERIPARTUM CARDIOMYOPATHY	0.0069707599999999995	0.261516079403232
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.006913659	0.2593738697087362
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.006870694	0.25776198831394426
ABLEPHARON MACROSTOMIA SYNDROME	0.006870694	0.25776198831394426
16P11.2P12.2 MICRODELETION SYNDROME	0.006870694	0.25776198831394426
HYPERTRYPTOPHANEMIA; HYPTRP	0.006857004	0.2572483922172446
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.006796098999999999	0.25496347108725964
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.0067246400000000005	0.252282604507708
NAIL-PATELLA SYNDROME	0.0067246400000000005	0.252282604507708
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00671095	0.2517690084110083
CANAVAN DISEASE	0.006702783	0.2514626140120495
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006702783	0.2514626140120495
SIALIDOSIS TYPE 2	0.006702783	0.2514626140120495
PETTIGREW SYNDROME	0.006689093	0.2509490179153498
GALLOWAY-MOWAT SYNDROME	0.006651093	0.24952340420646832
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.006651093	0.24952340420646832
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.006651093	0.24952340420646832
HEART AND BRAIN MALFORMATION SYNDROME	0.006651093	0.24952340420646832
2Q31.1 MICRODELETION SYNDROME	0.006651093	0.24952340420646832
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.006651093	0.24952340420646832
MACDERMOT-WINTER SYNDROME	0.006651093	0.24952340420646832
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.006651093	0.24952340420646832
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.0066373199999999995	0.24900669426929922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.006605163999999999	0.2478003249423836
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.006605163999999999	0.2478003249423836
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.006601029	0.24764519566116716
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.00659022	0.24723968359329085
METATROPIC DYSPLASIA	0.00659022	0.24723968359329085
FRONTORHINY	0.00659022	0.24723968359329085
GM1 GANGLIOSIDOSIS	0.006553929	0.24587818498515876
HERMANSKY-PUDLAK SYNDROME	0.00653345	0.24510989174452233
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.006422309	0.24094030929139604
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.006415603	0.24068872598792868
ISOLATED ECTOPIA LENTIS	0.006412009999999999	0.24055393046013893
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.006390152999999999	0.2397339399644804
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.006390152999999999	0.2397339399644804
PETERS-PLUS SYNDROME; PTRPLS	0.006348203	0.23816013746217574
COFFIN-SIRIS SYNDROME	0.006348202999999999	0.23816013746217568
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.006334513	0.23764654136547606
SMITH-LEMLI-OPITZ SYNDROME	0.006334513	0.23764654136547606
FREEMAN-SHELDON SYNDROME	0.00632514	0.23729490248933535
FOCAL DERMAL HYPOPLASIA	0.00632514	0.23729490248933535
GORDON SYNDROME	0.00632514	0.23729490248933535
DIASTROPHIC DWARFISM	0.00632514	0.23729490248933535
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00632514	0.23729490248933535
CAMPTODACTYLY-TALL STATURE-SCOLIOSIS-HEARING LOSS SYNDROME	0.00632514	0.23729490248933535
HEREDITARY ACROKERATOTIC POIKILODERMA	0.00632514	0.23729490248933535
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00632514	0.23729490248933535
15Q26 OVERGROWTH SYNDROME	0.00631145	0.23678130639263567
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.00631145	0.23678130639263567
FRONTOMETAPHYSEAL DYSPLASIA	0.00631145	0.23678130639263567
PROXIMAL SYMPHALANGISM	0.00631145	0.23678130639263567
CRANIOFACIAL-DEAFNESS-HAND SYNDROME	0.00631145	0.23678130639263567
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.006294163	0.23613276470354527
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0062440939999999995	0.234254368577493
OROFACIODIGITAL SYNDROME I; OFD1	0.006239959	0.23409923929627652
HURLER SYNDROME	0.006161364	0.231150657468657
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.006161364	0.231150657468657
MUCOPOLYSACCHARIDOSIS, TYPE II	0.006157229	0.23099552818744057
BARDET-BIEDL SYNDROME	0.00614693	0.23060914935618343
MOSAIC TRISOMY 9	0.006109674	0.22921144766307583
8Q22.1 MICRODELETION SYNDROME	0.006109674	0.22921144766307583
PENTASOMY X	0.006109674	0.22921144766307583
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.006109674	0.22921144766307583
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.006105539	0.2290563183818594
BOWEN-CONRADI SYNDROME	0.006105539	0.2290563183818594
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.006105539	0.2290563183818594
DISTAL TRISOMY 15Q	0.006105539	0.2290563183818594
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.006105539	0.2290563183818594
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.005941763	0.22291207336118105
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.005941763	0.22291207336118105
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.005941763	0.22291207336118105
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.005941763	0.22291207336118105
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.005941763	0.22291207336118105
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.005941762999999999	0.22291207336118105
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.005941762999999999	0.22291207336118105
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.005941762999999999	0.22291207336118105
SIMPSON-GOLABI-BEHMEL SYNDROME	0.005894663	0.22114506268517264
MOSAIC TRISOMY 14	0.005894663	0.22114506268517264
MARFAN SYNDROME; MFS	0.00588089	0.22062835274800358
CRONKHITE-CANADA SYNDROME	0.005870049	0.22022164016331974
MALIGNANT ATROPHIC PAPULOSIS	0.005870049	0.22022164016331974
BEHÃ‡ET DISEASE	0.005870049	0.22022164016331974
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0058487339999999995	0.21942198342108796
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.0058487339999999995	0.21942198342108796
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.0058487339999999995	0.21942198342108796
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.0058487339999999995	0.21942198342108796
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.005844599	0.2192668541398715
TETRASOMY 9P	0.005837892999999999	0.21901527083640412
FANCONI ANEMIA	0.005806784	0.21784818091878325
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.005802649	0.2176930516375668
DUBOWITZ SYNDROME	0.005802649	0.2176930516375668
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.0057930939999999995	0.21733458482208357
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.005788959	0.21717945554086712
NORRIE DISEASE	0.005788959	0.21717945554086712
CORNELIA DE LANGE SYNDROME	0.005788959	0.21717945554086712
CONGENITAL RUBELLA SYNDROME	0.005788959	0.21717945554086712
SENIOR-LOKEN SYNDROME	0.005752744000000001	0.21582080816015284
CLASSIC HOMOCYSTINURIA	0.005748609	0.2156656788789364
POTOCKI-SHAFFER SYNDROME	0.005716453	0.21445930955202075
COACH SYNDROME	0.005716453	0.21445930955202075
XFE PROGEROID SYNDROME; XFEPS	0.00569854	0.21378728275288408
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2A	0.00561581	0.21068357164404808
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.00561581	0.21068357164404808
VIRAL HEMORRHAGIC FEVER	0.005604969	0.21027685905936427
LASSA FEVER	0.005604969	0.21027685905936427
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.0056021199999999995	0.2101699755473484
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.0056021199999999995	0.2101699755473484
CINCA SYNDROME	0.005595414	0.2099183922438811
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.0055917729999999995	0.2097817959408801
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.0055917729999999995	0.2097817959408801
LEBER CONGENITAL AMAUROSIS	0.0055917729999999995	0.2097817959408801
VICI SYNDROME	0.005578083	0.20926819984418038
INFANTILE REFSUM DISEASE	0.005578083	0.20926819984418038
2P15-16.1 MICRODELETION SYNDROME	0.00556412	0.2087443618384669
SHPRINTZEN-GOLDBERG SYNDROME	0.00556412	0.2087443618384669
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 2	0.00556412	0.2087443618384669
TRISOMY 4P	0.00556412	0.2087443618384669
SHORT STATURE-CRANIOFACIAL ANOMALIES-GENITAL HYPOPLASIA SYNDROME	0.00556412	0.2087443618384669
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.00556412	0.2087443618384669
VENTRICULAR EXTRASYSTOLES WITH SYNCOPAL EPISODES-PERODACTYLY-ROBIN SEQUENCE SYNDROME	0.00556412	0.2087443618384669
FAMILIAL VISCERAL MYOPATHY	0.00556412	0.2087443618384669
APHALANGY-SYNDACTYLY-MICROCEPHALY SYNDROME	0.00556412	0.2087443618384669
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.00556412	0.2087443618384669
OROFACIODIGITAL SYNDROME TYPE 1	0.005483529	0.20572089777498087
KEUTEL SYNDROME; KTLS	0.005483529	0.20572089777498087
CADASIL	0.005469839000000001	0.20520730167828122
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.005469839000000001	0.20520730167828122
AICARDI-GOUTIERES SYNDROME 5	0.005400344	0.20260011681778856
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.005400344	0.20260011681778856
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.005396209	0.2024449875365721
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.005396209	0.2024449875365721
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.005396208999999999	0.2024449875365721
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.005389503	0.20219340423310478
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.0053895029999999995	0.20219340423310475
TRISOMY 8Q	0.005353244	0.20083310614178018
AARSKOG-SCOTT SYNDROME	0.005353244	0.20083310614178018
FLOATING-HARBOR SYNDROME	0.005353244	0.20083310614178018
WEAVER SYNDROME	0.005353244	0.20083310614178018
DISTAL TRISOMY 18Q	0.005353244	0.20083310614178018
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.005353244	0.20083310614178018
CRISPONI SYNDROME	0.0053491089999999995	0.2006779768605637
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.0053491089999999995	0.2006779768605637
INTELLECTUAL DISABILITY, WOLFF TYPE	0.0053491089999999995	0.2006779768605637
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.0053491089999999995	0.2006779768605637
ACROCARDIOFACIAL SYNDROME	0.0053491089999999995	0.2006779768605637
HENNEKAM SYNDROME	0.0053491089999999995	0.2006779768605637
HEMOCHROMATOSIS, TYPE 4; HFE4	0.00532863	0.1999096836199273
GENETIC HYPERFERRITINEMIA WITHOUT IRON OVERLOAD	0.00532863	0.1999096836199273
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.005303179999999999	0.19895489759647902
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.005303179999999999	0.19895489759647902
LEUKOENCEPHALOPATHY WITH BRAINSTEM AND SPINAL CORD INVOLVEMENT AND LACTATE ELEVATION; LBSL	0.005303179999999999	0.19895489759647902
SPASTIC PARAPLEGIA 2, X-LINKED; SPG2	0.005303179999999999	0.19895489759647902
SPASTIC PARAPLEGIA, OPTIC ATROPHY, AND NEUROPATHY; SPOAN	0.005303179999999999	0.19895489759647902
ADAMS-OLIVER SYNDROME 1; AOS1	0.005268063	0.19763744294872135
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.005247539999999999	0.19686749899747463
WERNER SYNDROME	0.00520719	0.1953537223355439
CARDIOMYOPATHY-CATARACT-HIP SPINE DISEASE SYNDROME	0.00520719	0.1953537223355439
SCALP-EAR-NIPPLE SYNDROME	0.00520719	0.1953537223355439
KAGAMI-OGATA SYNDROME	0.005185333	0.19453373183988543
ZTTK SYNDROME; ZTTKS	0.005185333	0.19453373183988543
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.005185333	0.19453373183988543
PRADER-WILLI-LIKE SYNDROME	0.005185333	0.19453373183988543
ALSTROM SYNDROME; ALMS	0.005175034	0.1941473530086283
JOUBERT SYNDROME 14	0.005175034	0.1941473530086283
ALEXANDER DISEASE	0.005170899	0.19399222372741182
LATHOSTEROLOSIS	0.005143383	0.1929599293375807
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.005143383	0.1929599293375807
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.005143383	0.1929599293375807
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.005143383	0.1929599293375807
MULTIPLE SULFATASE DEFICIENCY	0.005129693	0.19244633324088103
1Q21.1 MICRODELETION SYNDROME	0.005129693	0.19244633324088103
BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS	0.00506355	0.18996490251597184
WALDENSTRÃ–M MACROGLOBULINEMIA	0.00506355	0.18996490251597184
ARACHNOIDITIS	0.00506355	0.18996490251597184
PLAGUE	0.00506355	0.18996490251597184
DEAFNESS-LYMPHEDEMA-LEUKEMIA SYNDROME	0.00504986	0.18945130641927216
X-LINKED AGAMMAGLOBULINEMIA	0.00504986	0.18945130641927216
FAMILIAL COLD URTICARIA	0.00504986	0.18945130641927216
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00504986	0.18945130641927216
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.005046219	0.18931471011627116
CODAS SYNDROME	0.005036664	0.18895624330078792
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.005036664	0.18895624330078792
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.005032529	0.18880111401957148
NEURAMINIDASE DEFICIENCY	0.005032529	0.18880111401957148
NEONATAL ADRENOLEUKODYSTROPHY	0.005032529	0.18880111401957148
SIALIDOSIS TYPE 1	0.005032529	0.18880111401957148
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.005032529	0.18880111401957148
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.0049421099999999996	0.1854089412315884
TURNER SYNDROME	0.0049421099999999996	0.1854089412315884
MONOSOMY X	0.0049421099999999996	0.1854089412315884
MOSAIC MONOSOMY X	0.0049421099999999996	0.1854089412315884
MARSHALL-SMITH SYNDROME; MRSHSS	0.0049421099999999996	0.1854089412315884
JUVENILE PAGET DISEASE	0.0049421099999999996	0.1854089412315884
STIFF SKIN SYNDROME	0.00492842	0.18489534513488876
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00492842	0.18489534513488876
APERT SYNDROME	0.00492842	0.18489534513488876
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00492842	0.18489534513488876
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.0048547899999999995	0.18213303099317965
MICROCEPHALY WITH CHEMOTACTIC DEFECT AND TRANSIENT HYPOGAMMAGLOBULINEMIA	0.0048547899999999995	0.18213303099317965
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0048547899999999995	0.18213303099317965
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.0048547899999999995	0.18213303099317965
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.0048547899999999995	0.18213303099317965
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.0048547899999999995	0.18213303099317965
PONTOCEREBELLAR HYPOPLASIA, TYPE 12; PCH12	0.0048547899999999995	0.18213303099317965
JACOBSEN SYNDROME	0.0048547899999999995	0.18213303099317965
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.0048547899999999995	0.18213303099317965
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.0048547899999999995	0.18213303099317965
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.004843949	0.18172631840849585
MENKES DISEASE	0.004843948999999999	0.18172631840849585
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.004843948999999999	0.18172631840849585
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.004830752999999999	0.1812312552900116
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.004830752999999999	0.1812312552900116
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004830752999999999	0.1812312552900116
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.004830752999999999	0.1812312552900116
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00480769	0.18036602031717128
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00480769	0.18036602031717128
CAMPTODACTYLY-FIBROUS TISSUE HYPERPLASIA-SKELETAL DYSPLASIA SYNDROME	0.00480769	0.18036602031717128
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00480769	0.18036602031717128
DISTAL SYMPHALANGISM	0.00480769	0.18036602031717128
DIGITOTALAR DYSMORPHISM	0.00480769	0.18036602031717128
FRONTONASAL DYSPLASIA	0.00480769	0.18036602031717128
MESOMELIC DWARFISM-CLEFT PALATE-CAMPTODACTYLY SYNDROME	0.00480769	0.18036602031717128
SUMMITT SYNDROME	0.00480769	0.18036602031717128
TRISOMY 1Q	0.00480769	0.18036602031717128
ANTLEY-BIXLER SYNDROME	0.00480769	0.18036602031717128
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.00480769	0.18036602031717128
MASA SYNDROME	0.00480769	0.18036602031717128
ACROPECTOROVERTEBRAL DYSPLASIA	0.00480769	0.18036602031717128
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00480769	0.18036602031717128
SPONDYLOCAMPTODACTYLY SYNDROME	0.00480769	0.18036602031717128
SPONDYLOCAMPTODACTYLY	0.00480769	0.18036602031717128
ULNAR-MAMMARY SYNDROME	0.00480769	0.18036602031717128
DIGITAL EXTENSOR MUSCLE APLASIA-POLYNEUROPATHY	0.00480769	0.18036602031717128
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00480769	0.18036602031717128
CAMPTOBRACHYDACTYLY	0.00480769	0.18036602031717128
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00480769	0.18036602031717128
MICROPHTHALMIA-MICROTIA-FETAL AKINESIA SYNDROME	0.00480769	0.18036602031717128
OPHTHALMOMANDIBULOMELIC DYSPLASIA	0.00480769	0.18036602031717128
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00480769	0.18036602031717128
DIGITOTALAR DYSMORPHISM	0.00480769	0.18036602031717128
PELVIS-SHOULDER DYSPLASIA	0.00480769	0.18036602031717128
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.00480769	0.18036602031717128
FRANK-TER HAAR SYNDROME	0.00480769	0.18036602031717128
CAMPTODACTYLY 1; CAMPD1	0.00480769	0.18036602031717128
MUCKLE-WELLS SYNDROME	0.00480769	0.18036602031717128
PHAVER SYNDROME	0.00480769	0.18036602031717128
HYPOPLASTIC TIBIAE-POSTAXIAL POLYDACTYLY SYNDROME	0.00480769	0.18036602031717128
CHOLESTASIS WITH GALLSTONE, ATAXIA, AND VISUAL DISTURBANCE	0.00480769	0.18036602031717128
TRISOMY 20P	0.00480769	0.18036602031717128
LERI PLEONOSTEOSIS	0.00480769	0.18036602031717128
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00480769	0.18036602031717128
EXTENSOR TENDONS OF FINGER ANOMALIES	0.00480769	0.18036602031717128
KINDLER SYNDROME	0.00480769	0.18036602031717128
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00480769	0.18036602031717128
ENG-STROM SYNDROME	0.00480769	0.18036602031717128
ACROFRONTOFACIONASAL DYSOSTOSIS	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 3	0.00480769	0.18036602031717128
DESBUQUOIS SYNDROME	0.00480769	0.18036602031717128
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.00480769	0.18036602031717128
COOPER-JABS SYNDROME	0.00480769	0.18036602031717128
INFANTILE SYSTEMIC HYALINOSIS	0.00480769	0.18036602031717128
EPIDERMOLYSIS BULLOSA, JUNCTIONAL, NON-HERLITZ TYPE	0.00480769	0.18036602031717128
ECTRODACTYLY-POLYDACTYLY SYNDROME	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 4	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 2	0.00480769	0.18036602031717128
MESOMELIC DYSPLASIA, KANTAPUTRA TYPE	0.00480769	0.18036602031717128
ALLAN-HERNDON-DUDLEY SYNDROME	0.00480769	0.18036602031717128
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00480769	0.18036602031717128
ABSENCE OF FINGERPRINTS-CONGENITAL MILIA SYNDROME	0.00480769	0.18036602031717128
LOEYS-DIETZ SYNDROME	0.00480769	0.18036602031717128
MESOMELIC LIMB SHORTENING AND BOWING	0.00480769	0.18036602031717128
THORACO-ABDOMINAL ENTERIC DUPLICATION	0.00480769	0.18036602031717128
SYNDACTYLY TYPE 5	0.00480769	0.18036602031717128
CATEL-MANZKE SYNDROME	0.00480769	0.18036602031717128
COLOBOMA OF MACULA-BRACHYDACTYLY TYPE B SYNDROME	0.00480769	0.18036602031717128
RICHARDS-RUNDLE SYNDROME; RRNS	0.004771584	0.17901146219683242
GIANT CELL ARTERITIS	0.00475092	0.17823622846840276
ERDHEIM-CHESTER DISEASE	0.00475092	0.17823622846840276
PEDIATRIC-ONSET GRAVES DISEASE	0.004726644	0.1773254864053289
MONOSOMY 18P	0.004726644	0.1773254864053289
DUCHENNE MUSCULAR DYSTROPHY	0.004643914	0.17422177529649294
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.004643914	0.17422177529649294
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.004643914	0.17422177529649294
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.004643914	0.17422177529649294
MECKEL SYNDROME 13; MKS13	0.004643914	0.17422177529649294
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.004643914	0.17422177529649294
GLUTAMINE DEFICIENCY, CONGENITAL	0.004639779	0.1740666460152765
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.004639779	0.1740666460152765
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.004639779	0.1740666460152765
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.004639779	0.1740666460152765
HUNTINGTON DISEASE-LIKE 3	0.004639779	0.1740666460152765
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.004633073	0.17381506271180913
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.004633073	0.17381506271180913
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.004601964	0.17264797279418823
COFFIN-LOWRY SYNDROME	0.004584139	0.1719792474162721
RENPENNING SYNDROME	0.004584139	0.1719792474162721
WITTEVEEN-KOLK SYNDROME	0.004565673	0.17128647418605616
COFFIN-SIRIS SYNDROME 1; CSS1	0.004565673	0.17128647418605616
HSD10 DISEASE	0.004565672999999999	0.1712864741860561
CONGENITAL TOXOPLASMOSIS	0.004565672999999999	0.1712864741860561
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.004551983	0.17077287808935648
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.004551983	0.17077287808935648
COHEN SYNDROME	0.004551983	0.17077287808935648
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004551983	0.17077287808935648
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.004551983	0.17077287808935648
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.0045048	0.1690027535728787
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0045048	0.1690027535728787
CENANI-LENZ SYNDROME	0.0045048	0.1690027535728787
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.0045048	0.1690027535728787
RETINITIS PIGMENTOSA	0.0044911099999999995	0.168489157476179
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0044911099999999995	0.168489157476179
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.0044911099999999995	0.168489157476179
ACRO-RENAL-OCULAR SYNDROME	0.0044911099999999995	0.168489157476179
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.0044911099999999995	0.168489157476179
SPONDYLOOCULAR SYNDROME; SOS	0.0044911099999999995	0.168489157476179
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.0044911099999999995	0.168489157476179
LAURENCE-MOON SYNDROME	0.0044911099999999995	0.168489157476179
REFSUM DISEASE	0.0044911099999999995	0.168489157476179
USHER SYNDROME TYPE 2	0.0044911099999999995	0.168489157476179
LEBER CONGENITAL AMAUROSIS, TYPE I	0.0044911099999999995	0.168489157476179
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.0044911099999999995	0.168489157476179
REFSUM DISEASE	0.0044911099999999995	0.168489157476179
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.0044911099999999995	0.168489157476179
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0044911099999999995	0.168489157476179
MARSHALL SYNDROME	0.0044911099999999995	0.168489157476179
COWDEN SYNDROME	0.004386953	0.16458158781628504
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.004386953	0.16458158781628504
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.004386953	0.16458158781628504
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.004386953	0.16458158781628504
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.004319059	0.1620344663123166
MARINESCO-SJÃ–GREN SYNDROME	0.004289334	0.16091929874661917
MIETENS SYNDROME	0.004289334	0.16091929874661917
MEVALONIC ACIDURIA; MEVA	0.004289334	0.16091929874661917
PETERS PLUS SYNDROME	0.004289334	0.16091929874661917
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.004285199	0.16076416946540273
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.004285199	0.16076416946540273
PRIMARY CUTIS VERTICIS GYRATA	0.004285199	0.16076416946540273
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.004285199	0.16076416946540273
SECKEL SYNDROME 10; SCKL10	0.00418109	0.15685840058071998
DESANTO-SHINAWI SYNDROME	0.004108183	0.15412321061562986
MUENKE SYNDROME	0.004108183	0.15412321061562986
AASE-SMITH SYNDROME I	0.00409836	0.153754689471884
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1B	0.00409836	0.153754689471884
SLC39A13-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.00409836	0.153754689471884
MYOPATHY, TUBULAR AGGREGATE, 2; TAM2	0.00409836	0.153754689471884
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.00409836	0.153754689471884
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 1; ARCI1	0.00409836	0.153754689471884
GROWTH FACTORS, COMBINED DEFECT OF	0.00409836	0.153754689471884
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.00409836	0.153754689471884
ICHTHYOSIS HYSTRIX OF CURTH-MACKLIN	0.00409836	0.153754689471884
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00409836	0.153754689471884
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.00409836	0.153754689471884
ANAUXETIC DYSPLASIA 2; ANXD2	0.00409836	0.153754689471884
POTASSIUM-AGGRAVATED MYOTONIA	0.00409836	0.153754689471884
MYOPATHY, CENTRONUCLEAR, AUTOSOMAL DOMINANT	0.00409836	0.153754689471884
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00409836	0.153754689471884
RIGID SPINE MUSCULAR DYSTROPHY 1	0.00409836	0.153754689471884
MYASTHENIC SYNDROME, CONGENITAL, 2A, SLOW-CHANNEL; CMS2A	0.00409836	0.153754689471884
MYOPATHY, CONGENITAL, WITH FAST-TWITCH (TYPE II) FIBER ATROPHY; MYOFTA	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.00409836	0.153754689471884
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00409836	0.153754689471884
SPONDYLO-MEGAEPIPHYSEAL-METAPHYSEAL DYSPLASIA; SMMD	0.00409836	0.153754689471884
LIPODYSTROPHY DUE TO PEPTIDIC GROWTH FACTORS DEFICIENCY	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00409836	0.153754689471884
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00409836	0.153754689471884
NEONATAL MARFAN SYNDROME	0.00409836	0.153754689471884
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00409836	0.153754689471884
ADULT-ONSET NEMALINE MYOPATHY	0.00409836	0.153754689471884
ORAL SUBMUCOUS FIBROSIS	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, CONGENITAL, MEROSIN-POSITIVE	0.00409836	0.153754689471884
STIFF SKIN SYNDROME	0.00409836	0.153754689471884
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2E; CMT2E	0.00409836	0.153754689471884
RESTRICTIVE DERMOPATHY, LETHAL	0.00409836	0.153754689471884
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00409836	0.153754689471884
SALIH MYOPATHY; SALMY	0.00409836	0.153754689471884
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 3; PRAAS3	0.00409836	0.153754689471884
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00409836	0.153754689471884
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.00409836	0.153754689471884
CHRONIC GRAFT VERSUS HOST DISEASE	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 2; LGMDD2	0.00409836	0.153754689471884
MANDIBULOACRAL DYSPLASIA WITH TYPE B LIPODYSTROPHY; MADB	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.00409836	0.153754689471884
HYPERKALEMIC PERIODIC PARALYSIS	0.00409836	0.153754689471884
268650 RUDIGER SYNDROME	0.00409836	0.153754689471884
MAJEED SYNDROME	0.00409836	0.153754689471884
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00409836	0.153754689471884
TEMPLE SYNDROME	0.00409836	0.153754689471884
CZECH DYSPLASIA, METATARSAL TYPE	0.00409836	0.153754689471884
NEMALINE MYOPATHY 4	0.00409836	0.153754689471884
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00409836	0.153754689471884
CUTIS LAXA-MARFANOID SYNDROME	0.00409836	0.153754689471884
NEMALINE MYOPATHY 1; NEM1	0.00409836	0.153754689471884
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2A; LGMD2A	0.00409836	0.153754689471884
DRACUNCULIASIS	0.00409836	0.153754689471884
CHST3-RELATED SKELETAL DYSPLASIA	0.00409836	0.153754689471884
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY; MADA	0.00409836	0.153754689471884
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.00409836	0.153754689471884
BASAN SYNDROME	0.00409836	0.153754689471884
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00409836	0.153754689471884
ULLRICH CONGENITAL MUSCULAR DYSTROPHY 1	0.00409836	0.153754689471884
245160 KNIEST-LIKE DYSPLASIA WITH PURSED LIPS AND ECTOPIA LENTIS;;BURTON SYNDROME	0.00409836	0.153754689471884
MAJEED SYNDROME	0.00409836	0.153754689471884
BUSCHKE-OLLENDORFF SYNDROME; BOS	0.00409836	0.153754689471884
THYROID HEMIAGENESIS	0.004091654	0.15350310616841667
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.004091654	0.15350310616841667
PERIPHERAL HYPOTHYROIDISM	0.004091654	0.15350310616841667
THYROID HYPOPLASIA	0.004091654	0.15350310616841667
ATHYREOSIS	0.004091654	0.15350310616841667
FAMILIAL THYROID DYSHORMONOGENESIS	0.004091654	0.15350310616841667
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.004091654	0.15350310616841667
EBOLA HEMORRHAGIC FEVER	0.0040875189999999995	0.1533479768872002
NIPAH VIRUS DISEASE	0.0040875189999999995	0.1533479768872002
PROLACTINOMA	0.0040875189999999995	0.1533479768872002
SPONTANEOUS PERIODIC HYPOTHERMIA	0.0040875189999999995	0.1533479768872002
NON-FUNCTIONING PITUITARY ADENOMA	0.0040875189999999995	0.1533479768872002
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.0040875189999999995	0.1533479768872002
LUJO HEMORRHAGIC FEVER	0.0040875189999999995	0.1533479768872002
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.0040875189999999995	0.1533479768872002
ADDISON DISEASE	0.0040875189999999995	0.1533479768872002
BENIGN FAMILIAL INFANTILE EPILEPSY	0.0040875189999999995	0.1533479768872002
NOCARDIOSIS	0.0040875189999999995	0.1533479768872002
MIXED CONNECTIVE TISSUE DISEASE	0.0040875189999999995	0.1533479768872002
RIFT VALLEY FEVER	0.0040875189999999995	0.1533479768872002
GLIOBLASTOMA	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.0040875189999999995	0.1533479768872002
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.0040875189999999995	0.1533479768872002
ADIPOSIS DOLOROSA	0.0040875189999999995	0.1533479768872002
WHIPPLE DISEASE	0.0040875189999999995	0.1533479768872002
ACQUIRED METHEMOGLOBINEMIA	0.0040875189999999995	0.1533479768872002
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.0040875189999999995	0.1533479768872002
ATYPICAL JUVENILE PARKINSONISM	0.0040875189999999995	0.1533479768872002
GITELMAN SYNDROME	0.0040875189999999995	0.1533479768872002
LYMPHANGIOLEIOMYOMATOSIS	0.0040875189999999995	0.1533479768872002
ACUTE ADRENAL INSUFFICIENCY	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.0040875189999999995	0.1533479768872002
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.0040875189999999995	0.1533479768872002
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.0040875189999999995	0.1533479768872002
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.0040743229999999995	0.15285291376871596
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.0040743229999999995	0.15285291376871596
SRD5A3-CDG	0.0040743229999999995	0.15285291376871596
ERYTHROKERATODERMIA VARIABILIS	0.00405641	0.1521808869695793
CRI-DU-CHAT SYNDROME	0.00405641	0.1521808869695793
YUNIS-VARON SYNDROME	0.00405641	0.1521808869695793
19Q13.11 MICRODELETION SYNDROME	0.00405641	0.1521808869695793
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.00404272	0.1516672908728796
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00404272	0.1516672908728796
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00404272	0.1516672908728796
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.004024254	0.15097451764266367
CHARGE SYNDROME	0.004024254	0.15097451764266367
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.004024254	0.15097451764266367
PELIZAEUS-MERZBACHER DISEASE	0.004020119	0.15081938836144723
ISOLATED COMPLEX I DEFICIENCY	0.0040105639999999994	0.15046092154596397
KABUKI SYNDROME	0.004006429	0.15030579226474755
CHROMOSOME 18Q DELETION SYNDROME	0.004006429	0.15030579226474755
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.003970214	0.14894714488403324
POPOV-CHANG SYNDROME; POPCHAS	0.003970214	0.14894714488403324
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.003970214	0.14894714488403324
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.003970214	0.14894714488403324
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.003970214	0.14894714488403324
NEUROFIBROMATOSIS, TYPE I	0.003966079	0.1487920156028168
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.003966079	0.1487920156028168
PREECLAMPSIA/ECLAMPSIA 1	0.003966079	0.1487920156028168
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.003966079	0.1487920156028168
SNEDDON SYNDROME	0.003966079	0.1487920156028168
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.003966079	0.1487920156028168
BETA-KETOTHIOLASE DEFICIENCY	0.003966079	0.1487920156028168
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.003966079	0.1487920156028168
PRADER-WILLI SYNDROME	0.003966079	0.1487920156028168
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.003966079	0.1487920156028168
SNEDDON SYNDROME	0.003966079	0.1487920156028168
MERCURY POISONING	0.003966079	0.1487920156028168
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.003966079	0.1487920156028168
FAMILIAL DYSAUTONOMIA	0.003966079	0.1487920156028168
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.003966079	0.1487920156028168
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.003966079	0.1487920156028168
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.0038455340000000003	0.14426963127289258
TRANSKETOLASE DEFICIENCY	0.0038455340000000003	0.14426963127289258
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.0038455340000000003	0.14426963127289258
CHOPS SYNDROME; CHOPS	0.0038455340000000003	0.14426963127289258
ALPHA-MANNOSIDOSIS	0.0038455340000000003	0.14426963127289258
DYSKERATOSIS CONGENITA	0.0038455340000000003	0.14426963127289258
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0038455340000000003	0.14426963127289258
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.0038455340000000003	0.14426963127289258
MUCOPOLYSACCHARIDOSIS TYPE 3	0.003841399	0.14411450199167614
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.003841399	0.14411450199167614
LISSENCEPHALY 5; LIS5	0.003841399	0.14411450199167614
ZIMMERMANN-LABAND SYNDROME 1	0.003841399	0.14411450199167614
USHER SYNDROME TYPE 1	0.003831844	0.1437560351761929
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.003831844	0.1437560351761929
TRISOMY 13	0.0038277090000000003	0.14360090589497645
PAPILLORENAL SYNDROME	0.0038277090000000003	0.14360090589497645
ZIMMERMANN-LABAND SYNDROME	0.0038277090000000003	0.14360090589497645
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003809243	0.1429081326647605
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.0038092429999999995	0.1429081326647605
SPINOCEREBELLAR ATAXIA TYPE 13	0.0038092429999999995	0.1429081326647605
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.0038092429999999995	0.1429081326647605
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.0038092429999999995	0.1429081326647605
NARP SYNDROME	0.0038092429999999995	0.1429081326647605
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.0038092429999999995	0.1429081326647605
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.0038092429999999995	0.1429081326647605
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.0038092429999999995	0.1429081326647605
PONTINE TEGMENTAL CAP DYSPLASIA	0.003795553	0.14239453656806084
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.003795553	0.14239453656806084
LEIGH SYNDROME; LS	0.003795553	0.14239453656806084
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.003795553	0.14239453656806084
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.003795553	0.14239453656806084
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0037955529999999997	0.1423945365680608
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.003625933	0.1360310471654166
MEVALONIC ACIDURIA	0.003625933	0.1360310471654166
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.003625933	0.1360310471654166
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.003625933	0.1360310471654166
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.003625933	0.1360310471654166
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.003625933	0.1360310471654166
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.0036259329999999996	0.1360310471654166
MICRO SYNDROME	0.0036259329999999996	0.1360310471654166
LISSENCEPHALY 8; LIS8	0.0036259329999999996	0.1360310471654166
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.0036259329999999996	0.1360310471654166
KOOLEN-DE VRIES SYNDROME; KDVS	0.0036259329999999996	0.1360310471654166
PHACE SYNDROME	0.0036259329999999996	0.1360310471654166
JABERI-ELAHI SYNDROME; JABELS	0.0036259329999999996	0.1360310471654166
CLASSIC PHENYLKETONURIA	0.0036259329999999996	0.1360310471654166
WALKER-WARBURG SYNDROME	0.0036259329999999996	0.1360310471654166
KOOLEN-DE VRIES SYNDROME	0.0036259329999999996	0.1360310471654166
GALACTOSEMIA	0.0036259329999999996	0.1360310471654166
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.0036259329999999996	0.1360310471654166
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.0036259329999999996	0.1360310471654166
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.003562629	0.13365612479102096
SYMPTOMATIC FORM OF HEMOCHROMATOSIS TYPE 1	0.0035461	0.13303602034380774
HELLP SYNDROME	0.0035461	0.13303602034380774
POST-TRAUMATIC PITUITARY DEFICIENCY	0.0035461	0.13303602034380774
PITUICYTOMA	0.0035461	0.13303602034380774
UNCLASSIFIED MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380774
DUBIN-JOHNSON SYNDROME	0.0035461	0.13303602034380774
AGGRESSIVE SYSTEMIC MASTOCYTOSIS	0.0035461	0.13303602034380774
KAWASAKI DISEASE	0.0035461	0.13303602034380774
ALPHA-THALASSEMIA-MYELODYSPLASTIC SYNDROME	0.0035461	0.13303602034380774
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.0035461	0.13303602034380774
GASTROINTESTINAL STROMAL TUMOR	0.0035461	0.13303602034380774
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.0035461	0.13303602034380774
IDIOPATHIC/HERITABLE PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380774
THYMIC CARCINOMA	0.0035461	0.13303602034380774
AUTOSOMAL DOMINANT HYPOPHOSPHATEMIC RICKETS	0.0035461	0.13303602034380774
PEDIATRIC HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380774
WISKOTT-ALDRICH SYNDROME	0.0035461	0.13303602034380774
EISENMENGER SYNDROME	0.0035461	0.13303602034380774
RHEUMATIC FEVER	0.0035461	0.13303602034380774
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.0035461	0.13303602034380774
EOSINOPHILIC FASCIITIS	0.0035461	0.13303602034380774
SEVERE CONGENITAL HYPOCHROMIC ANEMIA WITH RINGED SIDEROBLASTS	0.0035461	0.13303602034380774
POSTPOLIOMYELITIS SYNDROME	0.0035461	0.13303602034380774
HODGKIN LYMPHOMA	0.0035461	0.13303602034380774
CHRONIC NONBACTERIAL OSTEOMYELITIS/CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS	0.0035461	0.13303602034380774
MULTIPLE MYELOMA	0.0035461	0.13303602034380774
POEMS SYNDROME	0.0035461	0.13303602034380774
AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380774
AUTOSOMAL AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380774
KAPOSI SARCOMA	0.0035461	0.13303602034380774
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.0035461	0.13303602034380774
REFRACTORY ANEMIA	0.0035461	0.13303602034380774
TUBERCULOSIS	0.0035461	0.13303602034380774
THYMIC EPITHELIAL NEOPLASM	0.0035461	0.13303602034380774
PRIMARY FAMILIAL POLYCYTHEMIA	0.0035461	0.13303602034380774
CYCLIC NEUTROPENIA	0.0035461	0.13303602034380774
STEVENS-JOHNSON SYNDROME	0.0035461	0.13303602034380774
HEPATOCELLULAR CARCINOMA	0.0035461	0.13303602034380774
SCHNITZLER SYNDROME	0.0035461	0.13303602034380774
DRUG-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380774
CLASSIC HODGKIN LYMPHOMA	0.0035461	0.13303602034380774
EPIDERMOLYSIS BULLOSA SIMPLEX WITH MUSCULAR DYSTROPHY	0.0035461	0.13303602034380774
MIXED-TYPE AUTOIMMUNE HEMOLYTIC ANEMIA	0.0035461	0.13303602034380774
IATROGENIC BOTULISM	0.0035461	0.13303602034380774
INHALATIONAL BOTULISM	0.0035461	0.13303602034380774
AUTOIMMUNE HEMOLYTIC ANEMIA, WARM TYPE	0.0035461	0.13303602034380774
STEVENS-JOHNSON SYNDROME/TOXIC EPIDERMAL NECROLYSIS SPECTRUM	0.0035461	0.13303602034380774
RARE HEREDITARY HEMOCHROMATOSIS	0.0035461	0.13303602034380774
PANHYPOPITUITARISM	0.0035461	0.13303602034380774
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.0035461	0.13303602034380774
CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	0.0035461	0.13303602034380774
CHOLANGIOCARCINOMA	0.0035461	0.13303602034380774
PYOGENIC ARTHRITIS-PYODERMA GANGRENOSUM-ACNE SYNDROME	0.0035461	0.13303602034380774
LIPOSARCOMA	0.0035461	0.13303602034380774
CHOLESTASIS-LYMPHEDEMA SYNDROME	0.0035461	0.13303602034380774
PONTIAC FEVER	0.0035461	0.13303602034380774
PARATHYROID CARCINOMA	0.0035461	0.13303602034380774
MAST CELL SARCOMA	0.0035461	0.13303602034380774
CUTANEOUS MASTOCYTOSIS	0.0035461	0.13303602034380774
TYPHOID	0.0035461	0.13303602034380774
FUNCTIONING GONADOTROPIC ADENOMA	0.0035461	0.13303602034380774
CASTLEMAN DISEASE	0.0035461	0.13303602034380774
HYPOTONIA-CYSTINURIA SYNDROME	0.0035461	0.13303602034380774
CONGENITAL ANALBUMINEMIA	0.0035461	0.13303602034380774
MACROPHAGIC MYOFASCIITIS	0.0035461	0.13303602034380774
POLYMYOSITIS	0.0035461	0.13303602034380774
AUTOIMMUNE PULMONARY ALVEOLAR PROTEINOSIS	0.0035461	0.13303602034380774
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 1	0.0035461	0.13303602034380774
CRYPTOGENIC ORGANIZING PNEUMONIA	0.0035461	0.13303602034380774
LYME DISEASE	0.0035461	0.13303602034380774
ADULT-ONSET STILL DISEASE	0.0035461	0.13303602034380774
PRIMARY MYELOFIBROSIS	0.0035461	0.13303602034380774
AMYOTROPHIC LATERAL SCLEROSIS	0.0035461	0.13303602034380774
RELAPSING FEVER	0.0035461	0.13303602034380774
GAMMA-HEAVY CHAIN DISEASE	0.0035461	0.13303602034380774
AREGENERATIVE ANEMIA	0.0035461	0.13303602034380774
PRIMARY PARATHYROID HYPERPLASIA	0.0035461	0.13303602034380774
BABESIOSIS	0.0035461	0.13303602034380774
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.0035461	0.13303602034380774
MARBURG HEMORRHAGIC FEVER	0.0035461	0.13303602034380774
REYNOLDS SYNDROME	0.0035461	0.13303602034380774
X-LINKED SIDEROBLASTIC ANEMIA	0.0035461	0.13303602034380774
BLACKFAN-DIAMOND ANEMIA	0.0035461	0.13303602034380774
BOTULISM	0.0035461	0.13303602034380774
JUVENILE DERMATOMYOSITIS	0.0035461	0.13303602034380774
PRIMARY SCLEROSING CHOLANGITIS	0.0035461	0.13303602034380774
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 37	0.0035461	0.13303602034380774
COLD AGGLUTININ DISEASE	0.0035461	0.13303602034380774
ACUTE MONOBLASTIC LEUKEMIA	0.0035461	0.13303602034380774
KIKUCHI-FUJIMOTO DISEASE	0.0035461	0.13303602034380774
LEISHMANIASIS	0.0035461	0.13303602034380774
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.0035461	0.13303602034380774
CYSTINOSIS	0.0035461	0.13303602034380774
THYMOMA	0.0035461	0.13303602034380774
DERMATOMYOSITIS	0.0035461	0.13303602034380774
BECKER MUSCULAR DYSTROPHY	0.0035461	0.13303602034380774
CENTRAL CONGENITAL HYPOTHYROIDISM	0.0035461	0.13303602034380774
CONGENITAL DYSERYTHROPOIETIC ANEMIA TYPE III	0.0035461	0.13303602034380774
HUGHES-STOVIN SYNDROME	0.0035461	0.13303602034380774
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, MYOPATHIC FORM	0.0035461	0.13303602034380774
AUTOIMMUNE HEMOLYTIC ANEMIA, COLD TYPE	0.0035461	0.13303602034380774
ISOLATED AGAMMAGLOBULINEMIA	0.0035461	0.13303602034380774
DOPAMINE BETA-HYDROXYLASE DEFICIENCY	0.0035461	0.13303602034380774
ACUTE PROMYELOCYTIC LEUKEMIA	0.0035461	0.13303602034380774
CHRONIC MYELOID LEUKEMIA	0.0035461	0.13303602034380774
MANTLE CELL LYMPHOMA	0.0035461	0.13303602034380774
LEGIONELLOSIS	0.0035461	0.13303602034380774
REFRACTORY ANEMIA WITH EXCESS BLASTS	0.0035461	0.13303602034380774
PULMONARY ARTERIAL HYPERTENSION	0.0035461	0.13303602034380774
ACUTE PANMYELOSIS WITH MYELOFIBROSIS	0.0035461	0.13303602034380774
PRIMARY BILIARY CHOLANGITIS	0.0035461	0.13303602034380774
SYSTEMIC CAPILLARY LEAK SYNDROME	0.0035461	0.13303602034380774
EBSTEIN MALFORMATION	0.0035461	0.13303602034380774
SUBCUTANEOUS PANNICULITIS-LIKE T-CELL LYMPHOMA	0.0035461	0.13303602034380774
MALT LYMPHOMA	0.0035461	0.13303602034380774
NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA	0.0035461	0.13303602034380774
FOLLICULAR LYMPHOMA	0.0035461	0.13303602034380774
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.0035461	0.13303602034380774
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.0035461	0.13303602034380774
EVANS SYNDROME	0.0035461	0.13303602034380774
TOXIC EPIDERMAL NECROLYSIS	0.0035461	0.13303602034380774
MASTOCYTOSIS	0.0035461	0.13303602034380774
KLATSKIN TUMOR	0.0035461	0.13303602034380774
TREMOR, HEREDITARY ESSENTIAL, 2; ETM2	0.0035461	0.13303602034380774
HYPOCALCIURIC HYPERCALCEMIA, FAMILIAL, TYPE III	0.0035461	0.13303602034380774
%241150 HYPOKALEMIC ALKALOSIS, FAMILIAL, WITH SPECIFIC RENAL TUBULOPATHY;;HYPOKALEMIA, FAMILIAL;;GULLNER SYNDROME	0.0035461	0.13303602034380774
SATOYOSHI SYNDROME	0.0035461	0.13303602034380774
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.0035461	0.13303602034380774
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2B; LGMD2B	0.0035461	0.13303602034380774
ADIPOSIS DOLOROSA	0.0035461	0.13303602034380774
HEMOCHROMATOSIS, TYPE 3; HFE3	0.0035461	0.13303602034380774
BARTH SYNDROME; BTHS	0.0035461	0.13303602034380774
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.0035461	0.13303602034380774
MYXEDEMA	0.0035461	0.13303602034380774
265400 PULMONARY HYPERTENSION, PRIMARY, AUTOSOMAL RECESSIVE	0.0035461	0.13303602034380774
CREATINE PHOSPHOKINASE, ELEVATED SERUM	0.0035461	0.13303602034380774
ANISOCORIA	0.0035461	0.13303602034380774
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0035461	0.13303602034380774
PEROXISOME BIOGENESIS DISORDER 10B	0.003532904	0.13254095722532352
DISTAL TRISOMY 6P	0.003532904	0.13254095722532352
KNOBLOCH SYNDROME	0.003528769	0.13238582794410708
OCULOCEREBRORENAL SYNDROME OF LOWE	0.003528769	0.13238582794410708
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.0035287689999999997	0.13238582794410705
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.0035287689999999997	0.13238582794410705
ALG2-CDG	0.0035287689999999997	0.13238582794410705
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.0034786999999999995	0.13050743181805474
ERMINE PHENOTYPE	0.00346501	0.1299938357213551
APPARENT MINERALOCORTICOID EXCESS	0.00342466	0.12848005905942433
FAMILIAL PSEUDOHYPERKALEMIA	0.00342466	0.12848005905942433
%613944 IGA NEPHROPATHY, SUSCEPTIBILITY TO, 2; IGAN2	0.00342466	0.12848005905942433
NEPHRONOPHTHISIS 1	0.00342466	0.12848005905942433
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00342466	0.12848005905942433
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00342466	0.12848005905942433
ACQUIRED GENERALIZED LIPODYSTROPHY	0.00342466	0.12848005905942433
GRANGE SYNDROME	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
LCAT DEFICIENCY	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 1; IGAN1	0.00342466	0.12848005905942433
MYH7-RELATED LATE-ONSET SCAPULOPERONEAL MUSCULAR DYSTROPHY	0.00342466	0.12848005905942433
SICKLE CELL ANEMIA	0.00342466	0.12848005905942433
LONG QT SYNDROME 13; LQT13	0.00342466	0.12848005905942433
FIBRONECTIN GLOMERULOPATHY	0.00342466	0.12848005905942433
PARAGANGLIOMAS 6	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 2; FSGS2	0.00342466	0.12848005905942433
SECONDARY POLYCYTHEMIA	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA	0.00342466	0.12848005905942433
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA	0.00342466	0.12848005905942433
%161900 RENAL FAILURE, PROGRESSIVE, WITH HYPERTENSION; RFH1;;NEPHROPATHY, FAMILIAL;;NEPHRITIS, FAMILIAL, WITHOUT DEAFNESS OR OCULAR DEFECT;;RENAL FAILURE, ADULT-ONSET; AORF	0.00342466	0.12848005905942433
%123550 CRYOGLOBULINEMIA, FAMILIAL MIXED;;MELTZER SYNDROME	0.00342466	0.12848005905942433
PLIN1-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
NAIL-PATELLA-LIKE RENAL DISEASE	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.00342466	0.12848005905942433
GLOMERULOPATHY WITH FIBRONECTIN DEPOSITS 1; GFND1	0.00342466	0.12848005905942433
PITUITARY ADENOMA 4, ACTH-SECRETING; PITA4	0.00342466	0.12848005905942433
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00342466	0.12848005905942433
POSTERIOR URETHRAL VALVE	0.00342466	0.12848005905942433
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00342466	0.12848005905942433
CYSTIC HAMARTOMA OF LUNG AND KIDNEY	0.00342466	0.12848005905942433
ARTERIOSCLEROSIS, SEVERE JUVENILE	0.00342466	0.12848005905942433
NELSON SYNDROME	0.00342466	0.12848005905942433
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2	0.00342466	0.12848005905942433
FAMILIAL THORACIC AORTIC ANEURYSM AND AORTIC DISSECTION	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 2	0.00342466	0.12848005905942433
CATECHOLAMINE-PRODUCING TUMOR	0.00342466	0.12848005905942433
PRIMARY MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 4 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD4	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
ALAGILLE SYNDROME 2	0.00342466	0.12848005905942433
RENAL AGENESIS	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIE; PHA2E	0.00342466	0.12848005905942433
PRIMARY LIPODYSTROPHY	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE IIC	0.00342466	0.12848005905942433
CONGENITAL ADRENAL HYPERPLASIA DUE TO 11-BETA-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00342466	0.12848005905942433
PREECLAMPSIA	0.00342466	0.12848005905942433
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00342466	0.12848005905942433
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00342466	0.12848005905942433
RHABDOID TUMOR	0.00342466	0.12848005905942433
POLYARTERITIS NODOSA, CHILDHOOD-ONSET	0.00342466	0.12848005905942433
CLASSIC CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE DEFICIENCY	0.00342466	0.12848005905942433
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.00342466	0.12848005905942433
INFLAMMATORY SKIN AND BOWEL DISEASE, NEONATAL, 2; NISBD2	0.00342466	0.12848005905942433
FAMILIAL PARTIAL LIPODYSTROPHY, KÃ–BBERLING TYPE	0.00342466	0.12848005905942433
AMYLOIDOSIS, FAMILIAL VISCERAL	0.00342466	0.12848005905942433
PITUITARY ADENOMA, GROWTH HORMONE-SECRETING, 1	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM TYPE 2	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 3	0.00342466	0.12848005905942433
PSEUDOXANTHOMA ELASTICUM	0.00342466	0.12848005905942433
CIRRHOSIS, FAMILIAL	0.00342466	0.12848005905942433
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE II; HALD2	0.00342466	0.12848005905942433
ATRIOVENTRICULAR SEPTAL DEFECT 3; AVSD3	0.00342466	0.12848005905942433
MOYAMOYA DISEASE WITH EARLY-ONSET ACHALASIA	0.00342466	0.12848005905942433
MEDULLARY CYSTIC KIDNEY DISEASE 1; MCKD1	0.00342466	0.12848005905942433
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEYS	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 4	0.00342466	0.12848005905942433
ACTH-INDEPENDENT MACRONODULAR ADRENAL HYPERPLASIA; AIMAH1	0.00342466	0.12848005905942433
DENYS-DRASH SYNDROME	0.00342466	0.12848005905942433
PRIMARY PROGRESSIVE FREEZING GAIT	0.00342466	0.12848005905942433
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT 2; ADCAD2	0.00342466	0.12848005905942433
LIDDLE SYNDROME 1; LIDLS1	0.00342466	0.12848005905942433
GANGLIONEUROMA	0.00342466	0.12848005905942433
AORTA COARCTATION	0.00342466	0.12848005905942433
OCHOA SYNDROME	0.00342466	0.12848005905942433
BRACHYDACTYLY-ARTERIAL HYPERTENSION SYNDROME	0.00342466	0.12848005905942433
NEPHROBLASTOMA	0.00342466	0.12848005905942433
ALAGILLE SYNDROME	0.00342466	0.12848005905942433
TETANUS	0.00342466	0.12848005905942433
IGA NEPHROPATHY, SUSCEPTIBILITY TO, 3	0.00342466	0.12848005905942433
INFANT BOTULISM	0.00342466	0.12848005905942433
CAUDAL REGRESSION SEQUENCE	0.00342466	0.12848005905942433
INTRACRANIAL HYPERTENSION, IDIOPATHIC	0.00342466	0.12848005905942433
MELORHEOSTOSIS WITH OSTEOPOIKILOSIS	0.00342466	0.12848005905942433
FRASIER SYNDROME	0.00342466	0.12848005905942433
FAMILIAL BICUSPID AORTIC VALVE	0.00342466	0.12848005905942433
LIDDLE SYNDROME 3; LIDLS3	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00342466	0.12848005905942433
POLYCYSTIC KIDNEY DISEASE 6 WITH OR WITHOUT POLYCYSTIC LIVER DISEASE; PKD6	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00342466	0.12848005905942433
NEUROBLASTOMA, SUSCEPTIBILITY TO	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 1	0.00342466	0.12848005905942433
MULTICENTRIC CARPOTARSAL OSTEOLYSIS SYNDROME; MCTO	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME 3; AOMS3	0.00342466	0.12848005905942433
PSEUDOHYPOALDOSTERONISM, TYPE II	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IA	0.00342466	0.12848005905942433
FOCAL SEGMENTAL GLOMERULOSCLEROSIS 1	0.00342466	0.12848005905942433
ARTERIAL CALCIFICATION, GENERALIZED, OF INFANCY, 1; GACI1	0.00342466	0.12848005905942433
PPARG-RELATED FAMILIAL PARTIAL LIPODYSTROPHY	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IC; GSD1C	0.00342466	0.12848005905942433
OBESITY DUE TO MELANOCORTIN 4 RECEPTOR DEFICIENCY	0.00342466	0.12848005905942433
CONGENITAL PULMONARY VEINS ATRESIA OR STENOSIS	0.00342466	0.12848005905942433
ABDOMINAL OBESITY-METABOLIC SYNDROME QUANTITATIVE TRAIT LOCUS 2	0.00342466	0.12848005905942433
HYPERALDOSTERONISM, FAMILIAL, TYPE IV	0.00342466	0.12848005905942433
LIDDLE SYNDROME 2; LIDLS2	0.00342466	0.12848005905942433
GLYCOGEN STORAGE DISEASE IB	0.00342466	0.12848005905942433
CORONARY ARTERY DISEASE, AUTOSOMAL DOMINANT, 1; ADCAD1	0.00342466	0.12848005905942433
TRIMETHYLAMINURIA	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 2	0.00342466	0.12848005905942433
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00342466	0.12848005905942433
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.00342466	0.12848005905942433
PIGMENTED NODULAR ADRENOCORTICAL DISEASE, PRIMARY, 1	0.00342466	0.12848005905942433
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.00342466	0.12848005905942433
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.00342466	0.12848005905942433
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00342466	0.12848005905942433
STIFF-PERSON SYNDROME; SPS	0.00342466	0.12848005905942433
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.003360853	0.12608626606146112
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.0033608529999999996	0.12608626606146112
DISTAL MONOSOMY 15Q	0.0033608529999999996	0.12608626606146112
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0033608529999999996	0.12608626606146112
KABUKI SYNDROME 1	0.0033608529999999996	0.12608626606146112
COFFIN-SIRIS SYNDROME 4; CSS4	0.0033608529999999996	0.12608626606146112
KLEEFSTRA SYNDROME	0.0033608529999999996	0.12608626606146112
PHELAN-MCDERMID SYNDROME	0.0033608529999999996	0.12608626606146112
CHROMOSOME 1P35 DELETION SYNDROME	0.0033608529999999996	0.12608626606146112
COFFIN-SIRIS SYNDROME 3; CSS3	0.0033608529999999996	0.12608626606146112
EMANUEL SYNDROME	0.0033608529999999996	0.12608626606146112
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0033608529999999996	0.12608626606146112
ALG11-CDG	0.0033608529999999996	0.12608626606146112
22Q11.2 MICRODUPLICATION SYNDROME	0.0033608529999999996	0.12608626606146112
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.0033608529999999996	0.12608626606146112
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.0033608529999999996	0.12608626606146112
RUBINSTEIN-TAYBI SYNDROME	0.0033608529999999996	0.12608626606146112
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.0033608529999999996	0.12608626606146112
BARAITSER-WINTER SYNDROME 1; BRWS1	0.0033471630000000002	0.12557266996476146
MONOSOMY 18Q	0.0033471630000000002	0.12557266996476146
CHROMOSOME 10Q26 DELETION SYNDROME	0.0033471630000000002	0.12557266996476146
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.0033471630000000002	0.12557266996476146
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.0033471630000000002	0.12557266996476146
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0033471630000000002	0.12557266996476146
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.0033471630000000002	0.12557266996476146
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0033471630000000002	0.12557266996476146
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0033471630000000002	0.12557266996476146
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.0033471630000000002	0.12557266996476146
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.0033471630000000002	0.12557266996476146
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0033471630000000002	0.12557266996476146
INFANTILE LIVER FAILURE SYNDROME 1	0.003347163	0.12557266996476144
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.003347163	0.12557266996476144
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.003347163	0.12557266996476144
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.003347163	0.12557266996476144
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.003347163	0.12557266996476144
ECTODERMAL DYSPLASIA-BLINDNESS SYNDROME	0.00329998	0.12380254544828366
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.00329998	0.12380254544828366
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.00329998	0.12380254544828366
NATHALIE SYNDROME	0.00329998	0.12380254544828366
AGEL AMYLOIDOSIS	0.00329998	0.12380254544828366
TOWNES-BROCKS SYNDROME	0.00329998	0.12380254544828366
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00329998	0.12380254544828366
BETA-THALASSEMIA MAJOR	0.00329998	0.12380254544828366
KNIEST DYSPLASIA	0.00329998	0.12380254544828366
SPASTIC PARAPARESIS AND DEAFNESS	0.00329998	0.12380254544828366
ACROOSTEOLYSIS DOMINANT TYPE	0.00329998	0.12380254544828366
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.00329998	0.12380254544828366
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00328629	0.12328894935158398
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.00328629	0.12328894935158398
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00328629	0.12328894935158398
DYSTONIA, JUVENILE-ONSET	0.00328629	0.12328894935158398
STICKLER SYNDROME	0.00328629	0.12328894935158398
STICKLER SYNDROME TYPE 2	0.00328629	0.12328894935158398
NATHALIE SYNDROME	0.00328629	0.12328894935158398
STICKLER SYNDROME TYPE 1	0.00328629	0.12328894935158398
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.00328629	0.12328894935158398
NAIL-PATELLA SYNDROME	0.00328629	0.12328894935158398
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.00328629	0.12328894935158398
VOGT-KOYANAGI-HARADA DISEASE	0.00328629	0.12328894935158398
DUANE-RADIAL RAY SYNDROME; DRRS	0.00328629	0.12328894935158398
X-LINKED DOMINANT CHONDRODYSPLASIA PUNCTATA	0.00328629	0.12328894935158398
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00328629	0.12328894935158398
USHER SYNDROME TYPE 3	0.00328629	0.12328894935158398
NEUROFIBROMATOSIS TYPE 2	0.00328629	0.12328894935158398
STICKLER SYNDROME, TYPE II	0.00328629	0.12328894935158398
RELAPSING POLYCHONDRITIS	0.00328629	0.12328894935158398
SHORT SYNDROME	0.00328629	0.12328894935158398
STICKLER SYNDROME, TYPE I	0.00328629	0.12328894935158398
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003267824	0.12259617612136804
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003267824	0.12259617612136804
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003267824	0.12259617612136804
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.003267824	0.12259617612136804
OCULOCEREBROCUTANEOUS SYNDROME	0.003263689	0.12244104684015159
16Q24.3 MICRODELETION SYNDROME	0.003263689	0.12244104684015159
ACROCALLOSAL SYNDROME; ACLS	0.003263689	0.12244104684015159
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.003263689	0.12244104684015159
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.003263689	0.12244104684015159
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.003263689	0.12244104684015159
KRABBE DISEASE	0.003263689	0.12244104684015159
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0032636889999999997	0.12244104684015157
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.0032636889999999997	0.12244104684015157
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0032541339999999997	0.12208258002466835
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.0032541339999999997	0.12208258002466835
PEROXISOME BIOGENESIS DISORDER 6B	0.0032541339999999997	0.12208258002466835
WAARDENBURG-SHAH SYNDROME	0.0032541339999999997	0.12208258002466835
PEROXISOME BIOGENESIS DISORDER 5B	0.0032541339999999997	0.12208258002466835
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.0032541339999999997	0.12208258002466835
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.0032541339999999997	0.12208258002466835
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0032541339999999997	0.12208258002466835
WOLFRAM SYNDROME	0.003249999	0.1219274507434519
KALLMANN SYNDROME	0.003249999	0.1219274507434519
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.003249999	0.1219274507434519
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.003084514	0.11571909062202414
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003084514	0.11571909062202414
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.003084514	0.11571909062202414
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003084514	0.11571909062202414
CONGENITAL VARICELLA SYNDROME	0.003084514	0.11571909062202414
OCULO-PALATO-CEREBRAL SYNDROME	0.003084514	0.11571909062202414
3Q29 MICRODELETION SYNDROME	0.003084514	0.11571909062202414
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.0030803790000000003	0.1155639613408077
INCONTINENTIA PIGMENTI; IP	0.0030803790000000003	0.1155639613408077
PHENYLKETONURIA	0.0030803790000000003	0.1155639613408077
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.0030803790000000003	0.1155639613408077
ASPARTYLGLUCOSAMINURIA; AGU	0.0030803790000000003	0.1155639613408077
LATHOSTEROLOSIS	0.0030803790000000003	0.1155639613408077
HARROD SYNDROME	0.0030803790000000003	0.1155639613408077
NEVUS COMEDONICUS SYNDROME	0.003080379	0.1155639613408077
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.003080379	0.1155639613408077
8P11.2 DELETION SYNDROME	0.003048223	0.11435759201389208
CHROMOSOME 19P13.13 DELETION SYNDROME	0.003048223	0.11435759201389208
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.003048223	0.11435759201389208
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.003048223	0.11435759201389208
ADENYLOSUCCINASE DEFICIENCY	0.003048223	0.11435759201389208
MONOSOMY 9P	0.003048223	0.11435759201389208
20Q11.2 MICRODUPLICATION SYNDROME	0.003048223	0.11435759201389208
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.003048223	0.11435759201389208
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.003048223	0.11435759201389208
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.003048223	0.11435759201389208
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.003048223	0.11435759201389208
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.003048223	0.11435759201389208
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.003048223	0.11435759201389208
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.003048223	0.11435759201389208
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.003048223	0.11435759201389208
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.003048223	0.11435759201389208
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.003048223	0.11435759201389208
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.0030482229999999996	0.11435759201389205
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0030482229999999996	0.11435759201389205
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.0030482229999999996	0.11435759201389205
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.0030482229999999996	0.11435759201389205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0030482229999999996	0.11435759201389205
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0030482229999999996	0.11435759201389205
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00302121	0.1133441682476285
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00302121	0.1133441682476285
COWCHOCK SYNDROME; COWCK	0.00302121	0.1133441682476285
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00302121	0.1133441682476285
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.0029873499999999997	0.11207387140071459
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.0029873499999999997	0.11207387140071459
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.0029873499999999997	0.11207387140071459
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.0029873499999999997	0.11207387140071459
ISOLATED ANIRIDIA	0.0029873499999999997	0.11207387140071459
ANIRIDIA	0.0029873499999999997	0.11207387140071459
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.0029873499999999997	0.11207387140071459
ANTERIOR SEGMENT DYSGENESIS 2; ASGD2	0.0029873499999999997	0.11207387140071459
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.0029873499999999997	0.11207387140071459
SPONDYLO-OCULAR SYNDROME	0.0029873499999999997	0.11207387140071459
SPASTIC PARAPLEGIA 26, AUTOSOMAL RECESSIVE; SPG26	0.0029873499999999997	0.11207387140071459
X-LINKED IMMUNONEUROLOGIC DISORDER	0.0029873499999999997	0.11207387140071459
LEBER CONGENITAL AMAUROSIS 16	0.0029873499999999997	0.11207387140071459
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.0029873499999999997	0.11207387140071459
CATARACT-MICROCORNEA SYNDROME	0.0029873499999999997	0.11207387140071459
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 24; SCAR24	0.0029873499999999997	0.11207387140071459
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.0029873499999999997	0.11207387140071459
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.0029873499999999997	0.11207387140071459
NANCE-HORAN SYNDROME	0.0029873499999999997	0.11207387140071459
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.0029873499999999997	0.11207387140071459
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.0029873499999999997	0.11207387140071459
HEREDITARY MUCOEPITHELIAL DYSPLASIA	0.0029873499999999997	0.11207387140071459
MORNING GLORY DISC ANOMALY	0.0029873499999999997	0.11207387140071459
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0028695030000000002	0.10765270564412097
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.0028695030000000002	0.10765270564412097
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.0028695030000000002	0.10765270564412097
MONOSOMY 9Q22.3	0.002869503	0.10765270564412097
MEND SYNDROME	0.002869503	0.10765270564412097
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.002869503	0.10765270564412097
MEND SYNDROME; MEND	0.002869503	0.10765270564412097
JACOBSEN SYNDROME	0.002869503	0.10765270564412097
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.002869503	0.10765270564412097
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.002819434	0.10577430951806865
BRESEK SYNDROME	0.002819434	0.10577430951806865
WARSAW BREAKAGE SYNDROME; WABS	0.002819434	0.10577430951806865
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.002819434	0.10577430951806865
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.002819434	0.10577430951806865
OPTIC ATROPHY 11; OPA11	0.002819434	0.10577430951806865
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.002819434	0.10577430951806865
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.002819434	0.10577430951806865
17P11.2 MICRODUPLICATION SYNDROME	0.002819434	0.10577430951806865
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.002819434	0.10577430951806865
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0028152990000000003	0.10561918023685221
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0028152990000000003	0.10561918023685221
DISTAL MONOSOMY 3P	0.0028152990000000003	0.10561918023685221
MENTAL RETARDATION, X-LINKED 102	0.0028152990000000003	0.10561918023685221
CYCLIC VOMITING SYNDROME	0.0028152990000000003	0.10561918023685221
KLEEFSTRA SYNDROME	0.0028152990000000003	0.10561918023685221
XP22.13P22.2 DUPLICATION SYNDROME	0.0028152990000000003	0.10561918023685221
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.0028152990000000003	0.10561918023685221
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.002815299	0.10561918023685221
XYLOSIDASE DEFICIENCY	0.002815299	0.10561918023685221
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.002815299	0.10561918023685221
MICROPHTHALMIA, SYNDROMIC 3	0.0028057439999999998	0.10526071342136896
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0028057439999999998	0.10526071342136896
BRAIN-LUNG-THYROID SYNDROME	0.0028057439999999998	0.10526071342136896
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.0028057439999999998	0.10526071342136896
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0028057439999999998	0.10526071342136896
TOWNES-BROCKS SYNDROME 1; TBS1	0.0028057439999999998	0.10526071342136896
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.0028057439999999998	0.10526071342136896
CRANIOSYNOSTOSIS 6; CRS6	0.0028057439999999998	0.10526071342136896
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0028057439999999998	0.10526071342136896
MOYNAHAN SYNDROME	0.002801609	0.10510558414015253
KEARNS-SAYRE SYNDROME; KSS	0.002801609	0.10510558414015253
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.002801609	0.10510558414015253
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.002801609	0.10510558414015253
COFFIN-LOWRY SYNDROME; CLS	0.002801609	0.10510558414015253
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.002801609	0.10510558414015253
RENIER-GABREELS-JASPER SYNDROME	0.002801609	0.10510558414015253
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.002801609	0.10510558414015253
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.002801609	0.10510558414015253
WORSTER-DROUGHT SYNDROME	0.002801609	0.10510558414015253
TRIPLE A SYNDROME	0.002801609	0.10510558414015253
SCLEROSTEOSIS 1; SOST1	0.0027222699999999997	0.10212909029675911
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027222699999999997	0.10212909029675911
GAPO SYNDROME	0.0027222699999999997	0.10212909029675911
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.0027222699999999997	0.10212909029675911
RENAL COLOBOMA SYNDROME	0.0027222699999999997	0.10212909029675911
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027222699999999997	0.10212909029675911
FRIEDREICH ATAXIA	0.0027222699999999997	0.10212909029675911
SPINOCEREBELLAR ATAXIA TYPE 31	0.0027222699999999997	0.10212909029675911
DYSOSTEOSCLEROSIS	0.0027222699999999997	0.10212909029675911
AUTOSOMAL RECESSIVE SPINOCEREBELLAR ATAXIA-BLINDNESS-DEAFNESS SYNDROME	0.0027222699999999997	0.10212909029675911
OSTEOPETROSIS AND RELATED DISORDERS	0.0027222699999999997	0.10212909029675911
45,X/46,XY MIXED GONADAL DYSGENESIS	0.0027222699999999997	0.10212909029675911
SPINOCEREBELLAR ATAXIA TYPE 18	0.0027222699999999997	0.10212909029675911
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027222699999999997	0.10212909029675911
SPINOCEREBELLAR ATAXIA 13	0.0027222699999999997	0.10212909029675911
CHIARI MALFORMATION TYPE I	0.0027222699999999997	0.10212909029675911
RICHARDS-RUNDLE SYNDROME	0.0027222699999999997	0.10212909029675911
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027222699999999997	0.10212909029675911
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00270858	0.10161549420005943
CHANARIN-DORFMAN SYNDROME	0.00270858	0.10161549420005943
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00270858	0.10161549420005943
NOONAN SYNDROME	0.00270858	0.10161549420005943
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00270858	0.10161549420005943
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00270858	0.10161549420005943
ENDOSTEAL HYPEROSTOSIS, WORTH TYPE	0.00270858	0.10161549420005943
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.00270858	0.10161549420005943
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00270858	0.10161549420005943
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00270858	0.10161549420005943
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00270858	0.10161549420005943
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00270858	0.10161549420005943
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00270858	0.10161549420005943
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00270858	0.10161549420005943
FETAL IODINE SYNDROME	0.00270858	0.10161549420005943
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00270858	0.10161549420005943
MULTIPLE CARBOXYLASE DEFICIENCY	0.0026044230000000002	0.09770792454016548
SEVERE CANAVAN DISEASE	0.0026044230000000002	0.09770792454016548
MONOSOMY 22Q13.3	0.002604423	0.09770792454016548
17Q12 MICRODELETION SYNDROME	0.002604423	0.09770792454016548
TARP SYNDROME	0.002604423	0.09770792454016548
TAY-SACHS DISEASE	0.002604423	0.09770792454016548
CRANIOPHARYNGIOMA	0.002604423	0.09770792454016548
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.002604423	0.09770792454016548
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.002604423	0.09770792454016548
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.002604423	0.09770792454016548
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.002604423	0.09770792454016548
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.002604423	0.09770792454016548
KEUTEL SYNDROME	0.002604423	0.09770792454016548
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.002604423	0.09770792454016548
SMITH-MAGENIS SYNDROME; SMS	0.002604423	0.09770792454016548
FUCOSIDOSIS	0.002604423	0.09770792454016548
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.002604423	0.09770792454016548
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.002604423	0.09770792454016548
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0025907330000000004	0.09719432844346582
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.0025907330000000004	0.09719432844346582
DONNAI-BARROW SYNDROME	0.0025907330000000004	0.09719432844346582
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0025907330000000004	0.09719432844346582
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0025907330000000004	0.09719432844346582
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0025907330000000004	0.09719432844346582
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0025907330000000004	0.09719432844346582
DISTAL MONOSOMY 19P13.3	0.0025907330000000004	0.09719432844346582
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0025907330000000004	0.09719432844346582
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0025907330000000004	0.09719432844346582
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0025907330000000004	0.09719432844346582
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.0025907330000000004	0.09719432844346582
CHROMOSOME 2Q37 DELETION SYNDROME	0.0025907330000000004	0.09719432844346582
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.002590733	0.0971943284434658
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.002590733	0.0971943284434658
EAST SYNDROME	0.002590733	0.0971943284434658
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.002590733	0.0971943284434658
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00253896	0.0952520047974152
MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00253896	0.0952520047974152
MECKEL SYNDROME	0.00253896	0.0952520047974152
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP G; XPG	0.00253896	0.0952520047974152
MONOSOMY 13Q14	0.00253896	0.0952520047974152
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00253896	0.0952520047974152
STROMME SYNDROME; STROMS	0.00253896	0.0952520047974152
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00253896	0.0952520047974152
251190 MICROCEPHALIC PRIMORDIAL DWARFISM, TORIELLO TYPE	0.00253896	0.0952520047974152
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00253896	0.0952520047974152
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00253896	0.0952520047974152
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.00253896	0.0952520047974152
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.00253896	0.0952520047974152
MICROCEPHALIC OSTEODYSPLASTIC DYSPLASIA, SAUL-WILSON TYPE	0.00253896	0.0952520047974152
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00253896	0.0952520047974152
MARTSOLF SYNDROME	0.00253896	0.0952520047974152
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.00253896	0.0952520047974152
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.0025068039999999996	0.09404563547049959
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.0025068039999999996	0.09404563547049959
AICARDI-GOUTIERES SYNDROME 6	0.0025068039999999996	0.09404563547049959
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.0025068039999999996	0.09404563547049959
6Q16 MICRODELETION SYNDROME	0.0025068039999999996	0.09404563547049959
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.0025068039999999996	0.09404563547049959
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.0025068039999999996	0.09404563547049959
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.0025068039999999996	0.09404563547049959
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.0025068039999999996	0.09404563547049959
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0025068039999999996	0.09404563547049959
MENTAL RETARDATION, X-LINKED 106; MRX106	0.0025068039999999996	0.09404563547049959
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.002502669	0.09389050618928314
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002502669	0.09389050618928314
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.002502669	0.09389050618928314
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.002502669	0.09389050618928314
MEHMO SYNDROME	0.002502669	0.09389050618928314
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.002502669	0.09389050618928314
TYROSINEMIA TYPE 2	0.002502669	0.09389050618928314
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002502669	0.09389050618928314
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.002502669	0.09389050618928314
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.002502669	0.09389050618928314
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.002502669	0.09389050618928314
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.002502669	0.09389050618928314
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002502669	0.09389050618928314
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.0023280840000000002	0.0873407491007285
PELLAGRA-LIKE SYNDROME	0.0023280840000000002	0.0873407491007285
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.0023280840000000002	0.0873407491007285
SAUL-WILSON SYNDROME; SWILS	0.0023280840000000002	0.0873407491007285
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.0023280840000000002	0.0873407491007285
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.0023280840000000002	0.0873407491007285
ELSAHY-WATERS SYNDROME; ESWS	0.0023280840000000002	0.0873407491007285
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.0023280840000000002	0.0873407491007285
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.0023280840000000002	0.0873407491007285
ALDH18A1-RELATED DE BARSY SYNDROME	0.0023280840000000002	0.0873407491007285
TREACHER-COLLINS SYNDROME	0.0023280840000000002	0.0873407491007285
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.0023280840000000002	0.0873407491007285
GALACTOSE EPIMERASE DEFICIENCY	0.0023280840000000002	0.0873407491007285
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.002323949	0.08718561981951205
ADAMS-OLIVER SYNDROME	0.002323949	0.08718561981951205
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.002323949	0.08718561981951205
DYSEQUILIBRIUM SYNDROME	0.002323949	0.08718561981951205
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.002323949	0.08718561981951205
PROTEUS SYNDROME	0.002323949	0.08718561981951205
FLYNN-AIRD SYNDROME	0.002323949	0.08718561981951205
MUSCLE-EYE-BRAIN DISEASE	0.002323949	0.08718561981951205
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.002323949	0.08718561981951205
LINEAR VERRUCOUS NEVUS SYNDROME	0.002323949	0.08718561981951205
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.002323949	0.08718561981951205
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.002323949	0.08718561981951205
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.002323949	0.08718561981951205
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.002323949	0.08718561981951205
ECTODERMAL DYSPLASIA SYNDROME	0.002323949	0.08718561981951205
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.002323949	0.08718561981951205
CEREBROTENDINOUS XANTHOMATOSIS	0.002323949	0.08718561981951205
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.002323949	0.08718561981951205
HEREDITARY FRUCTOSE INTOLERANCE	0.002323949	0.08718561981951205
JOUBERT SYNDROME WITH RENAL DEFECT	0.002291793	0.08597925049259642
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.002291793	0.08597925049259642
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.002291793	0.08597925049259642
GRISCELLI SYNDROME	0.002291793	0.08597925049259642
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.002291793	0.08597925049259642
CHÃ‰DIAK-HIGASHI SYNDROME	0.002291793	0.08597925049259642
SCHINDLER DISEASE, TYPE I	0.002291793	0.08597925049259642
19P13.13 MICRODELETION SYNDROME	0.002291793	0.08597925049259642
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.002291793	0.08597925049259642
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.002291793	0.08597925049259642
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.002291793	0.08597925049259642
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.002291793	0.08597925049259642
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.002291793	0.08597925049259642
OCULOECTODERMAL SYNDROME; OES	0.002291793	0.08597925049259642
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.002291793	0.08597925049259642
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.002291793	0.08597925049259642
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.002291793	0.08597925049259642
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.002291793	0.08597925049259642
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.002291793	0.08597925049259642
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.002291793	0.08597925049259642
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.002291793	0.08597925049259642
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.002291793	0.08597925049259642
JOUBERT SYNDROME WITH OCULAR DEFECT	0.002291793	0.08597925049259642
OPTIC PATHWAY GLIOMA	0.002291793	0.08597925049259642
6Q TERMINAL DELETION SYNDROME	0.002291793	0.08597925049259642
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.002291793	0.08597925049259642
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.002291793	0.08597925049259642
ELEJALDE DISEASE	0.002291793	0.08597925049259642
FREE SIALIC ACID STORAGE DISEASE	0.002291793	0.08597925049259642
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.002291793	0.08597925049259642
OROFACIODIGITAL SYNDROME TYPE 6	0.002291793	0.08597925049259642
INFANTILE SIALIC ACID STORAGE DISEASE	0.002291793	0.08597925049259642
SALLA DISEASE	0.002291793	0.08597925049259642
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.002291793	0.08597925049259642
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.002291793	0.08597925049259642
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.002291793	0.08597925049259642
JOUBERT SYNDROME	0.002291793	0.08597925049259642
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.002291793	0.08597925049259642
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.002291793	0.08597925049259642
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.002291793	0.08597925049259642
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.002291793	0.08597925049259642
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.002291793	0.08597925049259642
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.002291793	0.08597925049259642
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.002291793	0.08597925049259642
48,XXYY SYNDROME	0.002291793	0.08597925049259642
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.002291793	0.08597925049259642
MENTAL RETARDATION, X-LINKED 104; MRX104	0.002291793	0.08597925049259642
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.002291793	0.08597925049259642
HARTNUP DISEASE	0.002291793	0.08597925049259642
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.002291793	0.08597925049259642
46,XX GONADAL DYSGENESIS	0.00227388	0.08530722369345972
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.00227388	0.08530722369345972
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00227388	0.08530722369345972
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.00227388	0.08530722369345972
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00227388	0.08530722369345972
DISTAL MONOSOMY 10P	0.00227388	0.08530722369345972
FETAL METHYLMERCURY SYNDROME	0.00227388	0.08530722369345972
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 53	0.00227388	0.08530722369345972
DIABETIC EMBRYOPATHY	0.00227388	0.08530722369345972
GROWTH HORMONE INSENSITIVITY SYNDROME	0.00227388	0.08530722369345972
FANCONI ANEMIA	0.00227388	0.08530722369345972
X-LINKED INTELLECTUAL DISABILITY, ABIDI TYPE	0.00227388	0.08530722369345972
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00227388	0.08530722369345972
FEINGOLD SYNDROME 1; FGLDS1	0.00227388	0.08530722369345972
MICROTRIPLICATION 11Q24.1	0.00227388	0.08530722369345972
PIEBALDISM	0.00227388	0.08530722369345972
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.00227388	0.08530722369345972
HOLOPROSENCEPHALY-RADIAL HEART RENAL ANOMALIES SYNDROME	0.00227388	0.08530722369345972
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00227388	0.08530722369345972
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.00227388	0.08530722369345972
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.00227388	0.08530722369345972
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00227388	0.08530722369345972
OTOMANDIBULAR SYNDROME	0.00226019	0.08479362759676005
FEINGOLD SYNDROME	0.00226019	0.08479362759676005
MICROCEPHALY-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00226019	0.08479362759676005
ACROOTOOCULAR SYNDROME	0.00226019	0.08479362759676005
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.00226019	0.08479362759676005
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00226019	0.08479362759676005
ACROCRANIOFACIAL DYSOSTOSIS	0.00226019	0.08479362759676005
SEVERE COMBINED IMMUNODEFICIENCY	0.00226019	0.08479362759676005
JOHANSON-BLIZZARD SYNDROME; JBS	0.00226019	0.08479362759676005
JOHANSON-BLIZZARD SYNDROME	0.00226019	0.08479362759676005
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00226019	0.08479362759676005
DE SANCTIS-CACCHIONE SYNDROME	0.00226019	0.08479362759676005
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.00226019	0.08479362759676005
3MC SYNDROME 2	0.0020630040000000002	0.07739596799677301
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.0020630040000000002	0.07739596799677301
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.0020630040000000002	0.07739596799677301
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.0020630040000000002	0.07739596799677301
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.0020630040000000002	0.07739596799677301
BARDET-BIEDL SYNDROME 16; BBS16	0.0020630040000000002	0.07739596799677301
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.0020630040000000002	0.07739596799677301
FRIED SYNDROME	0.0020630040000000002	0.07739596799677301
ISOLATED PLAGIOCEPHALY	0.0020630040000000002	0.07739596799677301
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.0020630040000000002	0.07739596799677301
COFFIN-SIRIS SYNDROME 7; CSS7	0.0020630040000000002	0.07739596799677301
AURICULOCONDYLAR SYNDROME	0.0020630040000000002	0.07739596799677301
DISTAL MONOSOMY 6P	0.0020630040000000002	0.07739596799677301
SWEENEY-COX SYNDROME; SWCOS	0.0020630040000000002	0.07739596799677301
8P23.1 DUPLICATION SYNDROME	0.0020630040000000002	0.07739596799677301
CHAR SYNDROME	0.0020630040000000002	0.07739596799677301
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0020630040000000002	0.07739596799677301
LYMPHEDEMA, HEREDITARY, III	0.0020630040000000002	0.07739596799677301
14Q22Q23 MICRODELETION SYNDROME	0.0020630040000000002	0.07739596799677301
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.0020630040000000002	0.07739596799677301
THANATOPHORIC DYSPLASIA	0.002058869	0.07724083871555655
CHIME SYNDROME	0.002058869	0.07724083871555655
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.002058869	0.07724083871555655
GALACTOSIALIDOSIS	0.002058869	0.07724083871555655
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.002058869	0.07724083871555655
BETA-MANNOSIDOSIS	0.002058869	0.07724083871555655
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.002058869	0.07724083871555655
RAMON SYNDROME	0.002058869	0.07724083871555655
THANATOPHORIC DYSPLASIA TYPE 1	0.002058869	0.07724083871555655
MYASTHENIA GRAVIS	0.002058869	0.07724083871555655
OHDO SYNDROME	0.002058869	0.07724083871555655
7Q11.23 MICRODUPLICATION SYNDROME	0.002058869	0.07724083871555655
CRIGLER-NAJJAR SYNDROME	0.002058869	0.07724083871555655
THANATOPHORIC DYSPLASIA TYPE 2	0.002058869	0.07724083871555655
NEUROFIBROMATOSIS, TYPE II	0.002058869	0.07724083871555655
CRIGLER-NAJJAR SYNDROME TYPE 1	0.002058869	0.07724083871555655
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.002058869	0.07724083871555655
PFEIFFER SYNDROME TYPE 3	0.002058869	0.07724083871555655
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.002058869	0.07724083871555655
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.002058869	0.07724083871555655
4Q21 MICRODELETION SYNDROME	0.002058869	0.07724083871555655
PITT-HOPKINS-LIKE SYNDROME	0.002058869	0.07724083871555655
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.002058869	0.07724083871555655
DYSOSTEOSCLEROSIS	0.002058869	0.07724083871555655
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.002058869	0.07724083871555655
ACQUIRED PARTIAL LIPODYSTROPHY	0.002058869	0.07724083871555655
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.002058869	0.07724083871555655
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.002058869	0.07724083871555655
GYRATE ATROPHY OF CHOROID AND RETINA	0.002058869	0.07724083871555655
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.002058869	0.07724083871555655
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.002058869	0.07724083871555655
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.002058869	0.07724083871555655
ADRENOLEUKODYSTROPHY	0.002058869	0.07724083871555655
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.002049314	0.07688237190007333
OPITZ G/BBB SYNDROME	0.002049314	0.07688237190007333
PEROXISOME BIOGENESIS DISORDER 3B	0.002049314	0.07688237190007333
LATERAL MENINGOCELE SYNDROME	0.002049314	0.07688237190007333
GALACTOSE EPIMERASE DEFICIENCY	0.002049314	0.07688237190007333
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.002049314	0.07688237190007333
STEEL SYNDROME; STLS	0.002049314	0.07688237190007333
8Q12 MICRODUPLICATION SYNDROME	0.002049314	0.07688237190007333
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.002049314	0.07688237190007333
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.002049314	0.07688237190007333
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.002049314	0.07688237190007333
NOONAN SYNDROME 11; NS11	0.002049314	0.07688237190007333
CDAGS SYNDROME	0.002049314	0.07688237190007333
THAUVIN-ROBINET-FAIVRE SYNDROME	0.002049314	0.07688237190007333
JOUBERT SYNDROME 21	0.002049314	0.07688237190007333
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.002049314	0.07688237190007333
NOONAN SYNDROME 6; NS6	0.002049314	0.07688237190007333
IMMUNODEFICIENCY 23; IMD23	0.002049314	0.07688237190007333
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.002049314	0.07688237190007333
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.002049314	0.07688237190007333
RETINITIS PIGMENTOSA 59; RP59	0.0020451790000000003	0.07672724261885688
HADDAD SYNDROME	0.0020451790000000003	0.07672724261885688
FOUNTAIN SYNDROME	0.0020451790000000003	0.07672724261885688
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.0020451790000000003	0.07672724261885688
FOUNTAIN SYNDROME	0.0020451790000000003	0.07672724261885688
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.0020451790000000003	0.07672724261885688
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.0020451790000000003	0.07672724261885688
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.0020451790000000003	0.07672724261885688
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.0020451790000000003	0.07672724261885688
CONGENITAL HYDROCEPHALUS	0.0020451790000000003	0.07672724261885688
ACUTE BILIRUBIN ENCEPHALOPATHY	0.0020451790000000003	0.07672724261885688
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.0020451790000000003	0.07672724261885688
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.0020451790000000003	0.07672724261885688
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.0020451790000000003	0.07672724261885688
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.0020451790000000003	0.07672724261885688
RAMON SYNDROME	0.0020451790000000003	0.07672724261885688
THYROCEREBRORETINAL SYNDROME	0.0020451790000000003	0.07672724261885688
SAETHRE-CHOTZEN SYNDROME	0.0020451790000000003	0.07672724261885688
HYPERLEUCINE-ISOLEUCINEMIA	0.0020451790000000003	0.07672724261885688
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.0020451790000000003	0.07672724261885688
IMMUNODEFICIENCY 47	0.0020451790000000003	0.07672724261885688
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.0020451790000000003	0.07672724261885688
THYROCEREBRORENAL SYNDROME	0.0020451790000000003	0.07672724261885688
LOWRY-WOOD SYNDROME	0.00196125	0.07357854964589067
EPIPHYSEAL DYSPLASIA, MICROCEPHALY, AND NYSTAGMUS	0.00196125	0.07357854964589067
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.00196125	0.07357854964589067
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 4; COXPD4	0.00196125	0.07357854964589067
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.00196125	0.07357854964589067
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00196125	0.07357854964589067
FOCAL DERMAL HYPOPLASIA; FDH	0.00196125	0.07357854964589067
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.00196125	0.07357854964589067
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.00196125	0.07357854964589067
ATAXIA-PANCYTOPENIA SYNDROME	0.00196125	0.07357854964589067
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.00196125	0.07357854964589067
MUCOLIPIDOSIS TYPE IV	0.00196125	0.07357854964589067
SHORT-RIB THORACIC DYSPLASIA 9 WITH OR WITHOUT POLYDACTYLY; SRTD9	0.00196125	0.07357854964589067
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001843403	0.06915738388929704
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.001843403	0.06915738388929704
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001843403	0.06915738388929704
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001843403	0.06915738388929704
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001843403	0.06915738388929704
HOLOPROSENCEPHALY 1; HPE1	0.001843403	0.06915738388929704
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001843403	0.06915738388929704
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001843403	0.06915738388929704
LISSENCEPHALY 4	0.001843403	0.06915738388929704
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.001843403	0.06915738388929704
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.001843403	0.06915738388929704
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929704
SMITH-MAGENIS SYNDROME	0.001843403	0.06915738388929704
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001843403	0.06915738388929704
15Q14 MICRODELETION SYNDROME	0.001843403	0.06915738388929704
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.001843403	0.06915738388929704
KBG SYNDROME	0.001843403	0.06915738388929704
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001843403	0.06915738388929704
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.001843403	0.06915738388929704
KLEEFSTRA SYNDROME 2; KLEFS2	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.001843403	0.06915738388929704
HOLOPROSENCEPHALY 2; HPE2	0.001843403	0.06915738388929704
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929704
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001843403	0.06915738388929704
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.001843403	0.06915738388929704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001843403	0.06915738388929704
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001843403	0.06915738388929704
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001843403	0.06915738388929704
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.001843403	0.06915738388929704
DPAGT1-CDG	0.001843403	0.06915738388929704
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001843403	0.06915738388929704
CK SYNDROME	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001843403	0.06915738388929704
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.001843403	0.06915738388929704
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001843403	0.06915738388929704
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001843403	0.06915738388929704
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001843403	0.06915738388929704
XQ28 (MECP2) DUPLICATION	0.001843403	0.06915738388929704
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.001843403	0.06915738388929704
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001843403	0.06915738388929704
RUVALCABA SYNDROME	0.001843403	0.06915738388929704
COFFIN-SIRIS SYNDROME 5	0.001843403	0.06915738388929704
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.001843403	0.06915738388929704
PITT-HOPKINS SYNDROME	0.001843403	0.06915738388929704
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.001843403	0.06915738388929704
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001843403	0.06915738388929704
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001843403	0.06915738388929704
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001843403	0.06915738388929704
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001843403	0.06915738388929704
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001843403	0.06915738388929704
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.001843403	0.06915738388929704
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001843403	0.06915738388929704
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.001843403	0.06915738388929704
DISTAL MONOSOMY 10Q	0.001843403	0.06915738388929704
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001843403	0.06915738388929704
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.001843403	0.06915738388929704
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001843403	0.06915738388929704
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001843403	0.06915738388929704
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001843403	0.06915738388929704
FILIPPI SYNDROME	0.001843403	0.06915738388929704
8P23.1 MICRODELETION SYNDROME	0.001843403	0.06915738388929704
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.001843403	0.06915738388929704
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.001843403	0.06915738388929704
SSR4-CDG	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.001843403	0.06915738388929704
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001843403	0.06915738388929704
ALG3-CDG	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.001843403	0.06915738388929704
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929704
STT3A-CDG	0.001843403	0.06915738388929704
STT3B-CDG	0.001843403	0.06915738388929704
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001843403	0.06915738388929704
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001843403	0.06915738388929704
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001843403	0.06915738388929704
KBG SYNDROME	0.001843403	0.06915738388929704
MATERNAL PHENYLKETONURIA	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001843403	0.06915738388929704
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.001843403	0.06915738388929704
2Q37 MICRODELETION SYNDROME	0.001843403	0.06915738388929704
C SYNDROME	0.001843403	0.06915738388929704
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001843403	0.06915738388929704
ALG1-CDG	0.001843403	0.06915738388929704
HOLOPROSENCEPHALY	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001843403	0.06915738388929704
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001843403	0.06915738388929704
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001843403	0.06915738388929704
RING CHROMOSOME 22 SYNDROME	0.001843403	0.06915738388929704
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001843403	0.06915738388929704
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001843403	0.06915738388929704
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.001843403	0.06915738388929704
17Q11.2 MICRODUPLICATION SYNDROME	0.001843403	0.06915738388929704
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001843403	0.06915738388929704
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001843403	0.06915738388929704
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001843403	0.06915738388929704
DISTAL MONOSOMY 1Q	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001843403	0.06915738388929704
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001843403	0.06915738388929704
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001843403	0.06915738388929704
MEHMO SYNDROME; MEHMO	0.001843403	0.06915738388929704
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.001843403	0.06915738388929704
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00178253	0.06687366327611957
OTODENTAL SYNDROME	0.00178253	0.06687366327611957
THANATOPHORIC DYSPLASIA, GLASGOW VARIANT	0.00178253	0.06687366327611957
MEGALOCORNEA	0.00178253	0.06687366327611957
RENAL TUBULAR ACIDOSIS, PROXIMAL, WITH OCULAR ABNORMALITIES AND MENTALRETARDATION	0.00178253	0.06687366327611957
MICROPHTHALMIA, ISOLATED 5	0.00178253	0.06687366327611957
IDIOPATHIC PANUVEITIS	0.00178253	0.06687366327611957
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00178253	0.06687366327611957
ICHTHYOSIS-INTELLECTUAL DISABILITY-DWARFISM-RENAL IMPAIRMENT SYNDROME	0.00178253	0.06687366327611957
ROTHMUND-THOMSON SYNDROME TYPE 2	0.00178253	0.06687366327611957
ROTHMUND-THOMSON SYNDROME TYPE 1	0.00178253	0.06687366327611957
PROTEUS-LIKE SYNDROME	0.00178253	0.06687366327611957
DERMATITIS, ATOPIC	0.00178253	0.06687366327611957
ENHANCED S-CONE SYNDROME	0.00178253	0.06687366327611957
POLYCYSTIC KIDNEY, CATARACT, AND CONGENITAL BLINDNESS	0.00178253	0.06687366327611957
MUSCULAR DYSTROPHY, CONGENITAL, WITH INFANTILE CATARACT AND HYPOGONADISM	0.00178253	0.06687366327611957
CATARACT 11, MULTIPLE TYPES; CTRCT11	0.00178253	0.06687366327611957
PACHYONYCHIA CONGENITA	0.00178253	0.06687366327611957
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.00178253	0.06687366327611957
%609376 CATARACT 35; CTRCT35;;CATARACT, CONGENITAL NUCLEAR, AUTOSOMAL RECESSIVE 1; CATCN1	0.00178253	0.06687366327611957
COENZYME Q10 DEFICIENCY	0.00178253	0.06687366327611957
NEONATAL INTRAHEPATIC CHOLESTASIS DUE TO CITRIN DEFICIENCY	0.00178253	0.06687366327611957
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00178253	0.06687366327611957
COATS DISEASE	0.00178253	0.06687366327611957
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00178253	0.06687366327611957
WEILL-MARCHESANI SYNDROME	0.00178253	0.06687366327611957
HYPERGONADOTROPIC HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.06687366327611957
HIDROTIC ECTODERMAL DYSPLASIA	0.00178253	0.06687366327611957
TRIPLOIDY	0.00178253	0.06687366327611957
MENTAL RETARDATION, TRUNCAL OBESITY, RETINAL DYSTROPHY, AND MICROPENIS SYNDROME; MORMS	0.00178253	0.06687366327611957
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00178253	0.06687366327611957
LYMPHEDEMA-DISTICHIASIS SYNDROME	0.00178253	0.06687366327611957
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00178253	0.06687366327611957
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.00178253	0.06687366327611957
LIMB-GIRDLE MUSCULAR DYSTROPHY, TYPE 1G; LGMD1G	0.00178253	0.06687366327611957
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00178253	0.06687366327611957
EYE DEFECTS-ARACHNODACTYLY-CARDIOPATHY SYNDROME	0.00178253	0.06687366327611957
STEINERT MYOTONIC DYSTROPHY	0.00178253	0.06687366327611957
WERNER SYNDROME; WRN	0.00178253	0.06687366327611957
GORLIN SYNDROME	0.00178253	0.06687366327611957
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00178253	0.06687366327611957
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00178253	0.06687366327611957
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00178253	0.06687366327611957
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.00178253	0.06687366327611957
INTERMEDIATE UVEITIS	0.00178253	0.06687366327611957
FRONTOFACIONASAL DYSPLASIA	0.00178253	0.06687366327611957
HYPERTROPHIC NEUROPATHY AND CATARACT	0.00178253	0.06687366327611957
MYOTONIC DYSTROPHY 1	0.00178253	0.06687366327611957
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00178253	0.06687366327611957
HEREDITARY HYPERFERRITINEMIA-CATARACT SYNDROME	0.00178253	0.06687366327611957
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.00178253	0.06687366327611957
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00178253	0.06687366327611957
AMOEBIC KERATITIS	0.00178253	0.06687366327611957
COLOBOMA, OCULAR, WITH OR WITHOUT HEARING IMPAIRMENT, CLEFT LIP/PALATE, AND/OR MENTAL RETARDATION; COB1	0.00178253	0.06687366327611957
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE I	0.00178253	0.06687366327611957
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00178253	0.06687366327611957
ANIRIDIA 3	0.00178253	0.06687366327611957
ANIRIDIA 2	0.00178253	0.06687366327611957
DOWN SYNDROME	0.00178253	0.06687366327611957
ALAGILLE SYNDROME 1; ALGS1	0.00178253	0.06687366327611957
DENT DISEASE	0.00178253	0.06687366327611957
EXFOLIATION SYNDROME; XFS	0.00178253	0.06687366327611957
INTELLECTUAL DEVELOPMENTAL DISORDER AND RETINITIS PIGMENTOSA; IDDRP	0.00178253	0.06687366327611957
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00178253	0.06687366327611957
BARDET-BIEDL SYNDROME 18; BBS18	0.00178253	0.06687366327611957
116100 CATARACT, MEMBRANOUS	0.00178253	0.06687366327611957
PROXIMAL MYOTONIC MYOPATHY	0.00178253	0.06687366327611957
GALACTOSEMIA	0.00178253	0.06687366327611957
IRIS PIGMENT LAYER, CLEAVAGE OF	0.00178253	0.06687366327611957
GALACTOKINASE DEFICIENCY	0.00178253	0.06687366327611957
MONILETHRIX	0.00178253	0.06687366327611957
DAHLBERG-BORER-NEWCOMER SYNDROME	0.00178253	0.06687366327611957
ANTERIOR SEGMENT DYSGENESIS 8	0.00178253	0.06687366327611957
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00178253	0.06687366327611957
127200 DWARFISM WITH STIFF JOINTS AND OCULAR ABNORMALITIES;;MOORE-FEDERMAN SYNDROME	0.00178253	0.06687366327611957
HYDROCEPHALY-CEREBELLAR AGENESIS SYNDROME	0.00178253	0.06687366327611957
SPONASTRIME DYSPLASIA	0.00178253	0.06687366327611957
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00178253	0.06687366327611957
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00178253	0.06687366327611957
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00178253	0.06687366327611957
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.00178253	0.06687366327611957
CONE-ROD DYSTROPHY 16	0.00178253	0.06687366327611957
%225200 ECTOPIA LENTIS ET PUPILLAE;;ECTOPIA LENTIS WITH ECTOPIA OF PUPIL	0.00178253	0.06687366327611957
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00178253	0.06687366327611957
175500 POLYPOSIS, SKIN PIGMENTATION, ALOPECIA, AND FINGERNAIL CHANGES;;CRONKHITE-CANADA SYNDROME	0.00178253	0.06687366327611957
POIKILODERMA, HEREDITARY FIBROSING, WITH TENDON CONTRACTURES, MYOPATHY, AND PULMONARY FIBROSIS; POIKTMP	0.00178253	0.06687366327611957
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00178253	0.06687366327611957
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.00178253	0.06687366327611957
ANIRIDIA, MICROCORNEA, AND SPONTANEOUSLY REABSORBED CATARACT	0.00178253	0.06687366327611957
ANIRIDIA-ABSENT PATELLA SYNDROME	0.00178253	0.06687366327611957
ALG8-CDG	0.00178253	0.06687366327611957
SPINAL MUSCULAR ATROPHY-DANDY-WALKER MALFORMATION-CATARACTS SYNDROME	0.00178253	0.06687366327611957
ANIRIDIA-INTELLECTUAL DISABILITY SYNDROME	0.00178253	0.06687366327611957
LEBER CONGENITAL AMAUROSIS, TYPE II	0.00178253	0.06687366327611957
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00178253	0.06687366327611957
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00178253	0.06687366327611957
BIRDSHOT CHORIORETINOPATHY	0.00178253	0.06687366327611957
CLASSIC GALACTOSEMIA	0.00178253	0.06687366327611957
WOOLLY HAIR	0.00178253	0.06687366327611957
ANIRIDIA AND ABSENT PATELLA	0.00178253	0.06687366327611957
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00178253	0.06687366327611957
VITREORETINAL DEGENERATION, SNOWFLAKE TYPE; SVD	0.00178253	0.06687366327611957
BASAL CELL NEVUS SYNDROME	0.00178253	0.06687366327611957
TRICHOMEGALY; TCMGLY	0.00178253	0.06687366327611957
BRANCHIO-OCULO-FACIAL SYNDROME	0.00178253	0.06687366327611957
RETINITIS PIGMENTOSA 84; RP84	0.00178253	0.06687366327611957
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.00178253	0.06687366327611957
CATARACT AND CONGENITAL ICHTHYOSIS	0.00178253	0.06687366327611957
HYPOGONADISM-CATARACT SYNDROME	0.00178253	0.06687366327611957
CATARACT, CRYSTALLINE CORALLIFORM	0.00178253	0.06687366327611957
GALACTOKINASE DEFICIENCY	0.00178253	0.06687366327611957
RETINITIS PIGMENTOSA 4; RP4	0.00178253	0.06687366327611957
OROFACIODIGITAL SYNDROME VI	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.0017503739999999999	0.06566729394920395
REVESZ SYNDROME	0.0017503739999999999	0.06566729394920395
NAVAJO NEUROHEPATOPATHY	0.0017503739999999999	0.06566729394920395
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA TYPE 29	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.0017503739999999999	0.06566729394920395
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.0017503739999999999	0.06566729394920395
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 32; JBTS32	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 31; JBTS31	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 7	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.0017503739999999999	0.06566729394920395
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 2	0.0017503739999999999	0.06566729394920395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0017503739999999999	0.06566729394920395
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.0017503739999999999	0.06566729394920395
CARDIOFACIOCUTANEOUS SYNDROME	0.0017503739999999999	0.06566729394920395
BAKER-GORDON SYNDROME; BAGOS	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA TYPE 7	0.0017503739999999999	0.06566729394920395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.0017503739999999999	0.06566729394920395
CEREBELLAR ATAXIA, CAYMAN TYPE	0.0017503739999999999	0.06566729394920395
FARBER DISEASE	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 27	0.0017503739999999999	0.06566729394920395
NEPHRONOPHTHISIS 11; NPHP11	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 26	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 24	0.0017503739999999999	0.06566729394920395
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.0017503739999999999	0.06566729394920395
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.0017503739999999999	0.06566729394920395
SENIOR-LOKEN SYNDROME 9	0.0017503739999999999	0.06566729394920395
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.0017503739999999999	0.06566729394920395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0017503739999999999	0.06566729394920395
CRANIOFRONTONASAL SYNDROME; CFNS	0.0017503739999999999	0.06566729394920395
JOUBERT SYNDROME 28	0.0017503739999999999	0.06566729394920395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.0017503739999999999	0.06566729394920395
ARIMA SYNDROME	0.0017503739999999999	0.06566729394920395
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.0017503739999999999	0.06566729394920395
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.001746239	0.06551216466798751
INFANTILE NEUROAXONAL DYSTROPHY	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.001746239	0.06551216466798751
LISSENCEPHALY, X-LINKED, 1; LISX1	0.001746239	0.06551216466798751
OCULOCEREBROCUTANEOUS SYNDROME	0.001746239	0.06551216466798751
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.001746239	0.06551216466798751
ATAXIA-TELANGIECTASIA	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.001746239	0.06551216466798751
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.001746239	0.06551216466798751
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.001746239	0.06551216466798751
MOMO SYNDROME	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.001746239	0.06551216466798751
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.001746239	0.06551216466798751
METACHROMATIC LEUKODYSTROPHY	0.001746239	0.06551216466798751
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.001746239	0.06551216466798751
EPISODIC ATAXIA TYPE 3	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.001746239	0.06551216466798751
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.001746239	0.06551216466798751
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.001746239	0.06551216466798751
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.001746239	0.06551216466798751
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.001746239	0.06551216466798751
GAPO SYNDROME; GAPOS	0.001746239	0.06551216466798751
MALAN OVERGROWTH SYNDROME	0.001746239	0.06551216466798751
EPISODIC ATAXIA, TYPE 6	0.001746239	0.06551216466798751
PERRAULT SYNDROME 5; PRLTS5	0.001746239	0.06551216466798751
SECONDARY SYRINGOMYELIA	0.001746239	0.06551216466798751
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.001746239	0.06551216466798751
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.001746239	0.06551216466798751
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.001746239	0.06551216466798751
HUNTINGTON DISEASE-LIKE 1	0.001746239	0.06551216466798751
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.001746239	0.06551216466798751
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.001746239	0.06551216466798751
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.001746239	0.06551216466798751
MESOMELIA-SYNOSTOSES SYNDROME	0.00151745	0.05692888217216409
184705 STEINFELD SYNDROME	0.00151745	0.05692888217216409
BROOKE-SPIEGLER SYNDROME	0.00151745	0.05692888217216409
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.00151745	0.05692888217216409
AUROCEPHALOSYNDACTYLY	0.00151745	0.05692888217216409
TUNE DEAFNESS	0.00151745	0.05692888217216409
DEAFNESS, X-LINKED 5; DFNX5	0.00151745	0.05692888217216409
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.00151745	0.05692888217216409
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.00151745	0.05692888217216409
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00151745	0.05692888217216409
PILI TORTI	0.00151745	0.05692888217216409
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.00151745	0.05692888217216409
MELNICK-NEEDLES SYNDROME	0.00151745	0.05692888217216409
ANUS, IMPERFORATE	0.00151745	0.05692888217216409
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00151745	0.05692888217216409
NAGER SYNDROME	0.00151745	0.05692888217216409
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.00151745	0.05692888217216409
PITUITARY CARCINOMA	0.00151745	0.05692888217216409
CHARCOT-MARIE-TOOTH DISEASE TYPE 1B	0.00151745	0.05692888217216409
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00151745	0.05692888217216409
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00151745	0.05692888217216409
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00151745	0.05692888217216409
USHER SYNDROME, TYPE ID	0.00151745	0.05692888217216409
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.00151745	0.05692888217216409
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.00151745	0.05692888217216409
TURCOT SYNDROME WITH POLYPOSIS	0.00151745	0.05692888217216409
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.00151745	0.05692888217216409
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.00151745	0.05692888217216409
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.00151745	0.05692888217216409
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.00151745	0.05692888217216409
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00151745	0.05692888217216409
CONE-ROD DYSTROPHY 1; CORD1	0.00151745	0.05692888217216409
3MC SYNDROME	0.00151745	0.05692888217216409
ISOLATED KLIPPEL-FEIL SYNDROME	0.00151745	0.05692888217216409
BARBER-SAY SYNDROME; BBRSAY	0.00151745	0.05692888217216409
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 2	0.00151745	0.05692888217216409
ABCD SYNDROME	0.00151745	0.05692888217216409
CAMPOMELIC DYSPLASIA	0.00151745	0.05692888217216409
LOCKED-IN SYNDROME	0.00151745	0.05692888217216409
DYSCHROMATOSIS UNIVERSALIS HEREDITARIA	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.00151745	0.05692888217216409
CONGENITAL NON-BULLOUS ICHTHYOSIFORM ERYTHRODERMA	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.00151745	0.05692888217216409
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.00151745	0.05692888217216409
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.00151745	0.05692888217216409
WILDERVANCK SYNDROME	0.00151745	0.05692888217216409
PAGET DISEASE OF BONE 4; PDB4	0.00151745	0.05692888217216409
CARNEY-STRATAKIS SYNDROME	0.00151745	0.05692888217216409
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00151745	0.05692888217216409
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.00151745	0.05692888217216409
RETICULAR DYSGENESIS	0.00151745	0.05692888217216409
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.00151745	0.05692888217216409
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.00151745	0.05692888217216409
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.00151745	0.05692888217216409
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.00151745	0.05692888217216409
THALIDOMIDE EMBRYOPATHY	0.00151745	0.05692888217216409
DEAFNESS-CRANIOFACIAL SYNDROME	0.00151745	0.05692888217216409
DEAFNESS, X-LINKED 7; DFNX7	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL DOMINANT 24	0.00151745	0.05692888217216409
EAR EXOSTOSES	0.00151745	0.05692888217216409
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.00151745	0.05692888217216409
PFEIFFER SYNDROME TYPE 1	0.00151745	0.05692888217216409
IVIC SYNDROME	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.00151745	0.05692888217216409
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00151745	0.05692888217216409
CAMURATI-ENGELMANN DISEASE	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.00151745	0.05692888217216409
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.00151745	0.05692888217216409
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00151745	0.05692888217216409
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.00151745	0.05692888217216409
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.00151745	0.05692888217216409
SPINOCEREBELLAR ATAXIA TYPE 36	0.00151745	0.05692888217216409
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.00151745	0.05692888217216409
CHARGE-LIKE SYNDROME, X-LINKED	0.00151745	0.05692888217216409
ACRODYSOSTOSIS	0.00151745	0.05692888217216409
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00151745	0.05692888217216409
MENIERE DISEASE	0.00151745	0.05692888217216409
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.00151745	0.05692888217216409
OTOSCLEROSIS 3; OTSC3	0.00151745	0.05692888217216409
DEMENTIA, FAMILIAL DANISH	0.00151745	0.05692888217216409
RETINAL VENOUS BEADING	0.00151745	0.05692888217216409
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00151745	0.05692888217216409
PULMONIC STENOSIS AND DEAFNESS	0.00151745	0.05692888217216409
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.00151745	0.05692888217216409
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00151745	0.05692888217216409
ISOLATED BRACHYCEPHALY	0.00151745	0.05692888217216409
CORNEODERMATOOSSEOUS SYNDROME	0.00151745	0.05692888217216409
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.00151745	0.05692888217216409
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.00151745	0.05692888217216409
CLEIDOCRANIAL DYSPLASIA; CCD	0.00151745	0.05692888217216409
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.00151745	0.05692888217216409
PAGET DISEASE OF BONE 3; PDB3	0.00151745	0.05692888217216409
BRANCHIOOTIC SYNDROME 2	0.00151745	0.05692888217216409
COXOAURICULAR SYNDROME	0.00151745	0.05692888217216409
OSTEOGENESIS IMPERFECTA, TYPE IV	0.00151745	0.05692888217216409
OSTEOGENESIS IMPERFECTA, TYPE I	0.00151745	0.05692888217216409
MAYER-ROKITANSKY-KÃœSTER-HAUSER SYNDROME TYPE 2	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.00151745	0.05692888217216409
WAARDENBURG-SHAH SYNDROME	0.00151745	0.05692888217216409
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.00151745	0.05692888217216409
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.00151745	0.05692888217216409
X-LINKED HYPOPHOSPHATEMIA	0.00151745	0.05692888217216409
SIFRIM-HITZ-WEISS SYNDROME	0.00151745	0.05692888217216409
OROFACIODIGITAL SYNDROME XVII	0.00151745	0.05692888217216409
N SYNDROME	0.00151745	0.05692888217216409
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.00151745	0.05692888217216409
OTOPALATODIGITAL SYNDROME TYPE 1	0.00151745	0.05692888217216409
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.00151745	0.05692888217216409
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00151745	0.05692888217216409
BRITTLE CORNEA SYNDROME 2; BCS2	0.00151745	0.05692888217216409
ESOPHAGEAL ATRESIA	0.00151745	0.05692888217216409
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00151745	0.05692888217216409
COXOAURICULAR SYNDROME	0.00151745	0.05692888217216409
INFANTILE ONSET SPINOCEREBELLAR ATAXIA	0.00151745	0.05692888217216409
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.00151745	0.05692888217216409
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.00151745	0.05692888217216409
CAMPOMELIC DYSPLASIA	0.00151745	0.05692888217216409
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.00151745	0.05692888217216409
RAPADILINO SYNDROME	0.00151745	0.05692888217216409
DISTAL TRISOMY 14Q	0.00151745	0.05692888217216409
MORQUIO SYNDROME A	0.00151745	0.05692888217216409
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.00151745	0.05692888217216409
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.00151745	0.05692888217216409
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.00151745	0.05692888217216409
SCLEROSTEOSIS 2; SOST2	0.00151745	0.05692888217216409
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.00151745	0.05692888217216409
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00151745	0.05692888217216409
ISOLATED ANORECTAL MALFORMATION	0.00151745	0.05692888217216409
PROLIDASE DEFICIENCY	0.00151745	0.05692888217216409
USHER SYNDROME, TYPE IID; USH2D	0.00151745	0.05692888217216409
KEARNS-SAYRE SYNDROME	0.00151745	0.05692888217216409
SENSORINEURAL DEAFNESS WITH DILATED CARDIOMYOPATHY	0.00151745	0.05692888217216409
GRACILE SYNDROME	0.00151745	0.05692888217216409
ALBERS-SCHÃ–NBERG OSTEOPETROSIS	0.00151745	0.05692888217216409
BARBER-SAY SYNDROME	0.00151745	0.05692888217216409
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.00151745	0.05692888217216409
TIETZ SYNDROME	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.00151745	0.05692888217216409
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.00151745	0.05692888217216409
CAMURATI-ENGELMANN DISEASE	0.00151745	0.05692888217216409
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00151745	0.05692888217216409
CAT-EYE SYNDROME	0.00151745	0.05692888217216409
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00151745	0.05692888217216409
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00151745	0.05692888217216409
HARDIKAR SYNDROME	0.00151745	0.05692888217216409
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00151745	0.05692888217216409
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00151745	0.05692888217216409
GLYCOGEN STORAGE DISEASE II	0.00151745	0.05692888217216409
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.00151745	0.05692888217216409
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.00151745	0.05692888217216409
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.00151745	0.05692888217216409
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.00151745	0.05692888217216409
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00151745	0.05692888217216409
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.00151745	0.05692888217216409
OTOSCLEROSIS 8; OTSC8	0.00151745	0.05692888217216409
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00151745	0.05692888217216409
3MC SYNDROME 3	0.00151745	0.05692888217216409
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.00151745	0.05692888217216409
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.00151745	0.05692888217216409
CONGENITAL VELOPHARYNGEAL INCOMPETENCE	0.00151745	0.05692888217216409
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.00151745	0.05692888217216409
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.00151745	0.05692888217216409
BOR SYNDROME	0.00151745	0.05692888217216409
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.00151745	0.05692888217216409
CLEFT LIP WITH OR WITHOUT CLEFT PALATE	0.00151745	0.05692888217216409
FETAL IODINE DEFICIENCY DISORDER	0.00151745	0.05692888217216409
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.00151745	0.05692888217216409
IVIC SYNDROME	0.00151745	0.05692888217216409
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.00151745	0.05692888217216409
BRITTLE CORNEA SYNDROME	0.00151745	0.05692888217216409
OPTICOCOCHLEODENTATE DEGENERATION	0.00151745	0.05692888217216409
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.00151745	0.05692888217216409
METAPHYSEAL CHONDRODYSPLASIA, SCHMID TYPE	0.00151745	0.05692888217216409
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00151745	0.05692888217216409
RHYNS SYNDROME	0.00151745	0.05692888217216409
AXENFELD-RIEGER SYNDROME	0.00151745	0.05692888217216409
CLEIDOCRANIAL DYSPLASIA	0.00151745	0.05692888217216409
OSTEOGENESIS IMPERFECTA	0.00151745	0.05692888217216409
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.00150376	0.05641528607546441
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00150376	0.05641528607546441
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00150376	0.05641528607546441
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00150376	0.05641528607546441
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00150376	0.05641528607546441
STICKLER SYNDROME, TYPE V; STL5	0.00150376	0.05641528607546441
PANHYPOPHYSITIS	0.00150376	0.05641528607546441
DEAFNESS, X-LINKED 1	0.00150376	0.05641528607546441
NASODIGITOACOUSTIC SYNDROME	0.00150376	0.05641528607546441
ADENOHYPOPHYSITIS	0.00150376	0.05641528607546441
GINGIVAL FIBROMATOSIS-PROGRESSIVE DEAFNESS SYNDROME	0.00150376	0.05641528607546441
FAMILIAL ISOLATED DILATED CARDIOMYOPATHY	0.00150376	0.05641528607546441
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00150376	0.05641528607546441
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.00150376	0.05641528607546441
KEIPERT SYNDROME	0.00150376	0.05641528607546441
ABRUZZO-ERICKSON SYNDROME	0.00150376	0.05641528607546441
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.05641528607546441
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00150376	0.05641528607546441
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00150376	0.05641528607546441
ERMINE PHENOTYPE	0.00150376	0.05641528607546441
USHER SYNDROME, TYPE IG	0.00150376	0.05641528607546441
THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME	0.00150376	0.05641528607546441
GEMIGNANI SYNDROME	0.00150376	0.05641528607546441
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00150376	0.05641528607546441
COGAN SYNDROME	0.00150376	0.05641528607546441
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00150376	0.05641528607546441
SCHEIE SYNDROME	0.00150376	0.05641528607546441
KEIPERT SYNDROME; KPTS	0.00150376	0.05641528607546441
HURLER-SCHEIE SYNDROME	0.00150376	0.05641528607546441
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00150376	0.05641528607546441
NEPHROPATHY-DEAFNESS-HYPERPARATHYROIDISM SYNDROME	0.00150376	0.05641528607546441
DEAFNESS-CRANIOFACIAL SYNDROME	0.00150376	0.05641528607546441
FACIOSCAPULOHUMERAL DYSTROPHY	0.00150376	0.05641528607546441
NEUTROPENIA-MONOCYTOPENIA-DEAFNESS SYNDROME	0.00150376	0.05641528607546441
KNUCKLE PADS-LEUKONYCHIA-SENSORINEURAL DEAFNESS-PALMOPLANTAR HYPERKERATOSIS SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00150376	0.05641528607546441
JUBERG-MARSIDI SYNDROME	0.00150376	0.05641528607546441
DEAFNESS-INFERTILITY SYNDROME	0.00150376	0.05641528607546441
CRANIOMETAPHYSEAL DYSPLASIA	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00150376	0.05641528607546441
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00150376	0.05641528607546441
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00150376	0.05641528607546441
WOLFRAM SYNDROME 2; WFS2	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00150376	0.05641528607546441
DEAFNESS-VITILIGO-ACHALASIA SYNDROME	0.00150376	0.05641528607546441
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00150376	0.05641528607546441
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00150376	0.05641528607546441
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00150376	0.05641528607546441
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00150376	0.05641528607546441
NEUTRAL LIPID STORAGE MYOPATHY	0.00150376	0.05641528607546441
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00150376	0.05641528607546441
KERATODERMA HEREDITARIUM MUTILANS	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00150376	0.05641528607546441
SCLEROSTEOSIS	0.00150376	0.05641528607546441
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00150376	0.05641528607546441
SHORT SYNDROME	0.00150376	0.05641528607546441
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.05641528607546441
OPTIC ATROPHY 8	0.00150376	0.05641528607546441
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00150376	0.05641528607546441
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00150376	0.05641528607546441
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.00150376	0.05641528607546441
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.00150376	0.05641528607546441
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00150376	0.05641528607546441
SPLIT HAND/FOOT MALFORMATION 1 (SHFM1)	0.00150376	0.05641528607546441
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.00150376	0.05641528607546441
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00150376	0.05641528607546441
VAN MALDERGEM SYNDROME 1; VMLDS1	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00150376	0.05641528607546441
MYH9-RELATED DISEASE	0.00150376	0.05641528607546441
FETAL CYTOMEGALOVIRUS SYNDROME	0.00150376	0.05641528607546441
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00150376	0.05641528607546441
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00150376	0.05641528607546441
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00150376	0.05641528607546441
ENLARGED VESTIBULAR AQUEDUCT	0.00150376	0.05641528607546441
ALBINISM-DEAFNESS SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, Y-LINKED 2; DFNY2	0.00150376	0.05641528607546441
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00150376	0.05641528607546441
AUTOSOMAL RECESSIVE HYPOPHOSPHATEMIC RICKETS	0.00150376	0.05641528607546441
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00150376	0.05641528607546441
KID SYNDROME	0.00150376	0.05641528607546441
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00150376	0.05641528607546441
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00150376	0.05641528607546441
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00150376	0.05641528607546441
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 50	0.00150376	0.05641528607546441
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.00150376	0.05641528607546441
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, MID-TONE NEURAL	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 1	0.00150376	0.05641528607546441
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 4	0.00150376	0.05641528607546441
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00150376	0.05641528607546441
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00150376	0.05641528607546441
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.00150376	0.05641528607546441
DEAFNESS-OLIGODONTIA SYNDROME	0.00150376	0.05641528607546441
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00150376	0.05641528607546441
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00150376	0.05641528607546441
SHORT STATURE-DEAFNESS-NEUTROPHIL DYSFUNCTION-DYSMORPHISM SYNDROME	0.00150376	0.05641528607546441
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00150376	0.05641528607546441
BRANCHIOOTIC SYNDROME	0.00150376	0.05641528607546441
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.00150376	0.05641528607546441
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00150376	0.05641528607546441
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00150376	0.05641528607546441
DEAFNESS, Y-LINKED 1	0.00150376	0.05641528607546441
WOODHOUSE-SAKATI SYNDROME	0.00150376	0.05641528607546441
EEC SYNDROME	0.00150376	0.05641528607546441
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00150376	0.05641528607546441
AUTOSOMAL DOMINANT OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00150376	0.05641528607546441
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00150376	0.05641528607546441
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00150376	0.05641528607546441
RENAL CALICEAL DIVERTICULI-DEAFNESS SYNDROME	0.00150376	0.05641528607546441
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00150376	0.05641528607546441
ACROCRANIOFACIAL DYSOSTOSIS	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.00150376	0.05641528607546441
HAMAMY SYNDROME; HMMS	0.00150376	0.05641528607546441
PALMOPLANTAR KERATODERMA-DEAFNESS SYNDROME	0.00150376	0.05641528607546441
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00150376	0.05641528607546441
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00150376	0.05641528607546441
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00150376	0.05641528607546441
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00150376	0.05641528607546441
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00150376	0.05641528607546441
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 113	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00150376	0.05641528607546441
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00150376	0.05641528607546441
SPONDYLOPERIPHERAL DYSPLASIA	0.00150376	0.05641528607546441
ACROCALLOSAL SYNDROME	0.00150376	0.05641528607546441
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00150376	0.05641528607546441
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00150376	0.05641528607546441
OCULOAURICULOVERTEBRAL SPECTRUM WITH RADIAL DEFECTS	0.00150376	0.05641528607546441
MIDDLE EAR NEUROENDOCRINE TUMOR	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00150376	0.05641528607546441
KALLMANN SYNDROME-HEART DISEASE SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 99	0.00150376	0.05641528607546441
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00150376	0.05641528607546441
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00150376	0.05641528607546441
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00150376	0.05641528607546441
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00150376	0.05641528607546441
ISOLATED SPLIT HAND-SPLIT FOOT MALFORMATION	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00150376	0.05641528607546441
KERATODERMA HEREDITARIUM MUTILANS WITH ICHTHYOSIS	0.00150376	0.05641528607546441
PERRAULT SYNDROME 2; PRLTS2	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00150376	0.05641528607546441
PENDRED SYNDROME	0.00150376	0.05641528607546441
VAN MALDERGEM SYNDROME 2; VMLDS2	0.00150376	0.05641528607546441
DEAFNESS, X-LINKED 4	0.00150376	0.05641528607546441
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00150376	0.05641528607546441
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00150376	0.05641528607546441
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 6	0.00150376	0.05641528607546441
BRACHYDACTYLY, TYPE B2	0.00150376	0.05641528607546441
LOWE-KOHN-COHEN SYNDROME	0.00150376	0.05641528607546441
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00150376	0.05641528607546441
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00150376	0.05641528607546441
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00150376	0.05641528607546441
DENTINOGENESIS IMPERFECTA-SHORT STATURE-HEARING LOSS-INTELLECTUAL DISABILITY SYNDROME	0.00150376	0.05641528607546441
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00150376	0.05641528607546441
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00150376	0.05641528607546441
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00150376	0.05641528607546441
HYPEROSTOSIS CORTICALIS GENERALISATA	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00150376	0.05641528607546441
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.00150376	0.05641528607546441
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00150376	0.05641528607546441
USHER SYNDROME, TYPE IIIA	0.00150376	0.05641528607546441
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00150376	0.05641528607546441
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00150376	0.05641528607546441
HEMIFACIAL MICROSOMIA	0.00150376	0.05641528607546441
FAMILIAL LONG QT SYNDROME	0.00150376	0.05641528607546441
MADRAS MOTOR NEURON DISEASE	0.00150376	0.05641528607546441
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00150376	0.05641528607546441
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00150376	0.05641528607546441
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 24	0.00150376	0.05641528607546441
BJÃ–RNSTAD SYNDROME	0.00150376	0.05641528607546441
HIRSCHSPRUNG DISEASE	0.00150376	0.05641528607546441
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00150376	0.05641528607546441
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 27	0.00150376	0.05641528607546441
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00150376	0.05641528607546441
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00150376	0.05641528607546441
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00150376	0.05641528607546441
MENTAL RETARDATION, X-LINKED 46	0.00150376	0.05641528607546441
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00150376	0.05641528607546441
SENSORINEURAL HEARING LOSS-EARLY GRAYING-ESSENTIAL TREMOR SYNDROME	0.00150376	0.05641528607546441
NON-ACQUIRED COMBINED PITUITARY HORMONE DEFICIENCY-SENSORINEURAL HEARING LOSS-SPINE ABNORMALITIES SYNDROME	0.00150376	0.05641528607546441
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00150376	0.05641528607546441
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00150376	0.05641528607546441
ARTHROGRYPOSIS-LIKE HAND ANOMALY-SENSORINEURAL DEAFNESS SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00150376	0.05641528607546441
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00150376	0.05641528607546441
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00150376	0.05641528607546441
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.00150376	0.05641528607546441
OTODENTAL DYSPLASIA	0.00150376	0.05641528607546441
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00150376	0.05641528607546441
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.00150376	0.05641528607546441
HIRSCHSPRUNG DISEASE-DEAFNESS-POLYDACTYLY SYNDROME	0.00150376	0.05641528607546441
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00150376	0.05641528607546441
RADIO-ULNAR SYNOSTOSIS-AMEGAKARYOCYTIC THROMBOCYTOPENIA SYNDROME	0.00150376	0.05641528607546441
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00150376	0.05641528607546441
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00150376	0.05641528607546441
WAARDENBURG SYNDROME TYPE 2	0.00150376	0.05641528607546441
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00150376	0.05641528607546441
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.001301984	0.04884542734590456
FETAL TRIMETHADIONE SYNDROME	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.001301984	0.04884542734590456
ALAZAMI-YUAN SYNDROME	0.001301984	0.04884542734590456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001301984	0.04884542734590456
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.001301984	0.04884542734590456
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001301984	0.04884542734590456
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.001301984	0.04884542734590456
TOLUENE EMBRYOPATHY	0.001301984	0.04884542734590456
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.001301984	0.04884542734590456
PHENOBARBITAL EMBRYOPATHY	0.001301984	0.04884542734590456
FETAL ALCOHOL SYNDROME	0.001301984	0.04884542734590456
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.001301984	0.04884542734590456
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.001301984	0.04884542734590456
ALAZAMI SYNDROME; ALAZS	0.001301984	0.04884542734590456
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001301984	0.04884542734590456
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001301984	0.04884542734590456
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.001301984	0.04884542734590456
LIG4 SYNDROME	0.001301984	0.04884542734590456
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.001301984	0.04884542734590456
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.001301984	0.04884542734590456
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.001301984	0.04884542734590456
12Q14 MICRODELETION SYNDROME	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.001301984	0.04884542734590456
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.001301984	0.04884542734590456
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.001301984	0.04884542734590456
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.001301984	0.04884542734590456
SECKEL SYNDROME 9; SCKL9	0.001301984	0.04884542734590456
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.001301984	0.04884542734590456
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001301984	0.04884542734590456
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.001301984	0.04884542734590456
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.001301984	0.04884542734590456
TURNPENNY-FRY SYNDROME; TPFS	0.001301984	0.04884542734590456
TRISOMY 9P	0.001301984	0.04884542734590456
FORSYTHE-WAKELING SYNDROME; FWS	0.001301984	0.04884542734590456
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.001301984	0.04884542734590456
LOWRY-MACLEAN SYNDROME	0.001301984	0.04884542734590456
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.001301984	0.04884542734590456
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001301984	0.04884542734590456
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.001301984	0.04884542734590456
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.001301984	0.04884542734590456
HARTSFIELD SYNDROME; HRTFDS	0.001301984	0.04884542734590456
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.001301984	0.04884542734590456
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.001301984	0.04884542734590456
HOLOPROSENCEPHALY 5; HPE5	0.001301984	0.04884542734590456
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.001301984	0.04884542734590456
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590456
RIDDLE SYNDROME	0.001301984	0.04884542734590456
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.001301984	0.04884542734590456
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.001301984	0.04884542734590456
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.001301984	0.04884542734590456
17Q21.31 MICRODUPLICATION SYNDROME	0.001301984	0.04884542734590456
OKAMOTO SYNDROME	0.001301984	0.04884542734590456
CRANIOTELENCEPHALIC DYSPLASIA	0.001301984	0.04884542734590456
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001301984	0.04884542734590456
OGDEN SYNDROME; OGDNS	0.001301984	0.04884542734590456
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.001301984	0.04884542734590456
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.001301984	0.04884542734590456
CEREBELLOFACIODENTAL SYNDROME	0.001301984	0.04884542734590456
ADAMS-OLIVER SYNDROME 3; AOS3	0.001301984	0.04884542734590456
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.001301984	0.04884542734590456
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001301984	0.04884542734590456
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.001301984	0.04884542734590456
HOLMES-GANG SYNDROME	0.001301984	0.04884542734590456
BARATELA-SCOTT SYNDROME	0.001301984	0.04884542734590456
HOLOPROSENCEPHALY 11	0.001301984	0.04884542734590456
HOYERAAL-HREIDARSSON SYNDROME	0.001301984	0.04884542734590456
TONNE-KALSCHEUER SYNDROME; TOKAS	0.001301984	0.04884542734590456
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.001301984	0.04884542734590456
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.001301984	0.04884542734590456
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.001301984	0.04884542734590456
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.001301984	0.04884542734590456
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.001301984	0.04884542734590456
RING CHROMOSOME 12 SYNDROME	0.001301984	0.04884542734590456
LIG4 SYNDROME	0.001301984	0.04884542734590456
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001301984	0.04884542734590456
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.001301984	0.04884542734590456
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.001301984	0.04884542734590456
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001301984	0.04884542734590456
OROFACIODIGITAL SYNDROME XIV; OFD14	0.001301984	0.04884542734590456
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001301984	0.04884542734590456
OROFACIODIGITAL SYNDROME TYPE 14	0.001301984	0.04884542734590456
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.001301984	0.04884542734590456
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001301984	0.04884542734590456
HOLOPROSENCEPHALY 3; HPE3	0.001301984	0.04884542734590456
GOLDBERG-SHPRINTZEN SYNDROME	0.001301984	0.04884542734590456
HYPERTRICHOSIS CUBITI	0.001301984	0.04884542734590456
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.001301984	0.04884542734590456
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.001301984	0.04884542734590456
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.001301984	0.04884542734590456
MONOSOMY 13Q34	0.001301984	0.04884542734590456
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.001301984	0.04884542734590456
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001301984	0.04884542734590456
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.001301984	0.04884542734590456
SECKEL SYNDROME 8; SCKL8	0.001301984	0.04884542734590456
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.001301984	0.04884542734590456
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.001301984	0.04884542734590456
AL-RAQAD SYNDROME; ARS	0.001301984	0.04884542734590456
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.001301984	0.04884542734590456
2Q32Q33 MICRODELETION SYNDROME	0.001301984	0.04884542734590456
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.001301984	0.04884542734590456
MUCOLIPIDOSIS IV; ML4	0.001301984	0.04884542734590456
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.001301984	0.04884542734590456
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.001301984	0.04884542734590456
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.001301984	0.04884542734590456
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.001301984	0.04884542734590456
HADZISELIMOVIC SYNDROME	0.001301984	0.04884542734590456
ANGELMAN SYNDROME (TYPE 2)	0.001297849	0.048690298064688116
DUPLICATION/INVERSION 15Q11	0.001297849	0.048690298064688116
WIEDEMANN-STEINER SYNDROME	0.001297849	0.048690298064688116
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.001297849	0.048690298064688116
ANGELMAN SYNDROME (TYPE 1)	0.001297849	0.048690298064688116
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.001297849	0.048690298064688116
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.001297849	0.048690298064688116
TETRASOMY 18P	0.001297849	0.048690298064688116
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.001297849	0.048690298064688116
ANGELMAN SYNDROME	0.001297849	0.048690298064688116
SJÃ–GREN-LARSSON SYNDROME	0.001297849	0.048690298064688116
CAMOS SYNDROME	0.001297849	0.048690298064688116
HEREDITARY METHEMOGLOBINEMIA	0.001297849	0.048690298064688116
ADENYLOSUCCINATE LYASE DEFICIENCY	0.001297849	0.048690298064688116
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.001297849	0.048690298064688116
3-HYDROXYISOBUTYRIC ACIDURIA	0.001297849	0.048690298064688116
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.001297849	0.048690298064688116
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.001297849	0.048690298064688116
SUPRABULBAR PARESIS, CONGENITAL	0.001297849	0.048690298064688116
COHEN SYNDROME	0.001297849	0.048690298064688116
DPM1-CDG	0.001297849	0.048690298064688116
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.001297849	0.048690298064688116
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.001297849	0.048690298064688116
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.001297849	0.048690298064688116
9Q33.3Q34.11 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
20P13 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.001297849	0.048690298064688116
TEMPLE-BARAITSER SYNDROME	0.001297849	0.048690298064688116
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.048690298064688116
ADNP SYNDROME	0.001297849	0.048690298064688116
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.001297849	0.048690298064688116
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.001297849	0.048690298064688116
FILIPPI SYNDROME; FLPIS	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.001297849	0.048690298064688116
BANGSTAD SYNDROME	0.001297849	0.048690298064688116
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.001297849	0.048690298064688116
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.001297849	0.048690298064688116
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.001297849	0.048690298064688116
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.001297849	0.048690298064688116
WOLF-HIRSCHHORN SYNDROME	0.001297849	0.048690298064688116
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.001297849	0.048690298064688116
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.001297849	0.048690298064688116
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.001297849	0.048690298064688116
PSEUDO-TORCH SYNDROME 2	0.001297849	0.048690298064688116
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.001297849	0.048690298064688116
5Q35 MICRODUPLICATION SYNDROME	0.001297849	0.048690298064688116
2Q23.1 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.001297849	0.048690298064688116
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.001297849	0.048690298064688116
HALL-RIGGS SYNDROME	0.001297849	0.048690298064688116
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.001297849	0.048690298064688116
PITT-HOPKINS SYNDROME	0.001297849	0.048690298064688116
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.001297849	0.048690298064688116
DISTAL MONOSOMY 7Q36	0.001297849	0.048690298064688116
14Q12 MICRODELETION SYNDROME	0.001297849	0.048690298064688116
SYMMETRICAL THALAMIC CALCIFICATIONS	0.001297849	0.048690298064688116
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.001297849	0.048690298064688116
MICROFORM HOLOPROSENCEPHALY	0.001297849	0.048690298064688116
C SYNDROME	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001297849	0.048690298064688116
PERRAULT SYNDROME 3	0.001297849	0.048690298064688116
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.001297849	0.048690298064688116
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001297849	0.048690298064688116
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.001297849	0.048690298064688116
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.001297849	0.048690298064688116
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.001297849	0.048690298064688116
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.001297849	0.048690298064688116
BRANCHIOSKELETOGENITAL SYNDROME	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.001297849	0.048690298064688116
LISSENCEPHALY 3; LIS3	0.001297849	0.048690298064688116
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.001297849	0.048690298064688116
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.001297849	0.048690298064688116
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.001297849	0.048690298064688116
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.001297849	0.048690298064688116
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.001297849	0.048690298064688116
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.001297849	0.048690298064688116
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001297849	0.048690298064688116
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.001297849	0.048690298064688116
LOWRY-MACLEAN SYNDROME	0.001297849	0.048690298064688116
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.001297849	0.048690298064688116
LEUKOCYTE ADHESION DEFICIENCY	0.001297849	0.048690298064688116
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.001297849	0.048690298064688116
SANJAD-SAKATI SYNDROME	0.001297849	0.048690298064688116
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.001297849	0.048690298064688116
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.001297849	0.048690298064688116
SECKEL SYNDROME 7; SCKL7	0.001297849	0.048690298064688116
WOLCOTT-RALLISON SYNDROME	0.001297849	0.048690298064688116
OCULOCUTANEOUS ALBINISM TYPE 4	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 43; SCA43	0.00120482	0.04520020812459503
EPISODIC ATAXIA WITH SLURRED SPEECH	0.00120482	0.04520020812459503
SPASTIC ATAXIA 8, AUTOSOMAL RECESSIVE, WITH HYPOMYELINATING LEUKODYSTROPHY; SPAX8	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.00120482	0.04520020812459503
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.00120482	0.04520020812459503
COLOBOMA, OCULAR	0.00120482	0.04520020812459503
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 18	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00120482	0.04520020812459503
JOUBERT SYNDROME 5	0.00120482	0.04520020812459503
EXUDATIVE VITREORETINOPATHY 7; EVR7	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 3	0.00120482	0.04520020812459503
%108650 SPASTIC ATAXIA 7, AUTOSOMAL DOMINANT; SPAX7;;SPASTIC ATAXIA WITH CONGENITAL MIOSIS;;MIOSIS, CONGENITAL, WITH SPASTIC ATAXIA	0.00120482	0.04520020812459503
X-LINKED RECESSIVE OCULAR ALBINISM	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 60	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 59	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM	0.00120482	0.04520020812459503
SENIOR-LOKEN SYNDROME 3	0.00120482	0.04520020812459503
SPASTIC ATAXIA, CHARLEVOIX-SAGUENAY TYPE	0.00120482	0.04520020812459503
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 14	0.00120482	0.04520020812459503
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00120482	0.04520020812459503
HYPOTRICHOSIS WITH JUVENILE MACULAR DEGENERATION	0.00120482	0.04520020812459503
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 5	0.00120482	0.04520020812459503
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 4; IBGC4	0.00120482	0.04520020812459503
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
ARNOLD-CHIARI MALFORMATION TYPE I	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00120482	0.04520020812459503
TREMOR, NYSTAGMUS, AND DUODENAL ULCER	0.00120482	0.04520020812459503
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00120482	0.04520020812459503
X-LINKED PROGRESSIVE CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
GILLESPIE SYNDROME; GLSP	0.00120482	0.04520020812459503
245800 LAURENCE-MOON SYNDROME	0.00120482	0.04520020812459503
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 6	0.00120482	0.04520020812459503
LARYNGEAL ABDUCTOR PARALYSIS WITH CEREBELLAR ATAXIA AND MOTOR NEUROPATHY	0.00120482	0.04520020812459503
SPASTIC ATAXIA 4, AUTOSOMAL RECESSIVE; SPAX4	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00120482	0.04520020812459503
VITREORETINOCHOROIDOPATHY; VRCP	0.00120482	0.04520020812459503
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.04520020812459503
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00120482	0.04520020812459503
AUTOSOMAL DOMINANT OPTIC ATROPHY AND CATARACT	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00120482	0.04520020812459503
EARLY-ONSET X-LINKED OPTIC ATROPHY	0.00120482	0.04520020812459503
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00120482	0.04520020812459503
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.00120482	0.04520020812459503
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00120482	0.04520020812459503
BENIGN PAROXYSMAL TONIC UPGAZE OF CHILDHOOD WITH ATAXIA	0.00120482	0.04520020812459503
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 12; LCA12	0.00120482	0.04520020812459503
FOVEAL HYPOPLASIA 2; FVH2	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00120482	0.04520020812459503
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 8	0.00120482	0.04520020812459503
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 26	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 3	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 2	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 1	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 2	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00120482	0.04520020812459503
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00120482	0.04520020812459503
BALLER-GEROLD SYNDROME	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00120482	0.04520020812459503
JOUBERT SYNDROME 4	0.00120482	0.04520020812459503
MELKERSSON-ROSENTHAL SYNDROME	0.00120482	0.04520020812459503
OLIVER-MCFARLANE SYNDROME	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 21	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00120482	0.04520020812459503
%300703 SPINOCEREBELLAR ATAXIA, X-LINKED 5; SCAX5	0.00120482	0.04520020812459503
ACHROMATOPSIA 7; ACHM7	0.00120482	0.04520020812459503
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00120482	0.04520020812459503
BRANCHIAL MYOCLONUS WITH SPASTIC PARAPARESIS AND CEREBELLAR ATAXIA	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 38; SCA38	0.00120482	0.04520020812459503
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.00120482	0.04520020812459503
JOUBERT SYNDROME 3; JBTS3	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 20	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE SPASTIC ATAXIA-OPTIC ATROPHY-DYSARTHRIA SYNDROME	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00120482	0.04520020812459503
TERATOMA, PINEAL	0.00120482	0.04520020812459503
OPHTHALMOPLEGIA, FAMILIAL STATIC	0.00120482	0.04520020812459503
CRANIOECTODERMAL DYSPLASIA 1	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 38	0.00120482	0.04520020812459503
NYSTAGMUS, VOLUNTARY	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA 20	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY 20; CORD20	0.00120482	0.04520020812459503
FAMILIAL PAROXYSMAL ATAXIA	0.00120482	0.04520020812459503
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00120482	0.04520020812459503
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.00120482	0.04520020812459503
CHIARI MALFORMATION TYPE II	0.00120482	0.04520020812459503
ALAND ISLAND EYE DISEASE	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA TYPE 7	0.00120482	0.04520020812459503
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00120482	0.04520020812459503
LICHTENSTEIN-KNORR SYNDROME; LIKNS	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA 12; RP12	0.00120482	0.04520020812459503
SPONDYLOMETAPHYSEAL DYSPLASIA, AXIAL; SMDAX	0.00120482	0.04520020812459503
X-LINKED RETINAL DYSPLASIA	0.00120482	0.04520020812459503
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.00120482	0.04520020812459503
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00120482	0.04520020812459503
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00120482	0.04520020812459503
DANDY-WALKER SYNDROME	0.00120482	0.04520020812459503
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 34; SCA34	0.00120482	0.04520020812459503
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00120482	0.04520020812459503
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.00120482	0.04520020812459503
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00120482	0.04520020812459503
EPISODIC ATAXIA TYPE 7	0.00120482	0.04520020812459503
SUBAORTIC STENOSIS-SHORT STATURE SYNDROME	0.00120482	0.04520020812459503
X-LINKED SPASTIC PARAPLEGIA TYPE 16	0.00120482	0.04520020812459503
OCULAR ALBINISM	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA TYPE 2	0.00120482	0.04520020812459503
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO WWOX DEFICIENCY	0.00120482	0.04520020812459503
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 6; MC1DN6	0.00120482	0.04520020812459503
CATARACT 19, MULTIPLE TYPES; CTRCT19	0.00120482	0.04520020812459503
229310 FRIEDREICH ATAXIA AND CONGENITAL GLAUCOMA	0.00120482	0.04520020812459503
PARAPLEGIA-INTELLECTUAL DISABILITY-HYPERKERATOSIS SYNDROME	0.00120482	0.04520020812459503
NYSTAGMUS, MYOCLONIC	0.00120482	0.04520020812459503
PETERS ANOMALY	0.00120482	0.04520020812459503
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.00120482	0.04520020812459503
RETINITIS PIGMENTOSA 14	0.00120482	0.04520020812459503
MESANGIAL SCLEROSIS, DIFFUSE RENAL, WITH OCULAR ABNORMALITIES	0.00120482	0.04520020812459503
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.00120482	0.04520020812459503
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.00120482	0.04520020812459503
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00120482	0.04520020812459503
SOTOS SYNDROME 2	0.00120482	0.04520020812459503
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00120482	0.04520020812459503
CONE DYSTROPHY 4	0.00120482	0.04520020812459503
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00120482	0.04520020812459503
LENTIGINES	0.00120482	0.04520020812459503
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.00120482	0.04520020812459503
CEREBELLAR HYPOPLASIA	0.00120482	0.04520020812459503
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.00120482	0.04520020812459503
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY 6; CORD6	0.00120482	0.04520020812459503
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 28	0.00120482	0.04520020812459503
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00120482	0.04520020812459503
EPISODIC ATAXIA, TYPE 8	0.00120482	0.04520020812459503
JALILI SYNDROME	0.00120482	0.04520020812459503
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00120482	0.04520020812459503
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00120482	0.04520020812459503
%601992 FRIEDREICH ATAXIA 2; FRDA2	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 46; SCA46	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA 45; SCA45	0.00120482	0.04520020812459503
ATAXIA-OCULOMOTOR APRAXIA 3; AOA3	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 26	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA TYPE 25	0.00120482	0.04520020812459503
OPTIC ATROPHY 10 WITH OR WITHOUT ATAXIA, MENTAL RETARDATION, AND SEIZURES	0.00120482	0.04520020812459503
ATAXIA WITH VITAMIN E DEFICIENCY	0.00120482	0.04520020812459503
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00120482	0.04520020812459503
CRANIOFACIAL DYSSYNOSTOSIS	0.00120482	0.04520020812459503
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.00120482	0.04520020812459503
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00120482	0.04520020812459503
CRANIOECTODERMAL DYSPLASIA	0.00120482	0.04520020812459503
%615312 ALBINISM, OCULOCUTANEOUS, TYPE V; OCA5	0.00120482	0.04520020812459503
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00120482	0.04520020812459503
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00120482	0.04520020812459503
PETERS ANOMALY	0.00120482	0.04520020812459503
302900 CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY AND FRIEDREICH ATAXIA,COMBINED	0.00120482	0.04520020812459503
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.00120482	0.04520020812459503
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.00120482	0.04520020812459503
SYRINGOMYELIA, ISOLATED	0.00120482	0.04520020812459503
Ã…LAND ISLANDS EYE DISEASE	0.00120482	0.04520020812459503
LEUKOENCEPHALOPATHY, PROGRESSIVE, WITH OVARIAN FAILURE; LKENP	0.00120482	0.04520020812459503
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00120482	0.04520020812459503
SPASMUS NUTANS	0.00120482	0.04520020812459503
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 16; SCAR16	0.00120482	0.04520020812459503
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00120482	0.04520020812459503
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00120482	0.04520020812459503
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.001086973	0.040779042368001395
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040779042368001395
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.040779042368001395
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.001086973	0.040779042368001395
XQ25 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.040779042368001395
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 7	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
11Q22.2Q22.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
HERNÃNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
CITRULLINEMIA, CLASSIC	0.001086973	0.040779042368001395
IMMUNODEFICIENCY 49; IMD49	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.040779042368001395
48,XXXY SYNDROME	0.001086973	0.040779042368001395
MAN1B1-CDG	0.001086973	0.040779042368001395
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.001086973	0.040779042368001395
49,XXXXY SYNDROME	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
L1 SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.040779042368001395
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
WIEDEMANN-STEINER SYNDROME; WDSTS	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040779042368001395
DIGEORGE SYNDROME; DGS	0.001086973	0.040779042368001395
PROPIONIC ACIDEMIA	0.001086973	0.040779042368001395
GAUCHER DISEASE, TYPE II	0.001086973	0.040779042368001395
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.001086973	0.040779042368001395
XP21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040779042368001395
TEMTAMY SYNDROME; TEMTYS	0.001086973	0.040779042368001395
TETRASOMY 5P	0.001086973	0.040779042368001395
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE TYPE C	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.001086973	0.040779042368001395
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.001086973	0.040779042368001395
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.040779042368001395
SIALURIA	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.040779042368001395
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.040779042368001395
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
NETHERTON SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.040779042368001395
PFEIFFER SYNDROME TYPE 2	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
20P12.3 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
XQ25 DUPLICATION SYNDROME	0.001086973	0.040779042368001395
PRADER-WILLI SYNDROME; PWS	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.001086973	0.040779042368001395
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 90	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
SHASHI-PENA SYNDROME; SHAPNS	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040779042368001395
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.040779042368001395
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
HELSMOORTEL-VAN DER AA SYNDROME	0.001086973	0.040779042368001395
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.001086973	0.040779042368001395
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.001086973	0.040779042368001395
MIRAGE SYNDROME; MIRAGE	0.001086973	0.040779042368001395
WILSON-TURNER SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
COFFIN-SIRIS SYNDROME 2; CSS2	0.001086973	0.040779042368001395
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.001086973	0.040779042368001395
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.040779042368001395
TRISOMY X	0.001086973	0.040779042368001395
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.00075643	0.028378341521295647
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00075643	0.028378341521295647
CHARGE SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 18, PRIMARY, AUTOSOMAL DOMINANT; MCPH18	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL DNA DEPLETION SYNDROME 11	0.00075643	0.028378341521295647
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 1; DKCB1	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIOMYOPATHY	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP W; FANCW	0.00075643	0.028378341521295647
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00075643	0.028378341521295647
IMMUNODEFICIENCY 55; IMD55	0.00075643	0.028378341521295647
HEREDITARY BULLOUS DYSTROPHY, MACULAR TYPE	0.00075643	0.028378341521295647
SCHISIS ASSOCIATION	0.00075643	0.028378341521295647
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
FRONTONASAL DYSPLASIA 2; FND2	0.00075643	0.028378341521295647
ENCEPHALOMALACIA, MULTILOCULAR	0.00075643	0.028378341521295647
CEREBROCOSTOMANDIBULAR SYNDROME	0.00075643	0.028378341521295647
DUBOWITZ SYNDROME	0.00075643	0.028378341521295647
NEU-LAXOVA SYNDROME 2; NLS2	0.00075643	0.028378341521295647
CERNUNNOS-XLF DEFICIENCY	0.00075643	0.028378341521295647
LETHAL OSTEOSCLEROTIC BONE DYSPLASIA	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00075643	0.028378341521295647
%236795 3-@HYDROXYISOBUTYRIC ACIDURIA	0.00075643	0.028378341521295647
SOLITARY MEDIAN MAXILLARY CENTRAL INCISOR; SMMCI	0.00075643	0.028378341521295647
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00075643	0.028378341521295647
DISTAL MONOSOMY 17Q	0.00075643	0.028378341521295647
HYPERREFLEXIA	0.00075643	0.028378341521295647
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00075643	0.028378341521295647
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00075643	0.028378341521295647
TRISOMY 18P	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 3; MGORS3	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 5; MGORS5	0.00075643	0.028378341521295647
RING CHROMOSOME 1 SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 5; SCKL5	0.00075643	0.028378341521295647
MICROCEPHALY WITH CERVICAL SPINE FUSION ANOMALIES	0.00075643	0.028378341521295647
BARTSOCAS-PAPAS SYNDROME	0.00075643	0.028378341521295647
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.00075643	0.028378341521295647
ISOLATED OSTEOPOIKILOSIS	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 13Q	0.00075643	0.028378341521295647
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.00075643	0.028378341521295647
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.00075643	0.028378341521295647
NON-DISTAL TRISOMY 10Q	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 8; MGORS8	0.00075643	0.028378341521295647
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
DISTAL MONOSOMY 13Q	0.00075643	0.028378341521295647
SECKEL SYNDROME 4	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
HEPATIC VENOOCCLUSIVE DISEASE WITH IMMUNODEFICIENCY	0.00075643	0.028378341521295647
RING CHROMOSOME 6 SYNDROME	0.00075643	0.028378341521295647
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS	0.00075643	0.028378341521295647
RING CHROMOSOME 7 SYNDROME	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 28	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 1; MKS1	0.00075643	0.028378341521295647
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 24	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 30	0.00075643	0.028378341521295647
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.00075643	0.028378341521295647
MICROCEPHALY 12, PRIMARY, AUTOSOMAL RECESSIVE; MCPH12	0.00075643	0.028378341521295647
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00075643	0.028378341521295647
DYSOSTOSIS, STANESCU TYPE	0.00075643	0.028378341521295647
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00075643	0.028378341521295647
FEINGOLD SYNDROME 2; FGLDS2	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.00075643	0.028378341521295647
233270 GOMBO SYNDROME;;GROWTH RETARDATION, OCULAR ABNORMALITIES, MICROCEPHALY, BRACHYDACTYLY,AND OLIGOPHRENIA	0.00075643	0.028378341521295647
BONNEMANN-MEINECKE-REICH SYNDROME	0.00075643	0.028378341521295647
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00075643	0.028378341521295647
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00075643	0.028378341521295647
LACTIC ACIDURIA DUE TO D-LACTIC ACID	0.00075643	0.028378341521295647
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MICROCEPHALY AND MENTAL SUBNORMALITY	0.00075643	0.028378341521295647
NIJMEGEN BREAKAGE SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME 2; SCKL2	0.00075643	0.028378341521295647
MMEP SYNDROME	0.00075643	0.028378341521295647
MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.00075643	0.028378341521295647
AORTIC ARCH ANOMALY WITH PECULIAR FACIES AND MENTAL RETARDATION	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00075643	0.028378341521295647
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
ACHALASIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.00075643	0.028378341521295647
TETRAPLOIDY	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.00075643	0.028378341521295647
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00075643	0.028378341521295647
TRIGLYCERIDE STORAGE DISEASE, TYPE I	0.00075643	0.028378341521295647
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO ZNF335 DEFICIENCY	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP D1	0.00075643	0.028378341521295647
BULLOUS DYSTROPHY, HEREDITARY MACULAR TYPE	0.00075643	0.028378341521295647
HUMERO-RADIAL SYNOSTOSIS	0.00075643	0.028378341521295647
MASA SYNDROME	0.00075643	0.028378341521295647
PAGOD SYNDROME	0.00075643	0.028378341521295647
WEAVER-WILLIAMS SYNDROME	0.00075643	0.028378341521295647
MITOCHONDRIAL MYOPATHY AND SIDEROBLASTIC ANEMIA	0.00075643	0.028378341521295647
608432 CRANIOSYNOSTOSIS, CALCIFICATION OF BASAL GANGLIA, AND FACIAL DYSMORPHISM	0.00075643	0.028378341521295647
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.00075643	0.028378341521295647
VERVERI-BRADY SYNDROME; VERBRAS	0.00075643	0.028378341521295647
MICROCEPHALY 21, PRIMARY, AUTOSOMAL RECESSIVE; MCPH21	0.00075643	0.028378341521295647
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00075643	0.028378341521295647
MENTAL RETARDATION, X-LINKED 63	0.00075643	0.028378341521295647
MÃœLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 23, PRIMARY, AUTOSOMAL RECESSIVE; MCPH23	0.00075643	0.028378341521295647
CHROMOSOME XP11.3 DELETION SYNDROME	0.00075643	0.028378341521295647
BARDET-BIEDL SYNDROME 20	0.00075643	0.028378341521295647
MICROCEPHALY-ALBINISM-DIGITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
SECKEL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CARDIAC DEFECT-LUNG MALSEGMENTATION SYNDROME	0.00075643	0.028378341521295647
ALANINURIA WITH MICROCEPHALY, DWARFISM, ENAMEL HYPOPLASIA, AND DIABETES MELLITUS	0.00075643	0.028378341521295647
ANONYCHIA-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-BRAIN DEFECT-SPASTICITY-HYPERNATREMIA SYNDROME	0.00075643	0.028378341521295647
XK APROSENCEPHALY SYNDROME	0.00075643	0.028378341521295647
DIAMOND-BLACKFAN ANEMIA 1	0.00075643	0.028378341521295647
OSTEOPOROSIS-MACROCEPHALY-BLINDNESS-JOINT HYPERLAXITY SYNDROME	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.00075643	0.028378341521295647
SATOYOSHI SYNDROME	0.00075643	0.028378341521295647
9Q SUBTELOMERIC DELETION SYNDROME	0.00075643	0.028378341521295647
MYOPATHY, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA 1; MLASA1	0.00075643	0.028378341521295647
MICROCEPHALY 24, PRIMARY, AUTOSOMAL RECESSIVE; MCPH24	0.00075643	0.028378341521295647
POMT1-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R11	0.00075643	0.028378341521295647
CIRRHOSIS-DYSTONIA-POLYCYTHEMIA-HYPERMANGANESEMIA SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME, URBACH TYPE	0.00075643	0.028378341521295647
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00075643	0.028378341521295647
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00075643	0.028378341521295647
ISOLATED GROWTH HORMONE DEFICIENCY, TYPE V; IGHD5	0.00075643	0.028378341521295647
601453 TRICHODENTAL DYSPLASIA	0.00075643	0.028378341521295647
PSEUDOPROGERIA SYNDROME	0.00075643	0.028378341521295647
MILLER-DIEKER SYNDROME (MDS)	0.00075643	0.028378341521295647
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.00075643	0.028378341521295647
CRI DU CHAT SYNDROME (5P DELETION)	0.00075643	0.028378341521295647
RENAL TUBULAR DYSGENESIS	0.00075643	0.028378341521295647
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.00075643	0.028378341521295647
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00075643	0.028378341521295647
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00075643	0.028378341521295647
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.00075643	0.028378341521295647
1Q21.1 RECURRENT MICRODELETION (SUSCEPTIBILITY LOCUS FOR NEURODEVELOPMENTAL DISORDERS)	0.00075643	0.028378341521295647
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.00075643	0.028378341521295647
MONOSOMY 5P	0.00075643	0.028378341521295647
STIMMLER SYNDROME	0.00075643	0.028378341521295647
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00075643	0.028378341521295647
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00075643	0.028378341521295647
DISTAL 17P13.1 MICRODELETION SYNDROME	0.00075643	0.028378341521295647
RECURRENT 16P12.1 MICRODELETION (NEURODEVELOPMENTAL SUSCEPTIBILITY LOCUS)	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00075643	0.028378341521295647
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.00075643	0.028378341521295647
MEIER-GORLIN SYNDROME 6; MGORS6	0.00075643	0.028378341521295647
CHONDRODYSPLASIA-PSEUDOHERMAPHRODITISM SYNDROME	0.00075643	0.028378341521295647
POLAND SYNDROME	0.00075643	0.028378341521295647
SAY SYNDROME	0.00075643	0.028378341521295647
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.00075643	0.028378341521295647
RUVALCABA SYNDROME	0.00075643	0.028378341521295647
OROFACIODIGITAL SYNDROME TYPE 5	0.00075643	0.028378341521295647
HYPO- AND HYPERMELANOTIC CUTANEOUS MACULES-RETARDED GROWTH-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY-CERVICAL SPINE FUSION ANOMALIES SYNDROME	0.00075643	0.028378341521295647
AICARDI-GOUTIERES SYNDROME 2; AGS2	0.00075643	0.028378341521295647
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00075643	0.028378341521295647
KLIPPEL-TRÃ‰NAUNAY SYNDROME	0.00075643	0.028378341521295647
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
BOWEN-CONRADI SYNDROME	0.00075643	0.028378341521295647
DISTAL TRISOMY 5Q	0.00075643	0.028378341521295647
PSEUDOTRISOMY 13 SYNDROME	0.00075643	0.028378341521295647
BLOOM SYNDROME	0.00075643	0.028378341521295647
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00075643	0.028378341521295647
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00075643	0.028378341521295647
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.00075643	0.028378341521295647
DYSPLASTIC CORTICAL HYPEROSTOSIS	0.00075643	0.028378341521295647
RING CHROMOSOME 13 SYNDROME	0.00075643	0.028378341521295647
RHIZOMELIC SYNDROME	0.00075643	0.028378341521295647
FONTAINE PROGEROID SYNDROME; FPS	0.00075643	0.028378341521295647
GMS SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP U	0.00075643	0.028378341521295647
CARDIAC LIPIDOSIS, FAMILIAL	0.00075643	0.028378341521295647
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.00075643	0.028378341521295647
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00075643	0.028378341521295647
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.00075643	0.028378341521295647
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.00075643	0.028378341521295647
LETHAL HEMOLYTIC ANEMIA-GENITAL ANOMALIES SYNDROME	0.00075643	0.028378341521295647
FACIOCARDIOMELIC SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 7, PRIMARY, AUTOSOMAL RECESSIVE	0.00075643	0.028378341521295647
FRASER SYNDROME	0.00075643	0.028378341521295647
FRYNS-SMEETS-THIRY SYNDROME	0.00075643	0.028378341521295647
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
GENITOPALATOCARDIAC SYNDROME	0.00075643	0.028378341521295647
133750 EXTRASYSTOLES, MULTIFORM VENTRICULAR, WITH SHORT STATURE, HYPERPIGMENTATIONAND MICROCEPHALY	0.00075643	0.028378341521295647
OCULOPALATOCEREBRAL SYNDROME	0.00075643	0.028378341521295647
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.00075643	0.028378341521295647
CHROMOSOME 1Q21.1 DELETION SYNDROME, 1.35-MB	0.00075643	0.028378341521295647
COFFIN-SIRIS SYNDROME 10; CSS10	0.00075643	0.028378341521295647
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00075643	0.028378341521295647
%270750 SPASTIC PARAPLEGIA 23; SPG23;;SPASTIC PARAPLEGIA WITH PIGMENTARY ABNORMALITIES;;SPASTIC PARAPARESIS, VITILIGO, PREMATURE GRAYING, CHARACTERISTIC FACIES;;LISON SYNDROME	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00075643	0.028378341521295647
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.00075643	0.028378341521295647
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.00075643	0.028378341521295647
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00075643	0.028378341521295647
JUBERG-HAYWARD SYNDROME	0.00075643	0.028378341521295647
JOHNSON NEUROECTODERMAL SYNDROME	0.00075643	0.028378341521295647
PRIMARY PULMONARY HYPOPLASIA	0.00075643	0.028378341521295647
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00075643	0.028378341521295647
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00075643	0.028378341521295647
FANCONI ANEMIA, COMPLEMENTATION GROUP V	0.00075643	0.028378341521295647
207790 ARACHNOID CYSTS, INTRACRANIAL	0.00075643	0.028378341521295647
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00075643	0.028378341521295647
LARYNGEAL ABDUCTOR PARALYSIS-INTELLECTUAL DISABILITY SYNDROME	0.00075643	0.028378341521295647
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00075643	0.028378341521295647
MECKEL SYNDROME, TYPE 4; MKS4	0.00075643	0.028378341521295647
JUNG SYNDROME	0.00075643	0.028378341521295647
XYLT1-CDG	0.00075643	0.028378341521295647
OCULOAURICULOFRONTONASAL SYNDROME	0.00075643	0.028378341521295647
CULLER-JONES SYNDROME; CJS	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.02046708582460892
TRANSALDOLASE DEFICIENCY	0.000545554	0.02046708582460892
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.02046708582460892
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.02046708582460892
RITSCHER-SCHINZEL SYNDROME 1	0.000545554	0.02046708582460892
AUSTRALIA ANTIGEN	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000545554	0.02046708582460892
CURRARINO SYNDROME	0.000545554	0.02046708582460892
RABSON-MENDENHALL SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.000545554	0.02046708582460892
JOUBERT SYNDROME 1	0.000545554	0.02046708582460892
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.02046708582460892
TYSHCHENKO SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.02046708582460892
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.02046708582460892
JOUBERT SYNDROME 35; JBTS35	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.000545554	0.02046708582460892
COFFIN-SIRIS SYNDROME 6; CSS6	0.000545554	0.02046708582460892
TETRASOMY X	0.000545554	0.02046708582460892
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.000545554	0.02046708582460892
CHROMOSOME 9P DELETION SYNDROME	0.000545554	0.02046708582460892
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 2	0.000545554	0.02046708582460892
SEPTOOPTIC DYSPLASIA	0.000545554	0.02046708582460892
3C SYNDROME	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.02046708582460892
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.02046708582460892
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.02046708582460892
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.02046708582460892
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.02046708582460892
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.000545554	0.02046708582460892
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.02046708582460892
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.000545554	0.02046708582460892
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.02046708582460892
SYNDROMIC DIARRHEA	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.000545554	0.02046708582460892
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.02046708582460892
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000545554	0.02046708582460892
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.000545554	0.02046708582460892
WOLMAN DISEASE	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.02046708582460892
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.02046708582460892
CHAR SYNDROME	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.02046708582460892
XIA-GIBBS SYNDROME	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.02046708582460892
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.02046708582460892
HYDROXYKYNURENINURIA	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.02046708582460892
ALG6-CDG	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.02046708582460892
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.02046708582460892
AU-KLINE SYNDROME; AUKS	0.000545554	0.02046708582460892
FRIAS SYNDROME	0.000545554	0.02046708582460892
300270 ADRENOMYODYSTROPHY	0.000545554	0.02046708582460892
MCKUSICK-KAUFMAN SYNDROME	0.000545554	0.02046708582460892
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.02046708582460892
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.02046708582460892
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.02046708582460892
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.02046708582460892
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.02046708582460892
NOONAN SYNDROME 9; NS9	0.000545554	0.02046708582460892
JOUBERT SYNDROME 10	0.000545554	0.02046708582460892
NOONAN SYNDROME 3; NS3	0.000545554	0.02046708582460892
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.02046708582460892
PROPIONIC ACIDEMIA	0.000545554	0.02046708582460892
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.000545554	0.02046708582460892
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
LARSEN-LIKE SYNDROME	0.000545554	0.02046708582460892
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.02046708582460892
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.02046708582460892
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.000545554	0.02046708582460892
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.02046708582460892
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.02046708582460892
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
NOONAN SYNDROME 5; NS5	0.000545554	0.02046708582460892
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.02046708582460892
PSEUDOAMINOPTERIN SYNDROME	0.000545554	0.02046708582460892
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.02046708582460892
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.02046708582460892
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000545554	0.02046708582460892
ICF SYNDROME	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.02046708582460892
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.02046708582460892
INFANTILE DYSTONIA-PARKINSONISM	0.000545554	0.02046708582460892
JOUBERT SYNDROME 6	0.000545554	0.02046708582460892
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.02046708582460892
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.02046708582460892
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000545554	0.02046708582460892
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.02046708582460892
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.02046708582460892
MICROVILLUS INCLUSION DISEASE	0.000545554	0.02046708582460892
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.02046708582460892
ZEBRA BODY MYOPATHY	0.000545554	0.02046708582460892
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.02046708582460892
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.02046708582460892
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.02046708582460892
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.02046708582460892
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.02046708582460892
2Q23.1 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.02046708582460892
EVEN-PLUS SYNDROME	0.000545554	0.02046708582460892
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.02046708582460892
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.02046708582460892
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.000545554	0.02046708582460892
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.02046708582460892
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.000545554	0.02046708582460892
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.000545554	0.02046708582460892
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.02046708582460892
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.02046708582460892
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.02046708582460892
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.02046708582460892
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.02046708582460892
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.02046708582460892
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.02046708582460892
1P21.3 MICRODELETION SYNDROME	0.000545554	0.02046708582460892
CURRY-JONES SYNDROME	0.000545554	0.02046708582460892
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.000545554	0.02046708582460892
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.02046708582460892
JOUBERT SYNDROME 25	0.000545554	0.02046708582460892
HEREDITARY OROTIC ACIDURIA	0.000545554	0.02046708582460892
LAMB-SHAFFER SYNDROME	0.000545554	0.02046708582460892
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.02046708582460892
TARP SYNDROME; TARPS	0.000545554	0.02046708582460892
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.02046708582460892
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.02046708582460892
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.02046708582460892
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.02046708582460892
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.02046708582460892
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.000545554	0.02046708582460892
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.000545554	0.02046708582460892
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.02046708582460892
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.02046708582460892
FRONTOOCULAR SYNDROME	0.000545554	0.02046708582460892
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.02046708582460892
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.02046708582460892
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.02046708582460892
ABETAL34V AMYLOIDOSIS	0.000545554	0.02046708582460892
OGDEN SYNDROME	0.000545554	0.02046708582460892
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.02046708582460892
48,XYYY SYNDROME	0.000545554	0.02046708582460892
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.02046708582460892
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.02046708582460892
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.02046708582460892
OTOFACIOCERVICAL SYNDROME	0.000545554	0.02046708582460892
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.02046708582460892
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.02046708582460892
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.000545554	0.02046708582460892
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.02046708582460892
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.02046708582460892
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.02046708582460892
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000545554	0.02046708582460892
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.000545554	0.02046708582460892
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.02046708582460892
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.02046708582460892
ATELOSTEOGENESIS TYPE III	0.000545554	0.02046708582460892
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.02046708582460892
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.000545554	0.02046708582460892
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.02046708582460892
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.02046708582460892
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.000545554	0.02046708582460892
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.02046708582460892
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.000545554	0.02046708582460892
OCCIPITAL HORN SYNDROME	0.000545554	0.02046708582460892
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.000545554	0.02046708582460892
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.02046708582460892
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.02046708582460892
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.02046708582460892
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.02046708582460892
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.02046708582460892
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.02046708582460892
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.02046708582460892
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.000545554	0.02046708582460892
DISTAL MONOSOMY 9P	0.000545554	0.02046708582460892
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.000545554	0.02046708582460892
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.000545554	0.02046708582460892
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.000545554	0.02046708582460892
DEXTROCARDIA	0.000545554	0.02046708582460892
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.02046708582460892
TRISOMY 12P	0.000545554	0.02046708582460892
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.000545554	0.02046708582460892
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.02046708582460892
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.02046708582460892
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.02046708582460892
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.02046708582460892
GABRIELE-DE VRIES SYNDROME; GADEVS	0.000545554	0.02046708582460892
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.02046708582460892
TEMTAMY SYNDROME	0.000545554	0.02046708582460892
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.02046708582460892
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.02046708582460892
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.02046708582460892
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000545554	0.02046708582460892
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.02046708582460892
THYROID ECTOPIA	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.02046708582460892
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.02046708582460892
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.02046708582460892
JOUBERT SYNDROME 8	0.000545554	0.02046708582460892
JOUBERT SYNDROME 15	0.000545554	0.02046708582460892
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.02046708582460892
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.02046708582460892
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.000545554	0.02046708582460892
CHROMOSOME 16Q22 DELETION SYNDROME	0.000545554	0.02046708582460892
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.02046708582460892
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.02046708582460892
CUTIS LAXA	0.000545554	0.02046708582460892
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000545554	0.02046708582460892
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.02046708582460892
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.02046708582460892
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.02046708582460892
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.02046708582460892
ZECHI-CEIDE SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.02046708582460892
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.02046708582460892
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.02046708582460892
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.02046708582460892
OROTIC ACIDURIA	0.000545554	0.02046708582460892
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.02046708582460892
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.02046708582460892
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.02046708582460892
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.02046708582460892
COLE-CARPENTER SYNDROME	0.000545554	0.02046708582460892
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.02046708582460892
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.02046708582460892
GERODERMA OSTEODYSPLASTICA	0.000545554	0.02046708582460892
NIEMANN-PICK DISEASE, TYPE A	0.000545554	0.02046708582460892
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.02046708582460892
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.02046708582460892
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.02046708582460892
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.02046708582460892
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.02046708582460892
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.02046708582460892
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.020311956543392472
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392472
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
PARIETAL FORAMINA	0.000541419	0.020311956543392472
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392472
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.020311956543392472
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.020311956543392472
ASPARTYLGLUCOSAMINURIA	0.000541419	0.020311956543392472
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392472
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392472
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392472
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.000541419	0.020311956543392472
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392472
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392472
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392472
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392472
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392472
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392472
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392472
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392472
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392472
CROUZON SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392472
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392472
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392472
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392472
EPILEPSY, READING	0.000541419	0.020311956543392472
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392472
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392472
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392472
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392472
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.020311956543392472
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392472
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.000541419	0.020311956543392472
PARTINGTON SYNDROME	0.000541419	0.020311956543392472
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392472
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.000541419	0.020311956543392472
FRAGILE X SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392472
SMITH-KINGSMORE SYNDROME; SKS	0.000541419	0.020311956543392472
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.020311956543392472
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392472
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.020311956543392472
TENORIO SYNDROME; TNORS	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392472
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392472
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.000541419	0.020311956543392472
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 21	0.000541419	0.020311956543392472
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392472
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392472
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392472
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392472
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392472
5Q14.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392472
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392472
THREONINEMIA	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392472
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392472
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392472
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
1Q41Q42 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392472
AICA-RIBOSIDURIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392472
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392472
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392472
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392472
CITRULLINEMIA TYPE I	0.000541419	0.020311956543392472
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392472
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392472
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.020311956543392472
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392472
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392472
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392472
CYSTATHIONINURIA	0.000541419	0.020311956543392472
PGM3-CDG	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392472
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392472
FRYNS SYNDROME	0.000541419	0.020311956543392472
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.020311956543392472
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392472
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.020311956543392472
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392472
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392472
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392472
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA	0.000541419	0.020311956543392472
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392472
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392472
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392472
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.000541419	0.020311956543392472
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392472
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.000541419	0.020311956543392472
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392472
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392472
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392472
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392472
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392472
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.000541419	0.020311956543392472
HEREDITARY HYPEREKPLEXIA	0.000541419	0.020311956543392472
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392472
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392472
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392472
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392472
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392472
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392472
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392472
NASU-HAKOLA DISEASE	0.000541419	0.020311956543392472
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392472
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392472
EPENDYMOMA	0.000541419	0.020311956543392472
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.020311956543392472
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392472
POTOCKI-SHAFFER SYNDROME	0.000541419	0.020311956543392472
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392472
GURRIERI SYNDROME	0.000541419	0.020311956543392472
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392472
PORENCEPHALY	0.000541419	0.020311956543392472
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392472
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392472
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.020311956543392472
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392472
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392472
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392472
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392472
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392472
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392472
ALZHEIMER DISEASE 3; AD	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392472
MOYAMOYA DISEASE	0.000541419	0.020311956543392472
MICROSPORIDIOSIS	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.020311956543392472
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392472
PINEOBLASTOMA	0.000541419	0.020311956543392472
SUBEPENDYMOMA	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392472
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392472
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392472
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.000541419	0.020311956543392472
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392472
20Q13.33 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392472
KUFOR-RAKEB SYNDROME	0.000541419	0.020311956543392472
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392472
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392472
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392472
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392472
ZLOTOGORA-OGUR SYNDROME	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392472
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.020311956543392472
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392472
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.000541419	0.020311956543392472
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392472
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392472
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392472
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392472
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392472
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392472
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392472
DEND SYNDROME	0.000541419	0.020311956543392472
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.020311956543392472
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392472
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392472
RABIES	0.000541419	0.020311956543392472
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.000541419	0.020311956543392472
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.000541419	0.020311956543392472
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.000541419	0.020311956543392472
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.000541419	0.020311956543392472
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392472
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392472
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392472
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392472
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392472
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392472
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.020311956543392472
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392472
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.020311956543392472
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392472
HEREDITARY COPROPORPHYRIA	0.000541419	0.020311956543392472
AUTISM	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392472
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392472
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.000541419	0.020311956543392472
SCRUB TYPHUS	0.000541419	0.020311956543392472
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.000541419	0.020311956543392472
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392472
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392472
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392472
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392472
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392472
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.020311956543392472
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392472
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392472
ISOLATED SPINA BIFIDA	0.000541419	0.020311956543392472
COFFIN-SIRIS SYNDROME 8; CSS8	0.000541419	0.020311956543392472
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392472
47,XYY SYNDROME	0.000541419	0.020311956543392472
ALEXANDER DISEASE	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392472
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392472
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392472
PORPHYRIA VARIEGATA	0.000541419	0.020311956543392472
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392472
MOGS-CDG	0.000541419	0.020311956543392472
ALG9-CDG	0.000541419	0.020311956543392472
MPDU1-CDG	0.000541419	0.020311956543392472
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392472
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392472
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392472
HISTIOCYTOID CARDIOMYOPATHY	0.000541419	0.020311956543392472
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, INFANTILE	0.000541419	0.020311956543392472
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392472
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.000541419	0.020311956543392472
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392472
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392472
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392472
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392472
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.020311956543392472
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.000541419	0.020311956543392472
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392472
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392472
17Q24.2 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS	0.000541419	0.020311956543392472
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392472
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392472
NOONAN SYNDROME 7; NS7	0.000541419	0.020311956543392472
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392472
DIAMINOPENTANURIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392472
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392472
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392472
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.020311956543392472
FRONTAL ENCEPHALOCELE	0.000541419	0.020311956543392472
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.020311956543392472
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392472
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392472
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.020311956543392472
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392472
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392472
MEGALENCEPHALY WITH DYSMYELINATION	0.000541419	0.020311956543392472
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392472
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392472
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392472
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392472
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392472
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392472
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392472
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392472
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392472
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.020311956543392472
EPILEPSY-TELANGIECTASIA	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392472
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392472
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392472
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392472
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392472
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.020311956543392472
LHERMITTE-DUCLOS DISEASE	0.000541419	0.020311956543392472
ONDINE SYNDROME	0.000541419	0.020311956543392472
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392472
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
CENTRONUCLEAR MYOPATHY	0.000541419	0.020311956543392472
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392472
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392472
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392472
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392472
CRYPTOCOCCOSIS	0.000541419	0.020311956543392472
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392472
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392472
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392472
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392472
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.020311956543392472
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.000541419	0.020311956543392472
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392472
ROSAÃ-DORFMAN DISEASE	0.000541419	0.020311956543392472
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392472
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392472
